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ABBREVIATIONS
Abbreviations used in this thesis are as laid down in the 
Biochemical Journal Instructions to Authors (revised, 1975) with 
the following additions.
a) General
ATA Aurintricarboxylic acid
BSS Balanced salt solution
DATD Diallyltartardiamide
l~dimethylaminonapthalene-5-sulphonyl chlorideDansyl
chloride
DNS
DMSO
DTT
EGTA
FCS
MDL
NaDOC
NP-40
NRS
PAGE
PAG
PBS
PBSA
PCI
PEB
poly(A) RNA
Dansyl (when referring to amino acids)
Dimethyl sulphoxide
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Ethyleneglycol-biS“ (3 aminoethyl ether)
NN' tetraacetic acid
Foetal calf serum
Messenger-dependent lysate
Sodium deoxycholate
Nonidet P-4o (Non-ionic detergent)
Normal rabbit serum 
Polyacrylamide gel electrophoresis
Polyacrylamide gel
Phosphate buffered saline
++ ++
Phosphate buffered saline (no Ca or Mg ) 
Phenol/Chloroform/lsoamyl alcohol 
Phenol extraction buffer
RNA species containing poly(A) sequences at 
their 3' termini - functionally equivalent 
to mRNA in this study
PPO 2,5 diphenyloxazole
a )____General (Contd) : -
SDS Sodium dodecyl sulphate
TCA Trichloroacetic acid
TEiy®D NN N'N' tetraraethylethylenediamine
TMV Tobacco mosaic virus
TPCK L~.l-Tosylamlde-2~*phenylethyl
-chlorometiiyl ketone
b )____Immunological
Ig Immunoglobulin
H Ig heavy chain
L Ig light chain
■^ 2a' ^2b '
)
) classes of Ig H chains 
)
)
)
) classes of Ig L chains
Af, A^ )
pre L precursor to Ig L chain
a- “• anti-
CONTENTS
Page
TITLE i
ACKNOWLEDGEMENTS Ü
ABBREVIATIONS i ü
CONTENTS iv
SUMMARY V
Page
INTRODUCTION
1. MURINE MYELOMA CELL LINES 1
1.1. Introduction 1
1.2. Origins of plasmacytomas 2
1.3. Maintenance of plasmacytomas 3
1.4. Differences between plasma cells and plasmacytomas 4
2. MESSENGER RNA (mRNA) 5
2.1. The mRNA hypothesis 5
2.2. Early criteria for identification of mRNA 5
2.3. Recent developments in mRNA isolation 7
2.3.1. Cell-free systems 7
2.3.2. Poly(A) at 3' terminus of mRNA 8
2.3.3. Purification of mRNA using poly(A) sequence 9
2.4. Purification of individual mRNA species 9
2.4.1. Purification prior to poly(A) enrichment 9
2.4.2. Purification subsequent to poly(A) enrichment 10
3. CELL-FREE SYSTEMS 10
3.1. Introduction 10
3.2. Reticulocyte lysate 11
Page
3.3. Wheat germ 13
3.4. Krebs Ascites 14
3.5. Other cell-free systems 15
4. REGULATION OF PROTEIN SYNTHESIS 16
4.1. Introduction 15
4.2. General control by substrate availability 17
4.2.1. Protein synthetic machinery 17
4.2.2. Low MW components 18
4.2.3. Specific factors ' 18
4.2.4. Activation/inactivation of factors 19
4.3. Control exerted on the mRNA itself 20
4.3.1. Separation of mRNA from protein synthetic
machinery 20
4.3.1.1. Exit from the nucleus 20
4.3.1.2. raRNP particles 20
4.3.2. Processing of the mRNA prior to translation 21
4.3.3. Inherent structural features of the mRNA 22
4.3.3.1. 5' terminus 22
4.3.3.2. 3' terminus 23
4.4. Control of the interaction between mRNA and
the protein synthetic machinery -
kinetic factors 25
4.4.1. Initiation 25
4.4.1.1. The Lodish Model 25
4.4.1.2. Support for the Lodish Model 25
4.4.1.3. Opposition to the Lodish Model 27
4.4.1.4. Myeloma cells 29
Page
4.4.2, Elongation/termination? 29
4.5. Control of the rate of degradation of mRNA's 30
4.6. Conclusion 31
5. FACTORS AFFECTING THE SECRETION OF PROTEINS 32
5.1. Introduc tion 3 3
5.2. The "signal" hypothesis 34
5.3. The use of cell-free systems 35
5.3.1. Cell-free systems - advantages over
cellular studies' 36
5.3.2. Cell-free systems - the synthesis of
precursors 37
5.4.1. Existence of putative precursors to
many secreted proteins 38
5.4.2. Ig L chain synthesis in vitro 39
5.4.3. Ig H chain synthesis in vitro 40
5.5. Exceptions to the "signal" hypothesis 44
6. CONCLUDING REMARKS 46
MATERIALS
1. GENERAL 47
1.1. Radiochemicals 47
1.2. Chemicals for Liquid Scintillation Counting 47
1.3. Enzymes 47
1.4. Nucleic Acids 48
1.5 Photographic materials 48
1.6. Other materials 48
2. TISSUE CULTURE MATERIALS 49
2.1. Cell lines 49
2.2. Media 49
METHODS
1. TISSUE CULTURE 51
1.1. Maintenance of cell lines 51
Page
1.2. Counting cells and Estimation of Viability 51
1.3. Harvesting cells 52
2. PREPARATION OF RADIOACTIVELY LABELLED Ig. 52
2.1. General 52
2.2. Cell labelling conditions 53
2.3. Preparation of intra- and extra-cellular
Ig-containing fractions 54
2.4. Cell labelling in the presence of
2-deoxyglucose 54
3. PREPARATION OF POLYSOMES FROM MURINE MYELOMA
TISSUE CULTURE CELLS 55
3.1. Precautions against ribonuclease contamination 55
3.2. Solutions 56
3.3. Preparation of polysomes 57
3.4. Sucrose gradient sedimentation 59
3.5. Polysome integrity 60
4. PREPARATION OF"TOTAL POLYSOMAL RNA 60
4.1. Solutions 61
4.2. Ribonuclease precautions 61
4.3. Extraction of RNA 61
5. ISOLATION OF POLY(A)-CONTAINING RNA 62
5.1. Solutions 62
5.2. Procedure 63
6. RABBIT RETICULOCYTE LYSATE 64
6.1. Preparation of rabbit reticulocyte lysate 64
6.1.1. Induction of reticulocytosis 64
6.1.2. Estimation of the degreecf reticulocytosis
induced 64
6.1.3. Preparation of lysate 65
Page
6.1.4, Preparation of reticulocyte polysomes 56
6.1.5. Preparation of high salt wash factors 66
6.2. Reticulocyte lysate cell-free protein
synthesizing assays 67
6.2.1. Solutions 6 7
6.2.2. Assay conditions 67
7. THE MESSENGER DEPENDENT LYSATE (M.D.L.) 68
7.1. Preparation of M.D.L. 68
7.1.1. Standard solutions' 68
7.1.2. Preparation of M.D.L. 69
7.2. M.D.L. cell-free protein synthesis assays 7o
8. DETECTION OF RADIOACTIVE INCORPORATION 71
8.1. General Methods of preparing samples
for Scintillation Spectrometry 71
8.1.1. Samples on paper discs 71
8.1.2. Liquid samples 72
8.1.3. Gel Slices 72
8.2. Detection of incorporation of radioactivity
by reticulocyte lysates or M.D.L.'s. 73
8.2.1. Paper disc/toluene/PPO detection method 73
8.2.2. Triton/toluene/PPO detection method 74
8.3. Fluorographic detection of radioactivity
(Bonner and Laskey, 1974) 74
8.3.1. Polyacrylamide gels 74
8.3.2. Thin layer chromatographic plates 76
8.3.3. Quantitative analysis of Fluorographs 76
9. S.D.S. POLYACRYLAMIDE GEL ELECTROPHORESIS (PAGE) 76
9.1. Polyacrylamide tube gels 76
Page
9.1.1. Standard solutions 76
9.1.2. Pouring gels 77
9.1.3. Sample preparation 78
9.1.4. Electrophoresis conditions 78
9.1.5. Gel slicing 78
9.2. Polyacrylamide slab gels 79
9.2.1. Standard solutions 79
9.2.2. Preparation of gel solutions 80
9.2.3. Polyacrylamide slab gel apparatus 81
9.2.4. Pouring the gel 82
9.2.5. Preparation of samples 83
9.2.6. Electrophoresis conditions 84
9.2.7. Elution of polypeptides from polyacrylamide gels 84
10. PREPARATION AND USE OP DEXTRAN GEL (SEPHADEX) COLUMNS 85
10.1. Materials 85
10.2. Preparation and pouring of gels 85
10.3. Separation of Ig H and L chains on G-lOO
Sephadex 86
10.4. G-lO; G-25 Sephadex 87
11. IMMUNE PRECIPITATION TECHNIQUES 87
11.1. Antisera 87
11.2. Precipitation techniques 88
11.2.1. Direct 88
11.2.2. Indirect 89
12. N-TERMINAL AMINO GROUP ANALYSIS OF PROTEINS 90
12.1. Dansylation procedure 90
12.2. chromatography of dansylated amino acids
on polyamide layer sheets 90
Page
12.3. Non-N“terminal dansylated derivatives 91
13. PROTEOLYTIC CLEAVAGE BY TRYPSIN 92
13.1. Conditions for proteolysis 92
13.2. Separation of proteolytically generated peptides 93
13.3. Detection of peptides 94
13.3.1. Ninhydrin - cadmium acetate 94
13.3.2. Fluorographic detection of radioactivity on
cellulose sheets ■ 95
RESULTS
1. POLYSOME YIELDS USING THE METHOD OF BENNETT ET 96
2. TRANSLATION OF MYELOMA POLYSOMES IN THE RETICULOCYTE
LYSATE 97
3. POLYSOME-DEPLETED RETICULOCYTE LYSATE 103
4. MESSENGER-DEPENDENT LYSATE (M.D.L.) - OPTIMISATION OF
CONDITIONS 104
4.1. Incorporation of radioactivity 104
4.2. Determination of optimal conditions for
translation of myeloma mRNA 105
4.3. Endogenous levels of methionine 107
4.4. Dose response to myeloma mRNA llO
4.5. Myeloma mRNA in the M.D.L. - rounds of
translation 111
5. CELL LABELLING EXPERIMENTS 114
5.1.1, Pi.17 cells labelled with L-(^H) leucine 114
35
5.1.2. Pi.17 cells labelled with L-( S) methionine 114
5.2.1. 5563 cells labelled with L-(^H)leucine 115
35
5.2.2. 5563 cells labelled with L-( S) methionine 115
35
5.2.3. 5563 cells labelled with L-( S) methionine
in presence of 2-deoxyglucose 115
Page
35
5.3. SAMM 368 cells labelled with L~( S) methionine 116
6. RELATIVE PRODUCTION OF Ig H AND L CHAINS IN CULTURED CELLS 116
6.1. Introduction 116
35
6.2. Incorporation of L-( S) methionine into
specifically precipitable material 117
6.3. Effect of cycloheximide on incorporation of
radioactivity into specifically
precipitable material 118
6.4. Comparison of specific precipitation by
aPl and aK antisera 118
6.5. Methods of solubilisation of
immunoprecipitates 119
6.6. Effect of cycloheximide on Ig synthesis
relative to total protein synthesis 120
7. TRANSLATION IN M.D.L. 121
7.1. Comparison of endogenous products
of reticulocyte lysate and M.D.L, 121
7.2. Comparison of translation of myeloma
polysomes and myeloma poly(A) RNA 122
7.3. Comparison of poly(A) RNA-directed products
with cellular products 123
7.4. Methods for identification of Ig precursors 125
8. IMMUNOPRECIPITATION 126
8.1. Optimisation of immunoprécipitation 126
8.1.1. Optimisation of indirect immunoprécipitation 127
8.1.2. Optimisation of direct immunoprécipitation 132
8.2.1. Direct immunoprécipitation of Pi.17 and
5563 myeloma mRNA - directed products
in the M.D.L. 134
8.2.2. Indirect irnmunoprecipita.tion of Pi. 17 and
5563 myeloma mRNA - directed products
in the M.D.L. 135
8.2.3. Comparison of direct and indirect immuno­
précipitation of M.D.Lr synthesized
material 136
Page
8.2.4. Comparison of levels of specifically
precipitable material from M.D.L. assays
containing myeloma polysomes and from
myeloma cells labelled in culture 137
9. EFFECT OF INITIATION INHIBITORS ON THE RELATIVE SYNTHESIS
OF H AND L CHAINS IN THE M.D.L. 138
9.1, Effect of aurintricarboxylic acid (ATA)
on the H:L chain ratio 139
9.2. Effect of pactamycin on the H:L chain ratio 141
10. COMPARISON OF CELL-FREE PRODUCTS OF POLYSOMES FROM
PI.17.1 AND PI.17.4 CELLS 142
11. EFFECT OF 2-DEOXYGLUCOSE ON MYELOMA Ig PRODUCTS 143
12. TRANSLATION OF POLYSOMES FROM SAMM 368 IN M.D.L. 144
13. N-TERMINAL AMINO ACID DETERMINATION OF 5563
PRE L CHAIN 146
13.1. Separation of dansylated amino acid markers
on polyamide sheets 147
3513.2. Dansylation of L-( S) methionine 147
35
13.3. Behaviour of L-( S) methionine on
polyamide sheets 148
13.4. Dansylation of micrococcal nuclease 148
13.5. Dansylation of 5563 H and L chains 148
13.6. Dansylation of 5563 pre L chain 149
14. TRYPTIC MAPPING 150
14.1. General 150
14.2. Peptide mapping of cellular 5563 H and
L chains 150
14.3. Peptide mapping of putative 5563 H and L
chains produced in the M.D.L. 151
15. ATTEMPTED IMPROVEMENTS OF THE M.D.L. CELL-FREE SYSTEM 152
15.1. Rationale 152
Page
15.2.
15.3.
15.4.
15.5.
15.6.
15.7.
15.8.
15.9.
15.10.
15.11.
15.12.
15.13. 
DISCUSSION 
REFERENCES
Preparation and running of gel filtration 
columns
Preparation of M.D.L. from column eluant 
(cM.D.L.)
Effect of G-25 Sephadex gel filtration on 
reticulocyte lysate
Incorporation of radioactivity in column 
eluant M.D.L. (cM.D.L.)
Effect of an inhibitor of initiation on 
radioactive incorporation by cM.D.L. 
with exogenous polysomes
Effect of tRNA on incorporation
Experiments with G-10 cM.D.L.
Experiments with G-25 coarse cM.D.L.
Incorporation of radioactivity by M.D.L.: 
cM.D.L, mixtures
Dialysis of M.D.L.
Gel analysis of cM.D.L. products
Conclusion
153
154
155 
157
160
161
161
163
166
167
168
169
170 
195
SUMMARY
Studies on the translation of mRNA of several secreted 
proteins and polypeptides in heterologous cell-free protein 
synthesizing systems have indicated that such secreted proteins 
are synthesized in vitro as precursor molecules. These 
precursors contain additional amino acid residues at their 
N-termini which appear to be rapidly removed vivo. In 
cell-free systems, mRNA from Ig-secreting myeloma cells, which 
generally produce and secrete Ig H and L chains, has been shown 
to produce a higher MW precursor to L chain. Much less 
evidence exists for the presence of a precursor to H chains 
in vitro. Production of precursors to H and L chains of Ig was 
investigated in this project, using a recently developed cell- 
free system.
The presence of two major polypeptide products of 
myeloma mRNA also allowed the relative effect of various 
inhibitors of protein synthesis on different mRNA's to be 
investigated.
Cell-free translation of both polysomes and poly(A) RNA 
from several myeloma cell lines was investigated in this project.
Ig H and L chains were identified as products of cell- 
free translation of PI.17 polysomes in rabbit reticulocyte 
lysate by specific immunoprécipitation.
More rigorous identification, involving both direct and 
indirect immunoprécipitation and comparison of producing and 
non-producing cell lines was carried out in a messenger- 
dependent lysate system.
From/
From these studies the following conclusions were drawn :-
1. In all cell lines investigated, Ig L chain was synthesized 
as a higher MW precursor, when produced in the cell-free system.
In one cell line (5563) further characterisation by tryptic 
mapping showed the cell-free product to be related to the 
cellular product. This precursor also did not appear to have 
methionine as its N-terminal amino acid.
2. In all cell lines investigated, H chains, whether of
type a, or y^^, appeared to be synthesized in cell-free systems
with a lower apparent MW than the appropriate cellularly 
synthesized H chain. Inhibition of carbohydrate addition 
intracellularly mimicked this effect in one cell line (5563).
The work in this project left unresolved the question of 
the existence of a precursor to H chains.
Studies on the effect of inhibitors of initiation of 
protein synthesis on cell-free protein synthesis were carried 
out with Pi.17 mRNA. It was concluded that:-
1. Ig H and L chain mRNA's were much more resistant to
inhibition of initiation than other myeloma mRNA's,
2. Ig H chain mRNA was more resistant to inhibition of
initiation than Ig L chain mRNA.
Finally, an improved cell-free protein synthesizing system 
for the translation of polysomes was developed from the existing 
M.D.L. system by removal of endogenous amino acids.
1. Murine myelomas.
1.1. Introduction.
Much of the work discussed in this section has appeared in 
Potter's reviews (1972, 1975).
Myelomas of plasma cells, (plasmacytomas), producing myeloma 
proteins, are derived from mature differentiated lymphocytes which 
normally synthesize and secrete immunoglobulin (Ig) molecules. 
Plasmacytomas generally synthesize, and may secrete, one species 
of Ig molecule (although myelomas derived from lymphocytes at 
earlier stages of lymphocyte differentiation may synthesize and 
secrete more than one Ig species e.g SAMM 368, Results, Section 9 
The Ig produced is generally assumed to be a functional antibody 
but since myelomas apparently arise from previously stimulated 
lymphocytes, the specificity of the antibody is generally unknown.
(In some cases, e.g. MOPC 315, screening studies against a wide 
range of antigenic substances have revealed antibody-like affinities 
for some antigens).
The use of myeloma cell-lines producing and secreting a single 
Ig species has elucidated many features of Ig structure and function, 
most notably on the assembly of Ig molecules, and the amino acid 
sequence of Ig molecules. More recently, in view of their high 
levels of mRNA coding for Ig H and L chains, they have proved 
popular in studies aimed at producing purified mRNA's and studying 
their properties. (Mach, Faust and Vassali, 1972; Swan, Aviv and 
Leder, 1972) . They may also prove useful as model systems for the 
in vivo response to antigen stimulation, i.e. the formation of antibody- 
producing clones, although caution must be used in extrapolating the 
features/
9''
features of a pathological condition to that of the normal dm vivo 
situation. Finally, the use of cDNA probes derived from purified Ig 
mRNA may offer insights into the genetic mechanisms involved in the 
origin of antibody diversity (e.g. numbers of Ig genes, point of 
linking of V and C genes in the genome, etc.). These possibilities 
have been comprehensively reviewed in recent years (Rabbitts and Milstein, 
1977).
1.2. Origins of plasmacytomas.
Plasmacytomas may occur either spontaneously or by chemical 
induction. Chemical induction, whose effect is confined mainly to 
inbred strains of mice such as BALB/c or NZB, involves intraperitoneal 
injection or implantation of some foreign substance, most commonly 
mineral oils or plastic discs. Mineral oil injection at regular 
intervals produces plasmacytoma tumours within 6 months of the 
initial injection in over 60% of BAIB/c mice (Potter, 1972). The 
inducing factors in the oil are believed to be long chain and 
branched aliphatic hydrocarbons, such as pristane,
CH^ CH_I 3 I 3
Pristane52,6,10,14 tetramethyIpentadecane
The high incidence of such mineral oil induced plasmacytomas in BALB/c 
and NZB mice (and the low incidence in other strains of mice) may be 
due to several reasons:-
1) Genetic: BALB/c and NZB mice are much more susceptible to the
change/
change in control within plasma cells resulting in their conversion 
to rapidly proliferating species. This suggests a genetic 
susceptibility in these particular inbred strains. crosses of
BALB/c mice, with other mice which do not produce plasmacytomas in 
response to normal induction methods {pristane, etc), yield hybrid 
mice which are inducible (Potter, 1967).
2. Hormonal factors such as testosterone may also influence plasma 
cell tumour development either positively or negatively.
3. Virus involvement: Plasmacytoma cells from both spontaneous and 
chemically induced tumours have been shown to contain large numbers
of virus-like particles. Although no direct link between such 
particles and tumour formation has been made, it remains possible 
that the pathological transformation of plasma cells to plasmacytoma 
cells may be virus-linked. Moreover, it has been demonstrated (Potter
et al., 1973) that Abelson virus (MLV-A) can dramatically increase 
the occurrence of lymphosarcomas and plasmacytomas in response to 
pristane injection. The tumours also develop in a much shorter time.
1.3. Maintenance of plasmacytomas.
Plasma tumours are normally passaged in mice by insertion of 
small pieces of tumour tissue into previously tumour-free mice. 
Subcutaneous insertion results in the formation of solid tumours. 
Intraperitoneal insertion yields ascites fluid rich in plasmacytoma 
cells. The tumour is normally maintained as a solid tumour; 
ascites fluid is used for preparation of large amounts of secreted Ig. 
The solid tumour generally maintains its synthetic capacity over many 
passages.
Plasma/
Plasma tumour cells may also be adapted to in vitro culture, 
growing in specially prepared medium, usually supplemented with 
serum. Once established, the cell-lines are generally grown in 
suspension. Under these conditions, the cell-line is more prone to 
lose some or all of its Ig synthetic activity, always losing 
synthesis of Ig heavy chain first, than when maintained in solid 
tumour form.
1.4. Differences between plasma cells and plasmacytoma cells.
Differences exist between the normal and tumour cells which 
must be borne in mind when extrapolating data from tumour cells to 
the ^  vivo situation.
1) Mature plasma cells are non-proliferative whilst tumour cells
have generation times of as little as 12 hours.
2) Plasma cells are diploid; tumour cells are oligoploid, varying
between hyperdiploid and hypertetraploid, with a tendency to tetraploidy.
3) Tumour cells are well-characterised as regards production levels,
balance (or imbalance) of H and L chain synthesis; plasma cells are
not extensively characterised in this manner. It may not be valid 
to assume that what holds for tumour cells will hold for plasma cells.
In this study, two tissue culture cell lines were extensively 
utilised. One, (X5563) arose spontaneously in a C3H mouse. It 
has been maintained as a tumour and as a cell line continuously for 
almost twenty years (see Materials and Methods for details) without 
change of immunoglobulin synthesized. The other, AdjPCS (Pi.17) 
was mineral oil-induced in a BALB/c mouse. This line has recently 
been/
been re-cloned (T.R. Mossman, unpublished work) and clones producing 
either high levels of Ig or L chains only were isolated and adapted 
to large-scale culture (Pi.17.1 and Pi.17.4) (see Materials and 
Methods).
2 o_____Messenger RNA (mRNA) .
2.1. The messenger RNA hypothesis.
•The formulation of the messenger RNA hypothesis (Jacob and 
Monod, 1961) was swiftly followed by demonstrations of the existence 
of messenger RNA (mRNA) species in prokaryotic organisms (Nathans 
et al., 1962 and others). Debate as to the nature and even existence 
of mRNA in eukaryotic organisms, however, continued throughout the 
1960's (see Singer and Leder, 1966). Most of the controversy arose 
from the lack of clearly defined criteria for the isolation and 
identification of mRNA species. This, coupled with their occurrence 
in relatively low amounts in cells, compared to other RNA species, 
made their isolation, even in impure form, difficult. (In HeLa 
cells the relative proportions of mRNA, rRNA, tRNA and nuclear RNA 
have been measured as 3:79:12:5 approximately by Darnell, 1968).
2.2. Early criteria for identification of mRNA.
Most early attempts to distinguish mRNA from other RNA species 
were hampered by the fact that the criteria used to identify mRNA 
were not exclusive properties of mRNA. Base composition studies 
(Darnell, 1968), using the supposed "DNA-like" base composition of 
mRNA/
mRNA, and hybridisation data studies were both prone to difficulties 
in interpretation due to the problems in removing contaminating RNA 
species.
Use of the inhibitor of rRNA synthesis, Actinomycin D, in 
pulse labelling experiments proved more fruitful. Using low levels 
(0.04yg/ml) to block synthesis of rRNA, Penman et al., 1968 demonstrated 
the appearance in the cytoplasm of HeLa cells of low levels of radio­
active ly labelled RNA species. These species were found to associate 
with polysomes.
Association of RNA species with polysomes was another criterion 
used for identifying mRNA species. Electron microscopic investigations 
(most convincingly, those of Rich ejt ad. , 1963 and of Mathias et al. , 
1963) had revealed the existence of thin threads of material joining 
linear arrays of ribosomes from both eukaryotic and prokaryotic 
sources. The dimensions of these threads were consistent with those 
of RNA. Studies by Gierer (1963) had implicated mRNA in the 
formation of ribosome aggregates which could incorporate amino acids.
Disruption of polysomes by the addition of metal-ion chelating 
agents, e.g. EDTA (Chantrenne ejb ad., 1967; Darnell, 1968; Labrie,
1969; Penman ad., 1968; Lebleu et ad., 1971) or by run-off due
et al =■
to addition of puromycin (Darnell, 1968; PenmanK 1968; Blobel, 1972) 
yielded RNA species which could be purified of ribosomal contamination. 
Using polysomes isolated from cells producing no predominant protein 
species, the range of size of released RNA was wide^ In HeLa cells 
it was found to be 8S - 308 (Penman e^ ad., 1968) . Polysomes from 
reticulocytes, which produced mainly globin, however, were found to 
release a fairly discretely sedimenting 98 species (Chantrenne et al., 
1967/
1957 and others).
2.3. Recent developments in mRNA isolation.
As has been noted in two recent reviews (Mathews, 1974;
aj V-)
Brawerman, 1974) two major breakthroughs allowed the isolation and 
evaluation of pure mRNA on a relatively straightforward basis.
2.3.1. Eukaryotic cell-free protein synthesizing systems.
The first of these advances was the demonstration of the 
translation of 9S RNA,isolated from mouse reticulocytes by EDTA 
release,in a heterologous eukaryotic cell-free protein synthesizing 
system derived from rabbit reticulocytes (Lockard and Lingrel, 1969; 
Lingrel ejt ad., 1971) . Previously, only synthetic polynucleotides 
e.g. poly(U) had been shown to be translated in eukaryotic cell-free 
systems (Arnstein, Cox and Hunt, 1962; Arlinghaus and Schweet, 1962; 
Williamson et ad., 1967). Earlier work had attempted to demonstrate 
mRNA activity in cell extracts by translation in cell-free systems 
(Arnstein ^t ad. , 1964; Knip et. ' 1964) . Since the RNA species 
and cell-free system used had both been derived from rabbit 
reticulocytes, however, stimulation could not be unambiguously 
attributed to the translation of exogenous mRNA.
Prokaryotic cell-free systems, such as that described by 
Nirenberg et al., 1963, had been stimulated by the addition of 
eukaryotic mRNA-like species but had not yielded identifiable poly­
peptide products (Hardesty et ad., 1963; Schaeffer ^t ad., 1964) . 
Such/
Such lack of success may have been a combination of imperfect raRNA 
isolation techniques and of incompatibility between eukaryotic mRNA 
and prokaryotic protein synthetic machinery. Several eukaryotic 
cell-free systems have been subsequently developed (see Introduction, 
Section 3). The translation of "mRNA-like" species into identifiable 
polypeptides provided the one unambiguous criterion for the identification 
of mRNA.
2.3.2. Poly(A) as 3' terminus of mRNA.
Secondly, following the initial reports of Kates, 1970, and 
Lira and Canellakis, 1970, it was established by several groups that 
most eukaryotic mRNA's (as well as several viral RNA's) can be 
identified by the presence of regions of nucleotide sequence consisting 
predominantly, although not necessarily exclusively (Burr and Lingrel,
1971) of adenine nucleotides (Mendecki et al., 1972; Adesnik et al., 
1972; Molloy et al., 1972, also Kates, 1974 for review). Later work 
established that the adenine-rich or poly(A) sequence was to be found 
at the 3' end of the mRNA molecule (Mendecki et al., 1972) and that 
its length was between 150 and 200 nucleotides (Mendecki et ad., 1972; 
Nakazato ^  , 1973). This sequence is generally thought to be
added post-transcriptionally (Darnell et. .ËÎL' • .
The possible roles of the poly(A) sequence in control of mRNA 
translation will be discussed in Section 4.3.3.2 of the Introduction.
2.3.3./
2.3.3. Purification of mRNA using the poly(A) sequence.
The poly(A) sequence on mRNA has served as a basis for 
purification of mRNA both in phenol extraction techniques (Brawerman 
et al., 1972) and in methods utilising its affinity to immobilised 
polynucleotides such as Poly(U) (Adesnik e^ ad., 1972) or oligo(dT)
(Swan et al., 1972). These extraction methods have been recently 
reviewed by Brawerman, 1974 and Mathews, 1974. By these methods cellular 
mRNA can be recovered in a purified form, essentially free from rRNA 
or tRNA contamination.
2,4* Purification of individual mRNA species.
2.4.1. Purification prior to poly(A)-based enrichment.
Several properties of polysomes have been used to enrich 
preparations for particular mRNA's. Preliminary purification of 
mRNA has involved fractionation of cellular polysomes on the basis 
of size (Heywood and Nwagwa, 1969). Polysome size is roughly ^
proportional to the size of protein coded for by the mRNA. This rule 
does not, however, hold true in all cases (Hunt et al., 1968). This 
technique is useful when attempting to isolate mRNA's which are very 
large or very small and whose polysomes therefore lie outside the 
normal size range of polysomes.
Another widely exploited technique has been the isolation of 
specific mRNA's by antibody precipitation of their polysomes.
This makes use of the antigenicity of the nascent polypeptides 
distributed along the polysomes. It has been studied most thoroughly 
by Schimke and co-workers (Rhoads et al. , 1971; Palmiter et al. , 197^ 
Palacios et al., 1973) . In spite of many problems related to non­
specific/
wspecific interaction, trapping of non-specific polysomes and nuclease 
activity in antibody preparations, it has been used to isolate a number 
of mRNA species, such as ovalbumin (Rhoads et , 1971 et seq;
Schütz ^t ad., 1977), catalase and serum albumin (Uenoyama and Ono,
1972), Ig L chain (Delovitch et ad., 1972; Schechter, 1974), vitellogenin 
(Wetekam et ad.,1975), or histone H5 (Scott et al., 1975). Polysomes 
detected gem:ally show a wide range of size (Berridge ^  al., 1976) but 
poly(A)RNA isolated from them shows a discrete size on PAGE (Palacios 
et ^ . , 1973; Delovitch et , 1972). This may reflect heterogeneity 
in polysome size for individual mRNA's.
2.4.2. Purification subsequent to poly(A)-based enrichment.
Poly(A) RNA can be purified of remaining contaminating species 
(rRNA, tRNA) and individual mRNA species isolated by standard sucrose 
gradient centrifugation, and PAGE techniques. Globin mRNA, for 
example, has been partially separated into a and 3 globin mRNA's by 
electrophoresis in fully denaturing conditions using formamide-r 
polyacrylamide gels (Morrison et al., 1974). Such separation is not, 
however, necessarily complete due to poly(A) size heterogeneity and 
complete separation of a and 3 globin mRNA's required removal of the 
poly(A) sequence (Maniatis ejt a^., 1976). Such procedures may 
prove necessary for all mRNA's.
3. Eukaryotic cell-free protein synthesizing systems.
3.1. Introduction.
The use of cell-free protein synthesizing systems derived from 
eukaryotic/
eukaryotic cells has increased rapidly in the last ten years. Such 
systems provide a means of characterising non-homologous mRNA preparations 
and allow the polypeptide products coded for by such mRNA's to be 
assayed both qualitatively and quantitatively. This can be done under 
controlled conditions in the absence of some of the possible constraints 
which operate on their translation ^  vivo. They also allow the 
investigation of the effect of controlled changes in various physical 
parameters (salt concentration, pH, temperature, inhibitors) whose effect 
is difficult to interpret vivo. In vivo, factors such as membrane 
permeability, continued transcription of RNA in the nucleus and the 
operation of regulatory mechanisms within the cell combine to complicate 
interpretation of simple changes in the cellular environment.
Effective cell-free systems should meet (in part or in whole) the 
following criteria;-
1. Non-limiting levels of substrates and intact protein synthetic
apparatus.
2. Low levels of endogenous activity.
3. Repeated faithful translation of added mRNA.
4. Reproducibility of preparation.
Several cell-free systems have been developed. The most 
widely used of these are discussed below.
3.2. Reticulocyte lysate.
The reticulocyte lysate system originating from work on whole 
reticulocytes by Borsook's group (Borsook et al., 1957; Lingrel 
et al., 1963) , was first described by Lamfrom and Knopf (1964) . It 
was not, however, until the work of Adamson ^ _ a l . , (1968> with the 
introduction of haemin at an early stage in the preparation,that 
sustained/
sustained protein synthesis was achieved with the system. Using 
this system, Lockard and Lingrel (1969) first demonstrated 
unambiguously the translation of eukaryotic mRNA in a heterologous 
cell-free system. The system, consisting of cytoplasm from lysed 
reticulocytes (usually collected from rabbits or mice suffering from 
chemically induced anaemia) is generally supplemented with amino acids, 
salts and an energy source (e.g. creatine phosphate/creatine kinase). 
The addition of low levels of haemin to the system allows relatively 
long incubations without inactivation of protein synthesis (see 
Introduction, Section 4.2,4.).
The system has been shown to be very efficient in translating 
added mRNA. Palmiter, for example, calculated that each ovalbumin 
mRNA was translated between 18 and 47 times during incubation in a 
rabbit reticulocyte lysate (Palmiter, 1973), This indicated a 
substantial amount of re-initiation of translation by the endogenous 
ribosomes.
The major disadvantage of the reticulocyte lysate was, until 
recently, the presence of large quantities of endogenous mRNA (in 
particular, globin mRNA). Added mRNA had to compete for substrates, 
ribosomes, etc., against this mRNA, under conditions which would 
probably favour the endogenous mRNA. The recent modification of 
the system described by Pelham and Jackson (1976) has removed this 
disadvantage. Another drawback in radioactive labelling experiments 
is the existence of large pools of endogenous unlabelled amino acids. 
These dilute the specific activity of the added radioactive amino 
acid and hence reduce the amount of radioactivity incorporated.
Whilst this is, to some extent, compensated for by the high efficiency 
of/
- f
of translation, it nevertheless poses problems when trying to work 
with gel systems, where the capacity of the gel is limited by 
protein weight. Attempts to overcome this problem were made in 
the course of the present work.
3.3. Wheat germ system.
Two methods of preparing a cell-free system from wheat germ 
have been developed by Shih and Kaesberg, 1973,(using wheat germ 
embryos),and by Roberts and Paterson, 1972,(using whole wheat germ), 
respectively. The method of Shih and Kaesberg involves isolating 
whole embryos of wheat germ by flotation in organic solvents to remove 
chaff. As such its reproducibility is variable and its preparation 
rather tedious. The more widely used system (Roberts and Paterson,
1972) was developed from methods first applied to peanut cotyledons, 
(Marcus and Feeley, 1964) and subsequently adapted for a number of 
other cell sources, such as mouse ascites tumour cells (McDowell 
et al., 1972) . The preparation involves the rupture of wheat germ 
cells in a buffered salt solution by grinding wth sand.
Centrifugation removes large debris and the cytoplasmic extract is 
purified further by passing over a G-25 Sephadex column.
The column eluant fraction is normally supplemented with added 
amino acids, salts, and energy (creatine phosphate/ kinase; ATP;
GTP). A pre-incubation step is often included after the initial 
centrifugation step to lower background incorporation.
For many small size mRNA's, the wheat germ system is the system 
of choice for translation. Low background levels of incorporation 
are/
î
are combined with high levels of incorporation of radioactivity due 
to the absence of large endogenous amino acid pools. Much of the 
work which revealed the existence of precursor molecules to 
polypeptide hormones was carried out using the wheat germ system 
(see Introduction, Section 5) .
Unfortunately, the system has a tendency to cause premature 
termination of translation, especially with non-viral eukaryotic 
mRNA and particurly with longer mRNA's, Even short mRNA's are 
often only partially translated yielding a spectrum of complete and 
partially complete polypeptides (see, for example, Bursteia 
1976^ This drawback has tended to lessen the effectiveness of the 
system. Moreover, the activity of the system varies with wheat 
germ from different sources (Marcu and Dudock, 1974). 
Consequently, the system, whilst very effective at optimum can be 
unreliable and will not necessarily reflect the translational 
capacity of an unfractionated mRNA mixture.
3.4. Ascites cell-free systems.
Cell-free systems have been prepared from Krebs II (Mathews 
and Korner, 1970) and Ehrlich (Green et ad., 1976), ascites tumour 
cells by a method closely related to that used in preparing the 
wheat germ system. The system often requires supplementation by 
heterologous tRNA (Aviv et al., 1971: Metafora et , 1972).
It similarly offers lower background incorporation and high levels 
of incorporation of radioactivity. Its rate of translation, 
however, is much lower than that found in the reticulocyte lysate 
system/
system (Osborn and Mathews, 1973) . Moreover, it also suffers from 
premature termination problems (Swan, Aviv and Leder, 1972; Schechter 
et al., 1974) leading to synthesis of a range of polypeptides from 
full-size down. These have been shown, in the case of Ig L chain, 
to contain identical N-terminal sequences and hence presumably have 
varying lengths of polypeptide depending on the point of termination. 
Moreover, as has been conclusively demonstrated by Boime elb a^. , 1977, 
and implied by Swan et al., 1972 and Milston et al., 1972, Krebs ascites 
cell-free systems are often contaminated by variable levels of 
membrane fragments. These tend to cause processing of the primary 
translation products of added mRNA, removing precursor peptides. 
Consequently, results in the ascites cell-free system must be 
interpreted with caution.
3.5. Other cell-free systems.
The most widely used alternative method of producing a cell-free 
system involves the purification of the various components of 
protein synthesis (tRNA, ribosomes, cytosol "factors", etc.), often 
from different cell-types. These components are then mixed to
re-constitute an active cell-free system. Such systems have been 
devised by Crystal et al., (1972) ,Shafritz ^t al., (1972)using 
reticulocyte components and by Blobel and Dobberstein (1974)using 
both rabbit reticulocyte and dog pancreas components. While such 
systems may reveal interesting phenomena related to protein 
synthesis, they may suffer to some extent from incompatibility 
between components and from omission of necessary factors.
4./
4._____ Regulation of protein production.
4.1. Introduction.
In many biological systems, a balance must be struck. This 
is true both in a whole animal scale, where food consumption is 
correlated to energy consumption (except in exceptional circumstances 
such as starvation) and also at the level of the cell. With cells, 
the problem of balanced consumption and production are more acute 
since reserves of food and energy are not always available in the cell 
as they are in the whole animal. Even in the situation where energy 
and food supplies are not limiting, there exists a need for balance 
in the cell to maintain orderly growth. If the cell is growing and 
dividing,DNA must be replicated at fixed points in the cell cycle, RNA 
must be transcribed (sometimes also at fixed periods), and protein 
must be synthesized, both continuously and also at fixed periods.
Histones are synthesized predominantly in the S-phase of the cell- 
cycle (Robbins and Borun, 1967) in close synchrony with DNA replication, 
while immunoglobulin synthesis is confined to the late G and early 
S phase of the cell cycle (Finegold et al., 1968) although not in 
myeloma cells (Cowan and Milstein,1972). To maintain this "regularity" 
of growth, a system of checks and balances operates in the cell.
DNA synthesis is switched off and on by mechanisms as yet undis­
covered, whilst RNA synthesis is dependent on interactions in the 
cell nucleus between the DNA and its histone and nonhistone protein 
regulators which bind and are released from the genome in response 
to chemical signals. Most obvious are those effected by various 
hormones and their receptors.
Protein/
Protein synthesis is similarly subject to control. Much 
work on control of protein synthesis has been carried out in the 
past ten years. This has been mainly due to;-
a) The advent of eukaryotic cell-free protein synthesis systems
for use as models.
b) Fractionation of some systems (eg: reticulocyte) into
components and their subsequent reconstitution.
c) Isolation of purified mRNA species from many eukaryotic
■ organisms.
Several points of control of protein synthesis can be envisaged 
beyond the stage of transcription. These will be considered both 
as a means of exerting general control and also as a means of closely 
controlling synthesis of one or more specific proteins.
4.2. General control by substrate availability.
4.2.1. Availability of protein synthetic machinery, by control of 
rRNA and/or tRNA production could be used to control protein synthesis. 
Such control could be specific if, for example ribosomes or met tRNA^ 
species were limiting in the system. In this case, higher initiation 
rate constant or more plentiful (assuming initiation rates equal) 
mRNA's would be more likely to be translated (Lodish, 1974 and Section
4.4.1.1.). Similarly, tRNA production, if limiting or unbalanced, 
could affect the rate of translation of mRNAs. Sharma, Beezley and 
Roberts, 1976, have demonstrated such an effect using reticulocyte tRNA's 
in a tRNA-free ascites cell-free system. In this system, globin
mRNA is translatable in a normal manner. Non-reticulocyte mRNA
species/
species from hen oviduct and encephalorayocarditia (EMC) virus, 
however, showed much poorer stimulation of, and premature termination 
of, protein synthesis. Such a system could operate during development.
4.2.2. Low MW Substrates.
Small substrates for protein synthesis, such as ATP, GTP, 
amino acids, etc., could be limiting for protein synthesis. Live 
and Kaminskas (1975) have demonstrated that the effect of depletion 
of energy charge in ascites cells by starvation is to decrease protein
(1976a)
synthesis. In myeloma cells, Sonezishein and Brawerman^have found that 
whilst protein synthesis decreases during starvation, synthesis of 
Ig H and L chains is markedly less affected than overall protein 
synthesis. Rupniak and Quincey, 1975, have shown the importance 
to protein synthesis of maintaining energy charge in reticulocyte 
lysate assays. These results show the dependence of protein 
Synthesis on adequate supplies of energy.
It has also been discovered in reticulocyte lysate assays 
that use of 0-methyl threonine, an isoleucine antagonist, (effectively 
mimicking isoleucine depletion), can lead to preferential inhibition 
of a over 3 chain translation due to the differing distribution of 
isoleucine residues in the two chains. (Temple and Housman, 1972).
4.2.3. Specific protein factors.
Specific protein factors for translation of specific mRNA's 
have been suggested (Heywood & Nwagwü 1969; Rourke and Heywood, 1972) 
The/
The widespread translation of mRNA's in heterologous cell-free 
systems, however, seems to argue against such specific factors 
except perhaps in isolated incidences (see Introduction Section
4.4. for further discussion).
4.2.4. Non-specific protein factors.
Activation and inactivation of various components of protein 
synthesis apparatus could be envisaged as a means of controlling 
protein synthesis. Many workers have demonstrated protein synthesis 
inhibition due to lack of haemin both in whole reticulocytes (Waxman 
and Rabinowitz, 1965) and reticulocyte lysates (Gross & Rabinowitz, 
1972; Legon et , 1972). This inhibition is usually reversed 
upon addition of haemin and is thought to be due to the formation 
of an inhibitor of translation in reticulocyte lysates, whose 
formation can be prevented by the presence of haemin. Recent work 
has tentatively identified this inhibitor as a cyclic AMP independent 
protein kinase which prevents formation of the 40S - met-tRNA^ 
complex by phosphorylation of the initiation factor involved (Ranu 
and London, 1976).
Such a control process would be selective if one were to 
postulate specific protein factors involved in translation of specific 
messages (see above). The evidence in the case of the haemin- 
controlled inhibitor discussed above, however, points to general 
inhibition of all protein synthesis in reticulocyte lysates including 
that with exogenous mRNA's (Mathews et , 1973) .
4.3/
4.3. Control exerted on the mRNA itself.
4.3.1. Separation of mRNA from the protein synthetic machinery. 
Several possible mechanisms can be envisaged.
4.3.1.1. Prevention of exit of the mRNA from the nucleus.
Although mRNA transfer from the nucleoplasm to the cytoplasm 
can be blocked, or at least retarded, by the use of cordycepin, an 
inhibitor of the addition of poly(A) to mRNA 3' terminus (Penman et. 
al.,1970) no evidence for the prevention of release of specific 
mRNA's from the nucleus exists. It is interesting, however, in view 
of the continuing debate over the possible precursor-product 
relationship of HnRNA and mRNA (for review see Perry, 1976), to 
speculate that the mRNA phenotype found in cytoplasm is dictated 
not by regulation of transcription of the genotype but that 
continuous transcription of the entire genotype is modulated by the 
selective processing of HnRNA and selective release though the 
nuclear membrane.
4.3.1.2. Sequestration of the mRNA in-inactive messenger 
ribonucleoprotein (mRNP) particles.
The role, if any, of mRNP's in controlling which mRNA species 
are translated is still unclear. Several mRNA's have been isolated 
from post-ribosomal supernatant of cytoplasm in association with 
proteins, notably a  globin mRNA (Jacobs-Lorena and Baglioni, 1972). 
In this case, the occurrence of a globin mRNA in an mRNP particle 
may be the result of other control factors (see Introduction 4.4.) 
rather/
rather than a control itself. Reports of proteins bound to active 
mRNA released from reticulocyte polysomes by EDTA (Lebleu ejt al. , 
1971; Morel et al., 1971) or puromycin (Blobel, 1972) have shown 
some degree of agreement on the sizes of bound protein. Later 
work in Brawerman's laboratory (reviewed Brawerman, 1975) suggests 
that the protein is bound to the poly(A) sequence in such a way as 
to prevent nuclease digestion.
Several instances of inactive mRNP's releasing active mRNA 
have nevertheless been documented, notably in sea urchin embryos 
(reviewed by Kedes (1976). In that case, histone mRNA's 
manufactured during oogenesis are stored as mRNP's until fertili­
sation of the ovum.
The possibility of specific control by sequestration of mRNA 
in inactive particles therefore exists and may play a role in 
development.
Claims have also been made for a specific interaction between 
mRNA's and small "translational control" (tc) RNA's (by Heywood and 
Kennedy, 1976) but as yet the role of such factors is not well 
defined.
4.3.2. Processing of the mRNA for translation.
The processes leading to the ultimate release of mRNA from 
the nucleus into the cytoplasm have not yet been clarified. It 
is possible that mRNA undergoes a similar maturation process to 
that undergone by rRNA and tRNA, (see Perry, 1976).
4.3.3./
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4.3.3. Inherent structural features of mRNA.
Several structural features of mRNA have been suggested as 
possible controlling elements in translation.
4.3.3.1. The 5' terminal "cap".
It has been discovered that an unusual methylated terminal 
base sequence is found at the 5' termini of many, but not all, 
virus RNA's and, so far, all eukaryotic mRNA's (reviewed by 
Shatkin, 1976). The sequence, known as a "cap", is of the form
7m m _ 7m_ m
G  p p p X p Yp N p N p . . - or G p p p X p N p N p
This led to speculation as to its possible role in translation.
As reviewed by Shatkin, 1976, the following evidence for a role 
in translational control has been found
1. In vivo, and in vitro "capped" viral RNA's are found in
association with polysomes, whilst "uncapped" RNA's are not.
2. Removal of "cap" from some viral and from eukaryotic mRNA's
decreases the ability to direct protein synthesis in cell-free 
systems, although the stringency of the requirement for "cap" 
varied between systems. Some evidence suggests that the decrease 
in synthetic ability may in part be due to the severe conditions 
used to remove the "cap".
3. Naturally occurring "uncapped" viral mRNA's (e.g. poliovirus)
nevertheless direct protein synthesis efficiently in cell-free
sys tems.
4./
hâ
4. The 7-methyl guanosine apparently acts in initiation of 
protein synthesis by binding to the 40S subunit protein(s), after 
which it is protected from mclease digestion. After protease 
digestion of the protected residue, oligonucleotides of chain length 
31-65 bases, depending on the mRNA, have been recovered.
5. Evidence from "capped" synthetic polynucleotide studies 
suggests that binding to ribosomes may also be sequence specific.
Thus a role &r the "cap" in regulation of translation is 
feasible although the preliminary studies cited by Shatkin suggest 
no significant turnover of "caps" in cell-free systems.
4.3.3.2 3* poly(A) sequences.
The role of poly(A) regions in translational control of 
protein synthesis has been widely explored. This has generally 
been done by enzymatic removal of the poly(A) sequence and subsequent 
translation studies in cell-free systems (Bard al., 1974,
Soreq et al., 1974; Huez ai., 1974; Williamson et al., 1974; 
Sippel et al., 1974; Doel and Carey, 1976). The effect of poly(A) 
removal on translational capacity was found to vary depending on 
the cell-free system used for translation of the deadenylated mRNA 
(Soreq ejt ai., 1974; Doel and Carey, 1976). The Krebs II ascites 
and reticulocyte cell-free systems or Xenopus oocytes (Nudel ejt ai., 
1976) showed a decrease in incorporation with deadenylated mRNA.
This was not found in the wheat germ or wheat embryo cell-free system 
(Bard et al., 1974; Doel and Carey, 1976) but this may have been due 
to a low rate of re-initiation in this system. Criticism of such 
experiments can be made on the grounds of other unspecified damage 
occurring/
" 2 i
occurring to the mRNA in such deadénylation reactions. The 
findings with wheat germ cell-free systems, the formation of full- 
size products in all systems, and the ability of such deadenylated 
mRNA to be successfully copied into cDNA (Maniatis e^ al., 1976) 
argue against this.
Several theories have been proposed (e.g. Sussman, 1970) 
suggesting a progressive removal of A nucleotides from the poly(A) 
tail of mRNA's as they are translated, ultimately leading to 
degradation. Recent work by Lingrel et al., (1974) and by 
Brawerman (1976), has shown that initial' degradation of.the poly(A) 
tail takes place after appearance of the mRNA in the cytoplasm.
This rapid degradation reaches a modal value (= 60 for globin) after 
which the poly(A) tail is relatively stable for long periods. Whilst 
this may not occur for all mRNA's, it argues against any general 
"ticketing" hypothesis. Brawerman (1976) has suggested control of 
translation by poly(A) by interaction of the poly(A) tail with 
residues at the 5' end of the mRNA. In 3 globin mRNA, the complete 
sequence shows no stretches of U residues greater than 4 and no 
predominance of U residues in the untranslated region at the 5' end 
(Baralle, 1977; Efstratiadis et al., 1977).
Moreover, poly(A) sequences are not obligatory in mRNA.
Most histone mRNA contain no poly(A) sequences (Adesnik & Darnell, 1972; 
Greenberg & Perry, 1972; but see Levenson and Marcu, 1976), but 
translate faithfully both vivo and ^  vitro. In addition, both 
in sea urchin embryos (Nemer et al., 1974; Nemer and Surrey, 1976) and 
in HeLa cells (Milcarek et al., 1974) , a class of mRNA's lacking 
poly(A) sequences has been described (Nemer et al., 1974; Nemer and 
Surrey, 1976) accounting for upwards of 30% of all mRNA species 
present/
present. These species translate equally as well as poly(A) 
containing mRNA's.
It has also been reported that some protamine mRNAs exist 
both with and without poly(A) sequences (Gedamu et al., 1977), 
These species are equally able to direct protein synthesis.
Thus the role of the poly(A) sequence in controlling mRNA 
translation remains unresolved, although its presence or absence 
in some cases can affect the rates of initiation and elongation 
of protein synthesis.
4.4. Control of the interaction between mRNA and the protein 
synthetic machinery - kinetic factors.
4.4.1. Control at initiation step.
4.4.1.1. The Lodish Model.
Since the base sequence leading to the initiation codon of 
each mRNA is likely to be different, it can be envisaged that each 
mRNA will have a particular affinity for components which allow the 
initiation of protein synthesis (40S subunits, initiation factors). 
Consequently, the overall rate constant (K^ ) for initiation will 
vary among mRNA's. Lodish (1974) has developed a semi-mathematical 
description of the effects of various conditions on the relative 
rates of initiation of different mRNA's involving some simplifying 
assumptions. Using the a and B globin mRNA's as examples, he 
predicts that any change in conditions liable to decrease the 
favourability of the formation of initiation complexes would result 
in a more pronounced inhibition of the initiation (and translation) 
of/
of the poorer initiating species. In a series of experiments 
designed to test this, he demonstrated a shift in the ratio of 
synthesis of a and 3 globins chains in favour of 3 chain synthesis 
when inhibition of initiation occurred. . This occurred only with 
inhibitors which act to prevent the formation of the initial 
met-tRNA-40S-mRNA complex but not with inhibitors which act at initiation 
stages beyond this point. a  chain mRNA has been demonstrated to 
initiate at ' 2^/3 of the rate of 3 chain mRNA (Lodish, 1971; Lodish 
& Jacobsen, 1972). Thus for a and 3 globin mRNA's the hypothesis 
correctly predicted the effect of inhibition of initiation.
Systems where two major identifiable types of protein are 
produced, e.g. viral and cellular, internal and secreted, are 
especially well-suited for testing of this hypothesis. It should also 
be able to be successfully tested in cell-free protein synthesizing 
systems, where controlled variations in conditions can be made.
Evidence from a number of systems has been contradictory.
4.4,1.2. Support for the Lodish Model.
In support of his hypothesis, Lodish and his coworkers have
shown:
a) In reticulocyte lysates, addition of excess total globin
mRNA or 3 globin mRNA stimulates synthesis of relatively more 3 
globin than a globin, whereas addition of excess a globin mRNA 
stimulates synthesis of more a globin (Temple & Lodish, 1975).
This suggested that lower translation of a globin mRNA at normal 
levels was not due to a lack of a specific factor.
b)/
b) In superinfection studies of f2-infected E coli with t 4
phage, it was concluded that the method of inhibition of f2 RNA 
translation after superinfection was probably due to the higher 
initiation constant for T4 RNA (Goldman and Lodish, 1975). 
Evidence from bacterial systems where different mechanisms 
of protein synthesis are found, must however be treated with 
caution.
Further evidence for the validity of Lodish*s hypothesis 
has come from various systems : high salt inhibition studies of
vaccinia virus, immunoglobulin, collagen synthesis (Oppermann & 
Koch, 1976; Nuss and Koch, 1976; Koch ejt a^. , 1976), starvation 
high salt, and chemical inhibition studies of immunoglobulin 
synthesis both in whole cells (Sonensham & Brawerman, 1976a) and 
cell-free systems (ibid 1976b), "cap" analogue studies with 
reticulocyte lysates (Suzuki, 1976).
4.4,1,3. Opposition to the Lodish Model.
Opposition to the claims of the Lodish hypothesis have often 
been based on messenger-specific factors (e.g. Kennedy and Heywood, 
1976; Vaquero et al., 1975), whose addition to cell-free systems 
is claimed to direct the preferential translation of specific mRNA's. 
Heywood, however has admitted that his results can be interpreted 
on the basis of Lodish's hypothesis (Gilmore-Herbert & Heywood, 1976). 
Some other of his objections can be dismissed due to misunderstanding 
of the hypothesis, e.g. the assertion that myosin mRNA in mRNP's and 
polysomes, being identical by several criteria cannot be regarded 
as/
as"better" (polysomal) or "poorer" (mRNP) mRNA's (Kennedy and 
Heywood, 1976; Heywood & Kennedy, 1976). Such partitioning of 
mRNA's may simply reflect the level of growth of the system.
Indeed, mRNP's are degraded to yield polysomally active mRNA as 
development progresses (Heywood & Kennedy, 1976).
Other apparent anomalous results for the Lodish hypothesis 
may result from incomplete interpretation of data and use of 
proper controls. Bonanou-Tzedaki and Arnstein (1976) showed a 
temperature dependent inhibition of protein synthesis in rabbit 
reticulocytes or reticulocyte lysates, whose site of action was 
localised as being at the initiation step. While they found no 
change in the ratio of a:3 globin chains synthesized, an increase 
in the ratio of free a : 3 globin mRNA's found in the post ribosomal 
supernatant suggested that a chain initiation was preferentially 
inhibited. A more complex series of inhibitory processes may be
operating in this system. The work of Vaquero et al., (1975) on the
other hand showed an inhibitory process occurring in protein synthesis 
but did not localise it at the initiation step. Moreover, their 
experimental conditions did not allow for the variation in
under different conditions. One interesting exception to the Lodish
theory which may prove real is the findings of Kaufman et ai (1976) 
with poliovirus. This virus is one of the few eukaryotic mRNA's 
lacking a proper "cap" at its 5' terminal. Thus its interaction 
with 40S-mettRNA^ complexes may be unlike normal mRNA interactions. 
Lodish has discussed many of the challenges to his hypothesis in a 
recent review (Lodish, 1976).
4.4,1.4./
4.4.1.4, Ig production and the Lodish Model.
The studies most apposite to this project were conducted on
MPC-11 myeloma cells by two groups (Nuss and Koch, 1976; Sonensheiri 
& Brawerman, 1976). In part,their results are complementary and 
confirmatory. They can be summed up as follows:-
1. In whole cells, a variety of initiation inhibitors (high salt,
starvation, actinomycin D) inhibited non-Ig synthesis more than Ig 
synthesis, and H chain synthesis more than L chain synthesis. This
suggested increasing initiation constants as follows : non-Ig <
H chain < L chain in general.
2. Inhibitors of elongation (cycloheximide, emetine) showed no
preferential inhibition of Ig or non-Ig species, although this has 
been found by other workers (Stevens and Williamson, 1974).
3. In a cell-free system (wheat germ) observed effects were
similar to ^  vivo.
These results are consistent with the Lodish hypothesis if H 
and L chain mRNA's have high initiation constants.
In this project results are presented which indicate a similar 
preferential translation of Ig mRNA in a cell-free system under 
conditions of inhibition of initiation. They also suggest, however, 
that H chain mRNA can be preferentially translated over L chain mRNA, 
in contradiction to the results discussed above.
4.4.2. Control of elongation/termination?
The mechanisms of elongation and termination of protein 
synthesis are now fairly well understood (see review by Weissbach 
and/
and Ochoa, 1976). No specific elongation or termination factors 
specific for a particular mRNA have been discovered, and it is 
difficult to envisage how such factors might operate. After the 
specificity involved in initiation (S' terminal sequence, possible 
specific initiation factors), the elongation process will be limited 
solely by the rate of attachment of specific aa-tRNA's to the mRNA- 
ribosome-polypeptide complex and the termination process by 
reactions set in motion by the appearance of a "stop" codon in the 
reading frame of the mRNA. Limitation of specific tRNA's has been 
discussed earlier but such a system would be difficult to operate 
in order to produce an effect on specific mRNA's.
The rate of elongation may vary instantaneously according to 
the rate of diffusion of the required aa-tRNA complex to the ribosome 
but the overall rate of elongation has been shown in cell-free 
systems to be constant (Hunt, 1974), It is also well established 
that initiation, not elongation or termination is the rate limiting 
step in translation,.
4.5. Control of the rate of degradation of mRNA's.
The role of poly(A) sequences in preventing degradation of mRNA 
has already been discussed (Section 4.3.3.2.).
mRNA in prokaryotes can often be found simultaneously being 
transcribed, translated and degraded, the events occurring 
consecutively along the same mRNA from the 3' growing end where 
transcription is occurring, through a portion of the message being 
translated by ribosomes to the 5' end where degradation has set in. 
In/
In eukaryotes, mRNA is usually much longer-lived. mRNA must first 
be transcribed, post-transcriptionally modified and released into the 
cytoplasm, of course, but thereafter the mRNA's often have half-lives 
measured in hours (Brawerman, 1974) .
Most studies on mRNA degradation have involved actinomycin D 
blockage of all RNA synthesis but these results are open to criticism 
since actinomycin D in large amounts has been shown to block initiation 
of protein synthesis. As a consequence measurement of mRNA 
degradation on the basis of polysome disintegration is suspect. 
Experiments with pulse-chase labelling of mRNA using radioactive uridine 
(Murphy & Attardi, 1973) suggested half-lives of several days, whilst 
Penman's group (Singer and Penman, 1973)
have shown at least two distinct species of mRNA inHelAcells with half- 
lives of 7 hrs and 24hrs respectively. Moreover, in Xenopus oocytes, 
globin mRNA has been detected as being translated for several days 
after injection into fertilised eggs (Lane, Gurdon & Woodland, 1974).
Consequently, it is possible that selective degradation of mRNA 
may occur in the cell, although it has not been shown convincingly for 
any specific mRNA. Such selective degradation might be on the basis 
of labile nucleotide sequences in the mRNA which were easily 
attacked by nuclease action.
4.6. Conclusion.
While selection of mRNA before, during and after translation 
may occur, the most probable site of control is at the stage of 
initiation of protein synthesis. The next section will discuss 
control of the segregation of synthesis of proteins intended to 
remain/
remain within the cell and proteins due to be secreted.
5. Factors affecting the control of secretion of proteins.
5.1. Introduction.
It is now reasonably well established that proteins intended 
for secretion by cells are generally synthesized on membrane-assoc­
iated polysomes except in abnormal conditions.(recently reviewed by 
Shore and Tata, 1977). It is still, however, uncertain whether 
membrane bound polysomes are devoted exclusively to synthesis of 
secreted proteins (including, for the purposes of this discussion, 
species which are incorporated into membranes) (reviewed by McIntosh 
and O'Toole, 1976). How are polysomes containing mRNA coding for 
secreted proteins distinguished from those polysomes concerned with 
non-secreted protein synthesis? Evidence has been presented for 
the role(s) of the mRNA, ribosomes, the membrane and the nascent 
polypeptide in distinguishing which polysomes become membrane-bound 
and has been reviewed by Shore and Tata, 1977. Membranes themselves 
probably contain receptors for binding ribosomes and pores for the 
transfer of newly-synthesized secreted polypeptides into the cell lumen, 
These receptors have not yet been characterised and probably do not 
directly determine which polysomes are bound. Evidence exists for 
proteins which associate with ribosomes to prevent binding to 
membranes vitro but it is not unambiguous (see review of Shore 
and Tata, 1977). Such protein factors have not been shown to be 
specific for a particular class of polysomes within the cell (e.g. 
Blobel, 1976), Recently, the use of heterologous cell-free systems 
to translate mRNA has led to a growing amount of evidence that the 
nascent/
4 I  r ' i
nascent polypeptide is the major factor determining whether a 
polysome becomes membrane-bound.
5.2. The "signal" hypothesis (1971).
The concept of an attachment of polysomes to membranes 
directed by the nascent polypeptide was first discussed in 1971 
by Blobel and Sabatini and subsequently by Milstein et al., 1972,
Their hypothesis aimed to explain the segregation of polysomes 
synthesizing secreted proteins on membranes. In their original 
concept, the early stages of synthesis of secreted proteins 
occurred on free polysomes. The primary translation product, 
however, contained extra amino acids at the terminus (the "signal"
peptide). When this "signal" peptide was sufficiently well clear 
of the ribosome, it attached to a receptor site on the endoplasmic 
reticulum. This site directed the transfer of the polypeptide 
through the membrane and into the lumen, ready for secretion.
The "signal" peptide was postulated as common amino acid 
sequence for all secreted proteins derived from a unique codon sequence 
in mRNA's for secreted proteins.
Later versions of the "signal" hypothesis (Blobel and 
Dobberston,1974a) have been modified by the discovery of precursor 
sequences at the NH^ terminus of many secreted proteins. These 
sequences are not normally found in the mature secreted product but 
came to light following translation of mRNA's of secreted proteins 
and polypeptides in heterologous cell-free systems. Blobel and 
Dobberstein suggested that these precursor sequences constituted 
the "signal" peptides. They suggested that, after guiding the 
nascent/
nascent polypeptides through the membrane, such peptide sequences are 
proteolytically removed, possibly before the synthesis of the poly­
peptide is complete. Evidence for this will be discussed.
The amino acid sequencing data obtained by Schechter and his 
co-workers (see Fig. 1) from several Ig L chain precursors has ruled 
out the possibility of a unique amino acid sequence for the precursor 
peptide, although L chains from closely related cell lines have identical 
precursors (Schechter, 1977). A unique codon sequence for Ig L chain 
precursors, or even one allowing third base degeneracy, is also ruled 
out by consideration of the known amino acid variations. Ig L chains 
(and possibly H chains if these contain precursors) may, however, 
be a special case. Burstein & Schechter (1977) have suggested that 
the variability encountered in the L chain precursor peptides may be 
due to the precursor forming a part of the L chain variable region 
with which it is contiguous. Devilliers-Thiery et al., (1975) have 
shown much less heterogeneity between putative precursor sequences 
of several dog pancreas secreting proteins. Hence the uniqueness or 
otherwise of the "signal" peptide sequence has not been determined 
unambiguously.
Firmly established, from these studies, nevertheless, is the 
evidence of a high proportion of hydrophobic amino acids in the known 
precursor sequences. This is consistent with a role in directed 
transfer of secreted proteins through the membrane.
5.3/
FIG. 1.
PARTIAL AMINO ACID SEQUENCES OF THE N-TERMINI OF SEVERAL MYELOMA
L CHAIN PRECURSORS^
Amino acid^
NH^ terminus 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Cell line
MOPC 321 M * T * T L L L W V L L L W V P * * T *
MOPC 63 M * * * * L L L * * L L L * * P * S * ■k
r
MOPC 41 M *^M * A P A * I F * F L L L L F P * T * c
MOPC 104E A * * * L * L * L L A L * * * A * * *
Legend;
a Taken from Burstein and Schechter, 1976; Burstein, Kantor
and Schechter, 1976; Schechter and Burstein, 1976. 
b Single letter amino acid designations as follows
A = Ala; C = Cys; F = Phe;
I = lie; L = Leu; M = Met;
P = Pro; T = Thr; V = Val;
W = Trp * designates unknown residue 
c Found on ^75% of all molecules sequenced; otherwise first
two residues absent 
d Found on ^10% of all molecules sequenced; otherwise first
residue absent
5.3. The use of cell-free systems.
5.3.1. Cell-free systems - advantages over cellular studies.
The major advantage in most eukaryotic cell-free systems (e.g. 
reticulocyte lysate, wheat germ, but not Ascites cells) is that 
such systems do not contain large amounts of either membranes or 
membrane derived microsomes. This contrasts with most cells 
synthesizing secreted protein, which generally contain large amounts 
of endoplasmic reticulum. Reticulocyte lysate, derived from cells 
containing no visible endoplasmic reticulum is especially suitable 
in this respect. As a consequence of the lack of membranes, poly­
peptide products of cell-free systems are less prone to post- 
translational modification by membrane-associated synthesis. Two 
major processes are affected
i) Post-translational addition of carbohydrate residues 
(e.g. to Ig molecules).
ii) Post-translational cleavage of the polypeptide chain.
5.3.2. Cell-free systems - the synthesis of precursors.
The development of functional eukaryotic cell-free systems 
from reticulocytes (Lockard & Lingrel, 1969), wheat germ (Roberts 
and Paterson, 1972) and ascites cells (Aviv et al., 1971; Mathews 
& Korner, 1970), allowed the study of cell-free translation with 
mRNA's of secreted proteins.
Much work has been carried out with mRNA from secretory cells, 
either in an impure or fractionated form, since such cells often 
devote much of their protein synthetic activity towards production 
of a single (or small range of) proteins. This allows the possibility 
of/
of purification of a particular mRNA species in relatively 
homogenous form.
5.4.1. Existence of putative precursors to many secreted proteins.
Evidence has accumulated over recent years, through the use 
of cell-free systems, that many secreted proteins and polypeptide 
hormones are initially translated as higher MW precursors. To date 
much of this evidence is based on the lowered mobility on PAGE of 
immunologically identified cell-free products, compared to the 
cellularly produced material. A list of such species is presented 
in Table 1. A useful short review is that of Campbell & Blobel 
(1976).
From these reports it can be seen that the phenomenon of 
precursors to secreted proteins and polypeptides is widespread, 
occurring as a result of translation of mRNA from mammals, birds, 
fish and insects. It also seems to be reproducible in a number of 
cell-free systems, including both mammalian- and plant-derived 
systems. In some cell-free systems (e.g. Krebs ascites) partial 
processing of the precursor appears to occur. This has been 
attributed to the presence of membrane material in such systems. 
SzczeSna and Boime (1976) have demonstrated that membrane material 
is responsible for processing in their work. The precursor 
sequences detected vary in size. Using only those systems from 
which sequence data has been obtained, viz. mouse myeloma Ig L chain, 
rat insulin, bovine parathyroid hormone, prolactin, dog pancreatic
secretory proteins and rat liver serum albumin the range of precursor
ami 110 acids
sizes is 18 - 25^ Although smaller precursor sizes have been 
reported (e.g. a  lactalbumin 7 - 10) (Craig/
TABLE 1
CELL-FREE SYSTEM IDENTIFIED PRECURSOR-CONTAINING PROTEINS AND POLYPEPTIDES
Protein 
or
polypeptide 
(aa's in precursor)
Cell-
free
Identification Reference
a) Proteins
Mouse Ig L chain 
(19-22)
WG,KA,RL,EA M, 1/ s See Table 2
Dog Pancreatic
secreted proteins 
(%16)
H M, S Devilliers-Thiery 
et al., 1975
Guinea pig a- 
lactalbumin
WG, KA M, I Craig et al., 1976
Rat liver serum 
albumin (18)
WG M, 1/ s Strauss et al., 1977
Conalbumin, (hen ) 
oviduct) (19) )
Ovomucoid, (hen ) 
oviduct) (23) ) 
)
RL M, 1/ s Palmiter et al., 1977
Lysozyme, (hen ) 
oviduct)(18) )
Rabbit uteroglobulin KA, WG M, I Beato & Nieto, 1976
b) Polypeptide-hormones
Insulin (rat)(23) WG M, I, s Chan et al., 1976
(carp) WG M, I Rapoport et al., 1976
Growth hormone (GH) WG M, I Sussman et al., 1976
Prolactin WG M, I Evans & Rosenfeld, 1976
Placental lactogen WG, KA M, I Boime et al., 1975,1977
Parathyroid 
hormone (25)
WG, KA M, I, s Habener et al., 1975 
et seq.
Corticotropin (ACTH) WG M, I Nakanishi et al., 1974
Legend
Key : 1) Cell-free systems
WG = Wheat germ 
RL = Reticulocyte lysate 
KA = Krebs II Ascites 
H = Heterologous components 
EA = Ehrlich Ascites
2) Method of identification 
M = Mobility on PAGE 
I = Specific immunoprécipitation 
S = Sequence data
(Craig et al., 1976) these have been based on mobility data. Such 
measurements are of dubious validity.
An interesting feature of cell-free synthesized precursor 
molecules is that they are in fact often only precursors to pro­
polypeptides (e.g. prolactin, proinsulin, proalbumin) which undergo 
subsequent proteolytic cleavage during or after secretion to yield 
the final active protein or polypeptide. Such pro-sequences are 
generally short (e.g. 5 residues for albumin) and often basic in 
character (e.g. pro sequences of albumin or of parathyroid hormone 
contain 80% and 66% basic amino acids respectively). Such 
findings suggest several levels of control of secreted proteins, 
firstly in translocation across membranes, subsequently in producing 
the active protein.
5.4.2. Precursors of myeloma cell products. 
a) Ig L chains.
One of the most intensively investigated mRNA species has been 
that of the mRNA for Ig L chains. Initial studies on myeloma mRNA 
from MOPC 41A cells (Stavnezer & Huang, 1971) indicated the general 
antigenic identity of cell-free and cellularly produced L chain by 
immunoprécipitation. Tryptic peptide analysis, however, suggested 
that the N-terminal peptide differed between the cell-free and 
cellular products. Later workers, firstly with total mRNA from 
MOPC 21 cells (Milstein et al., 1972) and subsequently with MOPC 41 
mRNA enriched in L chain species (e.g. Mach, Faust & Vassali, 1972) 
demonstrated that cell-free L chain had lower mobility (and hence 
higher apparent MW) than cellular L chain on analysis by PAGE.
This/
This result has been confirmed using a number of other cell-free 
systems and a variety of myeloma cell lines for mRNA preparation.
So far mRNA from all cell lines studied has directed synthesis 
of L-chain-like material with higher MW's than secreted L chain.
The cell lines studied are listed in Table 2.
In all cases, the cell-free product had a higher apparent MW 
than the cellular product. This higher MW seemed to be due to the 
presence of an altered N-terminus (Stavnezer & Huang, 1971; Swan 
et al. -, 1972) and seemed to be a general phenomenon in cell-free 
systems. It has also been observed vivo under stringent 
protease inhibition conditions (Schmeckpeper ^t al., 1975).
The formation vitro of a primary translation product for 
L chain longer than that found in the cell offered support to the 
"signal" hypothesis, described earlier. Since then the study of 
L chain mRNA translation has continued to be interpretable on the 
basis of this hypothesis. The evidence accumulated by study of 
L chain translation can be summed up as follows:-
1. L chain precursor molecules appear to exceed the length of
cellular L chain by ^1 - 2000MW units or 19 - 22 amino acid residues 
located at the N terminus of the molecule. Much of the work on 
the size and sequence has been done by Schechter and his co-workers 
(Schechter, 1973; 1974a; 1974b; 1975; Schechter et al., 1975;
Schechter and Burstein 1976a,b; Burstein and Schechter, 1976; 
BUrstein ^t al., 1976) . These studies have revealed the partial 
sequences of the precursor segments of several myeloma L chains (MOPC 
321, MOPC 41, MOPC 63, MOPC 104E). These are shown in Fig. 1. A 
noticeable feature of these sequences ia the abundance of hydrophobic 
residues/
TABLE 2
TRANSLATION OF Ig L CHAIN mRNA IN CELL-FREE SYSTEMS
L chain
Cell line subgroup Cell-free system(s) Reference(s)
MOPC 21(P3K) K
MOPC 41 K
MOPC 41A K
MOPC 321 K
MOPC 63 K
MOPC 104E X
MOPC 315 X
RL,WG,KA
WG,KA,RL
WG,KA,RL
WG, KA
WG
WG
WG, RL, KA, EA
Milstein et al., 1972, 
Schmeckpeper et al., 1974, 
1977
Schechter and Burstein, 1976 
Swan £t al., 1972,
Mach et al., 1973
Schmeckpeper e_t al. , 1974, 
1977
Schechter and Burstein, 
1976a,b, Schechter, 1973
Burstein and Schechter,1976
Burstein et al., 1976
Schmeckpeper et ad., 1974, 
1977, Green et al., 1976
Legend
Key: RL = Reticulocyte lysate
WG = Wheat germ 
KA = Krebs II ascites 
EA = Ehrlich Ascites
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residues, as would be expected for a "signal" peptide which had to 
interact with endoplasmic reticulum. Similar hydrophobicity has 
been reported in precursors of proteins from other sources (De­
villiers-Thiery e^ al., 1975; Palmiter, 1977). It would not seem 
unlikely that a concentration of hydrophobic residues was a common 
feature of precursor sequences.
2. The precursor sequence is removed due to interaction with the 
endoplasmic reticulum. Milstein ^t ad., (1972) demonstrated that 
microsomes (with attached polysomes) from myeloma cells synthesized 
only mature-sized L chain. Their results from translation in the 
ascites system which contains small variable amounts of 
microsomal material also showed some processing of pre L to L 
chain. This has been found by other workers using ascites cells 
(Schechter et al., 1974; Swan et al., 1972). More convincing 
evidence for the role of membranes in cleavage of precursor sequences 
has been shown by Dobberstein & Blobel (1977). In their experiments, 
both heterologous ribosomes (wheat germ) and membranes (dog pancreas) 
were incubated in the wheat germ system with murine myeloma mRNA 
(MOPC 41)'. Under these circumstances, only mature L chain was 
detected. Addition of microsomes after the synthesis had been 
allowed to occur, however, did not process the precursor L chains
to L chains, indicating that processing was closely linked to 
translation. Other workers have confirmed this result (Schmeckpeper 
et al., 1977) . Moreover, the use of plant ribosomes and animal 
membranes indicated that the processing mechanism is widely distributed 
and shows functional homology between the plant and animal kingdoms.
3. Processed polypeptides are translocated through the membrane.
Again, the work of Dobberstein and Blobel (1974, 1977) has
demonstrated/
demonstrated that precursor L chain synthesized in the absence of 
membrane fractions is labile to proteolytic digestion. Products 
synthesized in the presence of membrane fractions are not only 
processed to mature L chain but are also resistant to proteolytic 
digestion unless detergents, which can disrupt membranes, are present,
5.4.3» Ig H chains.
■Fewer reports have been made of the synthesis of Ig H chains 
in cell-free systems. In part, this has been due to the nature 
of the cell-free systems available. As discussed earlier, the 
reticulocyte lysate system is hampered for translation of exogenous 
mRNA by the competition of large quantities of endogenous mRNA 
species. This problem has recently been overcome (Pelham and 
Jackson, 1976). The Krebs II or Ehrlich ascites system contains 
variable quantities of microsomal material which introduces the 
possible ambiguities of processing of primary translation products. 
They also contain significant amounts of nucleases (Jacobs-Lorena & 
Baglioni, 1972) and are dependent on added tRNA (Aviv et al., 1971), 
for mitigation of premature termination problems.
The wheat germ system, much used because of low endogenous 
mRNA levels and high incorporation of radioactivity, suffers from 
premature termination problems which become progressively worse as 
the length of the mRNA to be translated increases (Green et al., 1976; 
Sonez&sheia and Brawerman, 1976) , This results in very low levels of 
synthesis of H chains. Ano-ther possible problem, especially in 
systems with high levels of competing endogenous mRNA, is that H 
chain/
chain mRNA from some myeloma cells is a relatively poor initiator 
of synthesis (Nuss and Koch, 1976; Sonenshein and Brawerman, 1976). 
Consequently, it may be translated less frequently in the presence cf 
high levels of good initiating mRNA (e.g. globin mRNA).
Two final points to be borne in mind with cell-free synthesis 
of H chain concern presence of carbohydrate residues on the cellular 
H chain and the relatively small effect a precursor sequence would 
have on MW studies. In cell-free systems carbohydrate residues 
are unlikely to be added (see for example Cowan and Milstein, 1975) .
The presence of carbohydrate on H chains obviously increases their 
actual MW but also has a disproportionate effect on the apparent MW 
as estimated by PAGE. Consequently, in a cell-free system, its 
absence will cause H chain products to have greater mobility.
This poses interpretative problems when considering evidence for 
the existence of precursors to H chain.
If H chain is synthesized as a precursor in cell-free systems, 
the effect of a precursor sequence (^ 2^0 amino acids) on mobility of 
H chain (450 amino acids) is liable to be small (<5%). Such a small 
change in mobility might be difficult to detect by PAGE. Similar 
difficulties were experienced in searching for a precursor to rat 
liver serum albumin (Taylor and Schimlce, 1973? Peterson, 1976;
Strauss £t al., 1977).
Nevertheless, several studies on the synthesis of Ig H chains, 
in cell free systems have been carried out. Both total myeloma 
poly(A) RNA and H chain mRNA-enriched fractions have been investigated. 
The cell lines, and systems used are described in Table 3.
Cowan and Milstein's work (1974) indicated that, by the 
criterion of PAGE, P3K cell-free products directed by mRNA contained 
a/
TABLES
TRANSLATION OF Ig H CHAIN mRNA IN CELL-FREE SYSTEMS
Cell line
Class of 
H chain
H chain 
enriched 
mRNA?
Cell
free
system Reference
MOPC 21(P3K) RL Cowan and Milstein, 1973
WG Schmeckpeper £t aT., 1974
KA Schmeckpeper at al., 1977
RL Schmeckpeper et al., 1977
MOPC 315 WG
WG
KA
KA
RL
RL
Schmeckpeper e^ ^ 1. , 1974 
Green et ad., 1976 
Green e t  al., 1976 
Schmeckpeper et al., 1977 
Schmeckpeper et 5^. , 1977 
Bedard and Huang,1977
HPC 108 KA
RL
Schmeckpeper at ad., 1977 
Schmeckpeper et al., 1977
Legend
Key: RL = Reticulocyte lysate
WG = Wheat germ 
KA = Krebs Ascites
a species with a mobility slightly greater than that of marker H 
chains. They pointed out, however, that this may have been due to 
distortion caused by the presence of large amounts of carrier H chain. 
Polysomes or microsome directed cell-free synthesis yielded two species 
with mobilities slightly greater than H chains. They were not 
identified as H chain-like material other than by mobility. Tryptic 
analysis of poly(A) RNA-directed synthesis indicated the identity of 
the jni vivo H chain and the vitro putative H chain. They also 
showed the existence of an extra peptide in the vitro synthesized 
H chain which may have been part of a precursor to H chain.
Schmeckpeper e_t ad., (1974, 1977) have done valuable comparisons of 
cell-free products of P3K mRNA in three cell-free systems. No 
synthesis of H chain-like material was demonstrated in the wheat 
germ system (Schmeckpeper ^t aJ., 1974) but a little was found in 
the ascites system and reticulocyte lysate system (Schmeckpeper et al., 
1977). However, the data presented is difficult to interpret in 
mobility terms because of the use cf tube gels.
MOPC 315 and HPC 108 cell lines offer the possibility of yielding 
less ambiguous results, since both produce a-type heavy chains, which 
contain a large percentage of carbohydrate. Its removal should 
produce a measurable change in mobility unless the existence of a 
precursor sequence is involved.
Comparison of the work of the several groups who have studied 
cell-free translation of MOPC 315 mRNA is aided by the fact that their 
experiments duplicate each other to some extent. With wheat germ.
Green et aT were unable to demonstrate production of H-chain-like 
material. Schmeckpepèr e^ , (1974) on the other hand, not only 
demonstrated/
demonstrated its translation but identified the a  chain like product 
by immunoprécipitation. This a  chain seemed to have a lower
apparent MW than secreted MOPC 315 H chain, perhaps due to lack of
carbohydrate. This was confirmed by Schmeckpeper e;t al. , (1977) 
using the ascites system and the reticulocyte lysate system. Green 
et al., (1975) demonstrated the synthesis of 315 H and pre L chains 
by the ascites system using immunoprécipitation but failed to include 
proper controls such as internal or adjacent markers. The use by
both groups of secreted H chains as markers, however, can be
criticised since differences in mobility' between intracellular and 
secreted a  chains have been observed due to addition of carbohydrate 
residues during the final stages of secretion
Moreover secreted a chains electrophorese as diffuse bands due to 
variable amounts of carbohydrate residues. In contradiction to 
the above results, Bedard and Huang (1977) present evidence that cell- 
free synthesized and secreted H chain are identical, using rabbit 
reticulocyte lysate as cell-free system. Their gel analysis, as 
presented, however, is ambiguous, with blurring of the secreted H 
chain marker/Eue to the existence of at least two cell-free species 
in the H chain region. No attempt was made to identify the products 
by immunoprécipitation leaving in doubt which species was related to H 
chain. Their claim that cell-free a  chain had an equal MW to secreted 
a  chain suggests poor resolution in their gel system. Cyanogen 
bromide digestion, moreover, did not have sufficient resolution in 
their hands to detect minor changes in mobility of peptide fragments. 
Their results should therefore be treated with caution.
The MPC 108 results of Schmeckpeper et al., (1974, 1977) show
the/
the same effect and same shortcomings as their results with MOPC 315. 
Schechter has recently claimed that MOPC 315 a  chain contains a 
precursor sequence (1977).
The conclusion to be drawn from the above experiments is that 
the question of the nature of cell-free synthesized H chain products 
has not yet been satisfactorily investigated. Even the relative 
mobilities of cellular and cell-free synthesized H chains has not 
been resolved, let alone the possible existence of a precursor sequence, 
■ Results are presented in this thesis which indicate that the 
mobility of cell-free synthesized H chains from several myeloma 
cell-lines is generally higher than that of the intracellular dm vivo 
H chain product, i.e. that it has a lower apparent MW as determined 
by PAGE.
5.5. Exceptions to the "signal" hypothesis.
The generality, although not necessarily the limited validity, 
of the signal hypothesis could be challenged by the demonstration 
of cell-free synthesis of a secreted protein, or polypeptide, not 
involving synthesis of a precursor sequence. This would suggest 
at least that an alternative mechanism of secretion existed.
Several cases have been reported of non-precursor containing cell- 
free synthesized polypeptides corresponding to secreted proteins. 
Casein mRNA isolated from lactating rat mammary gland, was translated 
in the wheat germ system to yield 2 of the 3 major casein species 
(Rosen et al., 1975). These were identified by mobility (equal to 
markers) and immune reactivity with casein antibodies. The data 
can be criticised, however, since casein produced dm vivo is both 
glycosylated/
glycosylated and phosphorylated. This would affect the mobility of 
cell-free products lacking glycosylation or phosphorylation. Craig 
et aJL., (1976) reported that casein mRNA yielded three anticasein
antiserum-precipitable species. These each had mobilities greater
than iodinated marker proteins indicating a lower apparent MW 
in vitro.
Again, however, the effect of lack of glycosylation or 
phosphorylation on mobility was not tested. Moreover, with Ig H and 
L chains, iodination has been shown to alter mobilities on PAGE 
(P. Singer, personal communication), The interpretation of results 
of the translation of casein mRNA should therefore be treated with 
caution.
More serious evidence against the "signal" hypothesis has 
been the sequencing of cell-free products programmed by various hen 
oviduct mRNA's by Palmiter et al., (1977). Of four cell-free 
products sequenced, (lysozyme, ovomucoid, conalbumin and ovalbumin) 
three contained, as expected, a precursor sequence,whilst ovalbumin 
did not. The reticulocyte lysate cell-free system was used, thus 
eliminating the possibility of selective positive processing by 
membrane fragments, i.e. removal of precursor from only one of the 
four cell-free products. Negative processing (i.e. non removal 
of the ovalbumin precursor vivo) is reportedly ruled out by the 
NH^ terminal sequence of ovalbumin as sequenced by Palmiter et al., 
(1977) although his data is not shown. The possibility remains 
that ovalbumin is synthesized as a precursor but the sequence is 
particularly susceptible to proteolytic cleavage.
Palmiter's results suggest that the precursor peptide "signal" 
mechanism may not be the only mechanism whereby secreted proteins 
are/
are translocated across membranes (see also discussion of Ig H chains). 
His results, however, do not rule out the "signal" hypothesis; they 
merely show doubts in its complete generality.
_____ Concluding remarks.
The investigation of the translation of murine myeloma cell 
mRNA in a heterologous cell-free protein synthesizing system offers 
the possibility of answering some questions concerning the nature 
of the control of production and secretion of Ig molecules.
Cell-free products may be characterised by several criteria 
and compared with their cellular analogues. Precursor sequences 
can potentially be identified on the basis of mobility or by 
examination of protease digests of the cell-free and cellular 
species. The effect of the absence of action of other cellular 
processes (e.g. carbohydrate addition) can be investigated.
The control of the relative synthesis of different polypeptide 
species in cell-free systems can be examined by use of controlled 
changes in the environment in which protein synthesis occurs.
Results obtained by changing various parameters can be compared 
with predictions of their effects. This allows more understanding 
of the way control of protein synthesis may operate in myeloma cells 
themselves.
MATERIALS
General
1.1. RadioChemicals
All isotopically labelled compounds were obtained from the Radiochemical
Centre, Amersham, England.
L {4,5-^h } leucine
D {6-^h } glucosamine
L (methyl-^H) methionine
L {u-^^c} isoleucine 
35
L { S} methionine 
{^h } Amino-acid mixture
54 Ci/mmole 
19 Ci/mmole 
6 Ci/mmole
0.348 Ci/mmole 
250' - 1050 Ci/mmole 
ImCi /ml.
(contains all aminoacids except met, cys, trp, gin, asn)
1.2. Chemicals for Liquid Scintillation Spectrometry
The chemicals for liquid scintillation spectrometry were obtained as
follows :-
2,5 diphenyloxazole (PRO)
Toluene (AR Grade) 
Triton-X-100
Protosol
Koch-Light Laboratories Ltd., 
Colnbrook, England
Rohm & Haas (U.K.) Ltd.,
Jarrow, England
New England Nuclear, Boston, 
Massachusetts
1.3. Enzymes
Micrococcal nuclease (S. aureus)
Creatine kinase (Sigma grade) 
Pancreatic ribonuclease A 
Trypsin/
P-L Biochemicals, Inc., 
Milwaukee, Wisconsin
Sigma (U.K.) Ltd., London
Trypsin TPCK Worthington Biochemical Corp., 
Freehold, New Jersey
1,4. Nucleic Acids
Calf liver t-RNA Boehringer Corporation (London) Ltd., 
Sussex, England
Tobacco Mosaic Virus (TMV) RNA was kindly donated by Dr. R.T. Hunt, 
University of Cambridge.
1.5. Photographic materials
All photographic materials were supplied by Kodak Limited, London or by 
Kodak Canada Ltd.
1.6. Other materials
All other chemicals or materials were, wherever possible, "AnalaR" reagents, 
supplied by B.D.H, Chemicals Ltd., Poole, Dorset, except for the following:- 
Glutathione (reduced form) Sigma (U.K.) Ltd., London, England
Creatine phosphate 
Trizma base
Ethyleneglycol^bis-(g-amino-ethyl ether)
N,N* tetraacetic acid (EGTA)
Cycloheximide
Sucrose (Grade 1)
Sodium deoxycholate
D,L Dithiothreitol (DTT)
2- deoxyglucose
Triton-X-lOO (purified) Koch-Light Laboratories Ltd., 
Colnbrook, England
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Acrylamide
Trichloroacetic Acid (TCA)
3 methyl“l“butanol (isoamyl alcohol)
N-ethylmorpholine
Nembutal
Non isotopically labelled 
amino acids
Koch-Light Laboratories Ltd., 
Colnbrook, England
Hepari n (mucous)
NN' methylene bisacrylamide
Abbot Laboratories, Ltd., 
Queensborough, Kent
Calbiochem Ltd., San Diego, 
California.
Evans Medical Ltd., Speke, 
Liverpool
Eastman Kodak Co., Rochester, 
New York
2. Tissue culture materials
2.1. Cell lines
Several murine myeloma tissue culture cell lines, adapted to 
culture from murine plasmacytomas were used in the course of this 
project. Their characterisation and derivation are described in
Table 4, Production levels of these cell lines, where appropriate,
are discussed in Chapter 3, Results.
2.2. Media
2.2. Standard solutions
(a) RPMI 1640 (G.E. Moore, Roswell Park Memorial Institute, 
Buffalo, N.Y.) wassupplied by Gibco Biocult Ltd., Paisley, Scotland, 
in powder form, prepared routinely by technical staff, and stored 
sterile in 500ml bottles at 4°C. The composition of the medium 
is shown on Table 5^  Glutamine was omitted during preparation 
and/
TABLE 5
Composition of RPMI 1640 medium (Gibco Biocuit, Ltd.) 
Inorganic salts mg/litre
100.0
KCl 400.0
100.0
N a d  6000.0
MgSO^.VH^O
NaHCO,
Na^HPO^.VH^O
2000.0
1512.0
Other components 
Glucose
Glutathione (reduced) 
Phenol red
2000.0
1.0
5.0
Amino Acids 
L-Arginine (free base)
L-Asparagine 
L-Aspartic acid 
L-Cystine 
L-Glutamic acid 
L-Glutamine 
Glycine
L-Histidine (free base) 
L-Hydroxyproline 
L-Isoleucine (Alio free) 
L-Leucine (Methionine free) 
L~/
200.0
50.0
20.0
50.0
20.0 
300.0
10.0
15.0
20.0
50.0
50.0
TABLE
mg/litre
L-Lysine HCl 40,0
L-Methionine 15.0
L-Phenylalanine 15.0
L-Proline (Hydroxy-L-Proline free) 20.0
L-Serine 30.0
L-Threonine (Alio free) 20.0
L-Tryptophan 5,0
L-Tyrosine 20.0
L-Valine 20.0
Vitamins
Biotin 0. 2
D-Ca Pantothenate 0.25
Choline Cl 3.0
Folic Acid 1.0
i-Inositol 35 .0
Nicotinamide 1.0
Para-aminobenzoic acid 1.0
Pyridoxine HCl 1.0
Riboflavin 0.2
Thiamine HCl 1.0
vitamin 0.005
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and added separately before use.
(b) RPMI 1640 (for radioactive labelling) was prepared from powder, 
as described above, omitting the following constituents:- methionine, 
glutamine, cysteine, sodium hydrogen phosphate, etc. These components 
were prepared separately at lOO x normal concentration and stored 
sterile at 4°C. They were added in the appropriate combination at
1% (v/v) to the RPMI 1640 before use.
(c) Foetal Calf Serum (F.C.S.) was supplied by Gibco Biocult Ltd., 
Paisley, Scotland. 500ml bottles were heat inactivated by incubation 
at 56^0 for 60 minutes, then stored sterile in 100ml aliquots at 
-20°C.
(d) Glutamine (200mM) was prepared routinely by technical staff and
stored sterile in small aliquots at -20°C.
(e) Penicillin/streptomycin (10^ units/litre and 1% (w/v)
respectively) was prepared routinely by technical staff and stored 
sterile in small aliquots at -10°C.
(f) Trypan blue (0.1% (w/v) in PBS), was prepared from a stock 
solution of 1% (w/v) in PBS.
METHODS
1. Tissue culture
1.1. Maintenance of cell lines
Cells were maintained in RPMI 1640 medium, supplemented with 
10% (v/v) PCS, 1% (v/v) glutamine and 1% (v/v) penicillin/strepto­
mycin. Small volumes of cells were grown in plastic petri dishes 
(Falcon) whilst larger volumes of cells were grown either in 500ml 
glass bottles (Medical flats) or in 80oz roller bottles. Cell 
cultures growing in petri dishes were maintained in a 37°C constant 
temperature incubator with an atmosphere supplemented by 5% (v/v)
COg. Cell cultures growing in 80oz. roller bottles were maintained 
in a 37°c hot room, and the bottles flushed before sealing with 5%
(v/v) CO^• The bottles were continuously rotated at constant speed.
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Cells were maintained at a density of between 2 x 10 and 8 x 10 
cells/ml with regular checks on density and viability. Under these 
conditions the cells adhered loosely to the surface of their 
containers. Cultures were examined visually for contamination by 
yeast or bacteria and suspect cultures discarded.
1.2. Counting cells and estimation of viability
After shaking to dislodge adherent cells, a small volume of 
medium was removed aseptically and diluted with an equal volume of
0.1% (w/v) Trypan Blue stain. The solution was thoroughly mixed 
and a small volume expelled into a haemocytometer, and examined with 
illumination under a light microscope (25X). Several counting areas 
were examined, the cell counts totalled and averaged to give the cell 
density, taking account of the dilution by Trypan Blue. Cells 
staining/
staining dark blue were counted as dead and viability estimated by 
this method.
1.3. Harvesting cells
5
Cells were generally harvested at densities of 4 x 10
5
6 X lo cells/ml. Cells grown in 80oz bottles or medical flats were 
dislodged by vigorous shaking whilst cells grown in Petri dishes were 
dislodged by repeated pipetting of the medium over the cells. The 
cells were centrifuged at 500x g ,  and were then either resuspended for 
use or stored at -70°C as a frozen pellet.
2. Preparation of radioactively labelled Ig
2.1. General
Radioactively labelled Ig was required for two main reasons. 
Firstly, Ig produced by cells labelled radioactively in tissue culture 
served as a source of marker heavy (H) and light (L) chains. These 
were used for comparison of mobilities on P.A.G.'s of cell-free 
synthesized myeloma messenger RNA translation products, including 
putative H- and L-chain-like material.
Secondly, radioactive labelling, followed by immune precipitation 
of Ig, allowed measurement of the amount of protein synthesis devoted 
to Ig in cultured cells. This could be compared with the amount of 
protein synthesis devoted to the production of similarly immuno- 
reactive material in cell-free systems stimulated by added myeloma 
cell polysomes or poly(A) RNA,
A small volume of cells grown up for polysome extraction was 
often set aside for radioactive labelling to determine the percentage 
Ig/
Ig production at the time of polysome extraction.
2.2. Cell labelling conditions
Cells were harvested in the mid log phase of growth (cell 
5 5
density 4 x 10 - 6 x 10 cells/ml: cell viability >95%) .
7
Approximately 2 x 10 cells were used in a normal labelling experiment. 
The cells were centrifuged at room temperature at 500 x g for 10 
minutes in conical tubes. The cell pellet was resuspended in 50ml 
of RPMI medium lacking the amino acid used for labelling (usually 
methionine or leucine), and centrifuged again, as described above.
The washing step was repeated two times more. This step helped to 
deplete endogenous pools of the labelling amino acid. Cells were then 
suspended in Petri dishes in a small volume (^^-3ml) of the above 
medium and incubated at 37^C for 10 minutes in a constant temperature 
incubator with an atmosphere supplemented by 5% (v/v) CO^. After this 
initial incubation, the radioactively labelled amino acid was added 
(200yci) and the incubation continued for the appropriate time. For 
experiments to test production of Ig by the cells, the time of 
labelling was 15 minutes. For experiments in which a substantial 
amount of secreted Ig was required, incubations were for 60 or 90 
minutes. At all stages viability could be checked by the Trypan Blue 
staining technique described earlier and was >95% for shorter labelling 
periods (<30 minutes) but declined over longer periods. The 
incorporation of radioactive amino acid was halted by chilling the cells 
to 4°C.
2.3/
32.3' Preparation of intra- and extra-cellular Ig-containing fractions 
After labelling, the cells were centrifuged at 500 x g for 5 
minutes at 4^0. If labelled, secreted material was required, the 
supernatant from this centrifugation was carefully decanted and 
stored at 4°c until required. The cell pellet was disrupted, re­
suspended in 1ml 0.7% (v/v) Nonidet P-40 (NP-40) in PBS and incubated, 
with occasional agitation, for four minutes at 4°c, to lyse the cells.
The lysate was subjected to centrifugation at 1800 x g for 10 minutes 
at 4°c to pellet cellular debris and nuclei. The supernatant was 
decanted carefully and stored at 4°c. Small quantities of sodium 
azide were added to each fraction to prevent bacterial contamination.
These two fractions, or immune precipitates derived from them could be 
used on P.A.G.'s as described elsewhere. Ig production was estimated 
by comparison of total TCA-precipitable material with specifically 
immuno-precipitable material using methods described in Section 11-2.2 and using 
scintillation counting techniques for detection of radioactivity.
2.4. Cell labelling in the presence of 2-deoxyglucose^
For experiments involving 2-deoxyglucose the following 
modifications to the above method were made. 10^ cells were used 
and resuspended without washing in 200yl PBS, instead of RPMI which 
contained high levels of glucose (llmM) . The cell suspension was 
then supplemented with 2-deoxyglucose^ and radioactively labelled 
amino acid and incubated at 37°C for the appropriate period in a 
CO^-enriched atmosphere. Incorporation was halted and the cells 
centrifuged as above. The supernatant was discarded, since 
2/
52-deoxyglucose blocked secretion of Ig (Melchers 1973) and the 
cells lysed in 200yl of 0.7% (v/v) NP40 in PBS at 4^C.
3.____ Preparation of polysomes from murine myeloma tissue culture cells.
3.1. Precautions against ribonuclease contamination
a. Glassware
All glassware coming into contact with solutions involved in
preparing the polysomes, and with the cell lysate from which the 
polysomes were prepared,was soaked overnight in chromic acid (lO% (w/v) 
potassium dichromate in 25% (v/v) H^SO^ ) , washed six times with tap 
water, six further times with deionised water, allowed to drain and 
finally baked for several hours at 240^C, prior to use.
b . Other equipment
"Teflon" coated equipment was treated identically to the 
glassware. Centrifuge tubes and caps were soaked briefly in a 
dilute solution of (HCl) hydrochloric acid in deionised water, washed 
six times with tap water and six times with deionised water, then 
allowed to drain. Tubing and vessels involved in preparing
sucrose gradients, and tubing and glass spectrophotometrie cells 
involved in scanning sucrose gradients were thoroughly flushed through 
firstly by a dilute solution of hydrochloric acid followed by copious 
amounts of deionised water.
c. Experimenter precautions
All operations were carried out wearing fresh disposable plastic 
gloves which were replaced if thought to be contaminated. Direct 
contact with solutions was avoided.
d. Chemicals and preparation of solutions
All chemicals used were from bottles known to have been treated
as/
S'
as if ribonuclease-free. Chemicals were tipped from the bottles 
rather than removed by spatula. Weighing boats, previously 
unopened, were used for weighing. Liquids were dispensed using 
baked pipettes or sterile Eppendorf tips. Solutions were adjusted to 
the correct pH by addition of acid or alkali as described below and the 
pH measured either by testing the pH of aliquots with pH paper or by 
measurement of the pH of the solution on a pH meter with a carefully 
washed electrode. Solutions were prepared when possible on the day 
of the polysome extraction, or, at most, one day before and unused 
solutions were discarded after the extraction.
3.2. Solutions.
Most solutions used were based on solution C.
Solution C : 50mM Tris HCl (pH 7.4)
25mM N a d
5mM Mg acetate
7mM 2-mercaptoethanol
Solution Cl: as solution C with sucrose: 0.88M
heparin : Img/ml
cycloheximide: lOOyg/ml
triton X-100: 0.08% (v/v)
Solution C2: as solution C with sucrose 0.88M
heparin: Img/ml
cycloheximide: lOOyg/ml
triton X-100: 0.08% (v/v)
KCl: 0.2M
sodium
deoxycholate
(NaDOC): 0.06% (w/v)
Solution/
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Solution C3: as solution C with sucrose: 1.5M
Solution C4: as solution C with sucrose: 0.5M
Solution C5: as solution C with sucrose: 1.25M
Solution D: 0.25m  sucrose
3.3. Preparation of polysomes.
Polysomes were prepared by a procedure developed in this laboratory 
by Bennett, Fitzmaurice and Williamson (unpublished results), and it is 
described here with their permission. The procedure was developed 
from the published methods of Ascione and Arlinghaus, 1970, Buckingham 
et al., 1974, Palmiter, 1974, Schechter, 1974 and Shapiro ^  , 1974.
To approximately 100% viable myeloma cells, growing in mid-log phase was 
added sufficient of a concentrated solution of cycloheximide in PBS to 
bring the growth medium to a final concentration of lOOyg/ml , in 
cycloheximide, to inhibit the"run-off" of ribosomes from polysomes.
The resulting solution was mixed gently for two minutes, then the cells 
were collected by centrifugation at 500 x g for 5 minutes in 750ml 
centrifuge buckets. The cells were resuspended in a small volume of 
ice-cold PBS containing cycloheximide at lOOyg/ml and collected again 
by centrifugation at lOOO x g for 5 minutes. Subsequent steps were 
carried out at 4°C whenever possible.
The cells were resuspended in four volumes of solution Cl and 
transferred to a Bounce homogeniser. In solution Cl, heparin and 
Triton X-lOO acted to disrupt the cell membrane, cycloheximide 
prevented "run-off" and heparin also acted as a ribonuclease inhibitor.
The cells were ruptured with six gentle strokes from a loose fitting 
pestle/
5.
pestle, then transferred to 45ml MSE polypropylene tubes and 
centrifuged at 48000 x g for 20 min. The supernatant was collected and 
was described subsequently as Fraction I of any polysome extraction.
The pellet was resuspended in four volumes of solution 02 (In solution
C2, cycloheximide, Triton X-100 and heparin were used as described 
for solution Cl, whilst NaDOC was used as a further means of disrupting 
membranes and 0.2M KCl was used to remove tightly bound polysomes from 
membranes) transferred to a Bounce homogeniser and homogenised vigorously 
with a tight-fitting pestle. Again the homogenate was centrifuged at 
48000 X g in MSE tubes for 20 min. The supernatant was collected and 
was described subsequently as Fraction II of any polysome extraction.
At this stage Fractions I and II could be combined if necessary.
Otherwise, they were routinely kept separate. Each fraction was 
layered on a lOml cushion of solution C3 in a 30ml polyallomer tube and 
then centrifuged at 60,000 rpm for 2 hours at 4°C in a Beckman preparative 
ultracentrifuge. Model L5-65,using a Beckman 60 Ti fixed angle rotor.
After centrifugation, the supernatant was decanted, the tube 
drained and wiped, and any contaminating material was gently washed 
off the polysome pellet with solution B. The polysome pellet was 
resuspended in a small volume of solution B by gentle homogenisation 
with a Bounce pestle and the solution stored at -70°C. Polysomes 
derived from fractions I and II were designated Fraction I and 
Fraction II polysomes respectively.
3.4./
3.4. Sucrose gradient sedimentation.
To determine the integrity of polysomes produced by this method, 
solutions C4 and C5 were mixed on a Buchler gradient maker to produce 
linear 0.5 - 1.25M sucrose gradients in 13ml polyallomer tubes.
A small volume of solution D, containing 10 - 20 A^^^ units of 
polysomes, was layered carefully on top of the gradient which was 
then centrifuged for 90 min at 40,000 rpm using a Beckman SW41 rotor 
in a Beckman L5-65 preparative ultracentrifuge.
The sucrose gradient was displaced downwards through a 1 ml 
flow cell and monitored continuously for absorbance at 250nm by a Pye 
Unicam SP 1800 Ultraviolet Spectrophotometer. The absorbance was 
recorded on a Unicam AR 25 Linear Recorder. The displacement of 
the gradient was done using an LKB Bromma 12,000 Varioperpex 
Peristaltic Pump set to speed 4 x 10. The eluant was discarded.
A typical absorption profile of polysomes prepared from PI.17 cells, 
displayed on a 0.5M - 1.25M sucrose gradient, is shown in Fig. 2.
Pl.17 polysomes and 5563 polysomes gave essentially identical polysome 
profiles. The absorption profile of a sucrose gradient containing 
no polysomes is shown as a control. Polysomes are well resolved up 
to nonamers, i.e. ribosome-messenger RNA complexes containing nine 
attached ribosomes. This method of sucrose-gradient analysis was 
used to estimate the integrity of polysomes produced by the extraction 
procedure described above.
3.5./
Pig. 2 Sucrose gradient ana­
lysis of polysomes
o o o
Polysomes were prepared as 
described in Methods5.3 and '
displayed on sucrose gradin* 
ents, as described in Method 
3.4.
3.5. Polysome integrity.
The degree of degradation occurring during the isolation of 
polysomes was estimated in the first instance by the appearance of 
the polysome profiles displayed on sucrose gradients. Polysome 
preparations showing a low polysome :monosome ratio were judged to have 
been degraded to a greater or lesser extent (Figure 2. ). Unde­
graded polysome profiles displayed:-
(a) good resolution of individual polysome sizes 
up to nine or more attached ribosomes
(b) a low monosome:polysome ratio
(c) a high percentage of material with
size greater than nonamers
The second criterion used to estimate degradation was the 
ability of polysomes to stimulate the incorporation of radioactively 
labelled amino acids into TCA precipitable material in a cell-free 
protein synthesizing system (i.e. to be translatable). Polysomal 
material from preparations judged to be degraded on the basis of their 
appearance on sucrose density gradients invariably gave much lower 
incorporation of radioactivity per unit of polysomes added than
polysomes which yielded good polysome profiles.
4. Preparation of total polysomal RNA.
Polysomes, prepared as described above, were treated by a 
modification of the pH 9.0 phenol extraction method of Lee et al., 
1971.
4.1./
4.1. Solutions.
(a) Phenol Extraction Buffer (P.E.B.); lOOmM Tris HCl, pH 9.0;
lOOmM NaCl, ImM EDTA,
2% (w/v) SDS.
(b) Phenol: Chloroform: Isoamyl Alcohol (50:50:1 by volume)
(P.O.I.)
4.2. Ribonuclease Precautions.
As for polysome isolation (Section'3.1.) where appropriate.
4.3. Extraction of RNA.
Polysomes were resuspended in P.E.B. at a concentration of
10 A_- units/ml. To this was added an equal volume of P.O.I.,
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saturated with P.E.B., and the mixture was shaken vigorously at room 
temperature for 5-10 minutes. The resulting suspension was then 
centrifuged at 16,000 x g for 10 minutes in 30ml Corex tubes. The 
P.C.I. phase was removed by aspiration through the aqueous phase and 
the extraction repeated after addition of a similar volume of P.C.I. 
to the aqueous phase. After centrifugation as before, the aqueous 
phase was carefully removed and transferred to fresh tubes and the 
extraction procedure was repeated until a mirror-like interface 
between the aqueous and phenol phases was observed after centrifugation.
Subsequently, the aqueous phase was removed, diluted by the 
addition of 2 volumes of glass fibre-filtered ethanol, and'was iriade 
to 0.2M in sodium acetate pH 5 by addition of a small volume of 
concentrated/
concentrated sodium acetate solution. This solution was allowed to 
stand at ~20°C overnight and was then centrifuged at 16,000 x g for 
10 min. The supernatant was carefully decanted and the pellet of 
precipitated RNA was dried with a gentle air current. The pellet 
of RNA was redissolved in binding buffer for application to oligo- 
(dT) cellulose columns. Yields of RNA were, in general, 85% - 
100% of the polysome detected RNA.
5 ._____ Isolation of poly (A)-containing RNA.
Fractionation of total polysomal RNA into poly(A)- and 
non-poly(A)-containing species was carried out by making use of the 
selective retention at high salt concentrations of poly(A)-containing 
species by oligo(dT)-cellulose. This fractionation procedure was a 
modification of that described by Swan, Aviv and Leder, 1972.
5.1. Solutions.
Three solutions were used, each containing O.OlM Tris pH 7.5, 
0.1% (w/v) SDS, ImM EDTA. 0.1% SDS was present to prevent
ribonuclease degradation. In addition, the solutions contained
varying concentrations of LiCl as described below.
1. Loading buffer: 0.5M LiCl
2. Intermediate wash buffer: O.IM LiCl
3. Elution buffer: No LiCl
LiCl was used as the salt in these solutions because of the 
greater solubility of Lithium dodecyl sulphate at low temperatures. 
The/
The intermediate wash solution was included in the procedure to 
decrease the contamination of the poly(A) RNA fraction with ribosomal 
RNA.
5.2. Procedure.
Ig oligo dT cellulose (2.5ml) , equilibrated with loading buffer 
was held in a 10ml column, washed with 2 column volumes of O.lN NaOH, 
and re-equilibrated with loading buffer. Polysomal RNA (40-100 A^^^ 
units) was applied to the column in loading buffer and washed through 
the column with several volumes of loading buffer. The column was 
then washed with two volumes of intermediate wash buffer and the 
majority of poly(A) containing RNA species were eluted with one 
column volume of eluting buffer. Continuous monitoring of the 
optical density of the eluted volume (see Fig. 3. ) indicated that
approximately 3% of material applied to the column was retained and 
eluted after application of the elution buffer. Estimates based on 
the optical density of pooled bound and unbound material suggested 
that between 1% and 4% of total polysomal material adhered to the 
oligo dT column.
6./
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Total polysomal RNA, prepared 
as described in Methods 4> 
was fractionated as described \
in Methods 5, and the eluant 
monitored at 280 nm#
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6._____Rabbit reticulocyte lysate .
6.1. Preparation of rabbit reticulocyte lysate.
6.1.1. Induction of reticulocytosis.
Rabbit reticulocyte lysate was prepared by a modification of 
the method of Waxman & Rabinowitz, 1966. New Zealand white rabbits, 
weighing between two and four kilograms were injected subcutaneously 
on four successive days with a 2.5% (w/v) solution of phenyl- 
hydrazinium chloride, containing 2.5mM reduced glutathione, pH 7.0 
at a dosage of 0.4ml solution/kilogram body weight/day. After resting 
the rabbits for two days, on the seventh day of the regime they were 
anaesthetized using a solution containing equal volumes of sodium 
pentobarbitone solution (Nembutal) and 1% (w/v) heparin solution 
(173 units/mg), by ear vein injection. The rabbits were bled out by 
cardiac puncture, the blood being collected in cooled, heparinised 
vessels. Whilst still anaesthetized, the rabbits were surgically 
opened and the aortas severed in order to ensure death. This procedure 
generally yielded 80-150ml of blood per rabbit.
6.1.2. Estimation of the degree of reticulocytosis induced.
The extent of reticulocytosis was estimated using the staining 
technique developed by Brecher, 1949. A small volume of blood was 
mixed with an approximately equal volume of an aqueous solution of 
0.5% (w/v) New Methylene Blue dye ; 1.6% (w/v) potassium oxalate, 
and allowed to stand for ten minutes. The mixture was then expelled 
on to a glass microscope slide, smeared, and dried by a gentle current 
of air. The smear was examined by microscope at lOOX under oil 
imraeraon/
FIG‘ 4- COMPARISON OF NORMAL 
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Anaemia was induced as desc­
ribed in Methods6.1.1. The 
degree of reticulocytosis 
was determined as described 
in Methods 6.1.2.
immersion. Reticulocytes stained deep blue and appeared granular 
whilst erythrocytes stained light green. The degree of reticulocytosis 
was always greater than 50% and generally greater than 90%, In 
contrast, normal rabbit blood contains less than 2% reticulocytes (see 
Fig. 4 ).
6.1.3. Preparation of lysate.
All subsequent steps were performed at 4°c and with minimum 
delays. The rabbit blood cells were pelleted by centrifugation at 
500-1000 X g. The serum was removed by aspiration and the packed 
cells resuspended in approximately four volumes of ice cold BSS and 
pelleted as described above. The supernatant was removed by 
aspiration and white cells, constituting a "buffy coat" layer above 
the red blood cells, were also carefully removed by this method.
The above step was repeated two times more, after which an equal 
volume of deionised water was added to the packed cells and the 
mixture was agitated vigorously before being left on ice for three or 
four minutes. This step lysed the reticulocytes. The solution
was then centrifuged at 16,000 x g for 10 minutes to pellet cellular 
debris and unbroken cells. The supernate, deep ruby-red in colour, 
was the final reticulocyte lysate, and was divided into aliquots of
0.8ml and stored at -70°C.
6.1.4./
6.1.4. Preparation of reticulocyte polysomes.
Reticulocyte polysomes were prepared by centrifugation through
a sucrose cushion, as follows. 4-5ml of rabbit reticulocyte lysate
was supplemented with solutionE(see Section 7.1.1.) to a final
concentration of 25yM haerain, 12.5raM KCl, 5mM Tris HCl pH 8.2. The
lysate was layered on top of a 20ml cushion of solution C3 (see
Section 3.2.) in a 30ml polyallomer centrifuge tube. The remaining
volume was filled with solution C (see Section 3.2.) the tube sealed
and centrifuged at 60,000 rpm in a Beckman 60 Ti rotor by a Beckman
o
LS-65 centrifuge for 120 min at 4 c. The supernatant was decanted 
and the polysomes were resuspended in 0.25M sucrose, ImM MgOAc, O.lmM 
EDTA, Polysome yields were 8 A^^^ units/ml retie.lysate.
6.1.5. Preparation of high salt wash factors.
Polysomes were extracted to yield high salt wash factors as 
described by Gross, 1977. All steps were carried out at 4°C.
A 6mg/ml suspension of polysomes in the buffer described above was 
made 0.55M in KCl by the addition, with constant stirring, of small 
quantities of IM KCl solution. The final solution was stirred for 
one hour. The solution was then layered carefully on top of a 
cushion of solution C3 (see Section 3.2.) in a 10ml polyallomer tube, 
and centrifuged at 60,000 rpm in a Beckman SW 6o rotor by a Beckman 
L5-65 ultracentrifuge for 150 minutes, in order to pellet polysomes. 
The high salt layer was then removed carefully and stored at -70°C.
6.2./
6.2. Reticulocyte lysate cell-free protein synthesizing assays.
The system adopted, with some modifications, was that described 
by Maxwell ejt , 1971. This system has been proven to be success­
ful in translating exogenous messenger RNA, notably by Rhoads e^ a2., 
1971.
6,2.1. Solutions.
Assays performed using the system consisted of three components
1. Reticulocyte lysate, prepared as described 
previously - 30yl per assay
2. RNA or polysomes in aqueous solution,
prepared as described elsewhere (Methods 3, 4 and 5)
-25yl per assay
3. Supplement, composition described in Table 6 ^
-25vil per assay
6.2.2. Assay conditions.
Assays were carried out in Eppendorf 1.5ml micro test tubes,
held in a water bath heated by a Haake E52 Constant Temperature
Circulator to 25°C. Normally, assays were incubated for 60 min.
The incubations were stopped by cooling rapidly to 4°c and were
stored frozen. Measurement of the incorporation of radioactive
amino acids into total protein and into specifically precipitable
material were carried out following methods described in Sections 8.2.
and 11.2.
7./
TAB IE (>•
COMPONENTS OF RETICULOCYTE LYSATE SUPPLEMENT
Component
Percentage, 
by volume, 
of supplement
Final 
concentration 
in assay___
33mM ATP, adjusted to pH 7.2 with KOH
6.6mM GTP, adjusted to pH 7.2 with KOH
SOOmM creatine phosphate, adjusted to pH 7,2 
with HCl
19 L-(^H) amino acids, each at 1.3mM 
3.84M KCl 1
102mM MgOAc j
added together
Creatine kinase (lOmg/ml)
83yM L-(^H) leucine 
L“ (^ H) leucine (ImCi/ml)
Haemin, 60yg/ml in 5mM Tris HCl pH 7.2
lo
10
10
10
25
10
10
10
ImM
0.2mM
15mM
40ym
60mM
1.6mM
60yg/assay 
2 .6yM 
3.lyCi 
35yM
7._____The messenger dependent lysate (M,D,L.)
7.1. Preparation of M.D.L.
7.1.1. Standard solutions.
The following standard solutions were used throughout in experiments 
involving the M.D.L.
Solution A: 2m potassium chloride (KCl): lOmM magnesium chloride
(MgCl^)
Solution B: 
Solution C:
Solution D:
Solution E ;
Solution F: 
Solution G:
0.2M creatine phosphate 
19 unlabelled amino acids, each at a 
concentration of 0.8mM. Leucine or 
methionine was omitted as required. 
Creatine kinase: 0.5% (w/v) in 50%
(v/v) glycerol
ImM haemin: 20mM Tris,HCl, pH 8.2:
50mM KCl in 90% (v/v) ethanediol
O.lM calcium chloride (CaCl^) 
Micrococcal nuclease: Img/ml in
glass distilled H^O (specific activity 
22000 - 29000 units/mg)
Solution H: 0.5M Ethyleneglycol-bis-(g-aminoethyl
ether) N,N' Tetraacetic Acid (EGTA) 
neutralised to pH 7.4 with KOH.
All solutions were prepared using deionised water, unless 
otherwise stated. All solutions were stored as small aliquots at 
-20°C except solutions F and H which were stored at 4^c.
7.1.2./
7.1.2. Preparation of M.D.L.
M.D.L. was prepared following the method of Pelham and Jackson, 
1976. Rabbit reticulocyte lysate, prepared as described previously, 
and stored in 0.8ml aliquots at -70°C, was thawed rapidly to 4°C and 
the solutions described in the previous section added in the following 
order and in the volumes shown
800 yl rabbit reticulocyte lysate 
+ 25 yl Solution E
+ 10 yl Solution D
+ 50 yl Solution A
+ 50 y1 Solution B
+ 50 yl Solution C
All additions were made at 4°C.
In solution E, the presence of haemin prevented the formation 
of a translational inhibitor which forms rapidly in reticulocyte 
lysates at temperatures above 4°c (Gross and Rabinowitz, 1972).
Solution D (creatine kinase) and B (creatine phosphate) provided a 
source of energy which was non-limiting over the period used for 
assays whilst Solution C provided non-limiting quantities of those 
amino acids not radioactively labelled. These amino acids were in 
addition to the endogenous pools of amino acids found in the 
reticulocyte lysate. Solution A adjusted the potassium and 
magnesium concentrations to near the optimum levels for the M.D.L.
No ATP or GTP was added because studies by Balkow e_t al. , 1975 had 
suggested that these triphosphates have mutually antagonistic actions 
in the rabbit reticulocyte lysate system, when added in large quantities, 
and that endogenous pools of these compounds are sufficient for normal 
translation/
translation.
After these additions had been made, lOyl of solution F, 
providing Ca , followed by lOyLof solution G, containing calcium- 
dependent nuclease, were added. The supplemented lysate was 
shaken vigorously to allow complete mixing, and allowed to incubate 
for 15 minutes at 20°C. This step, involving a calcium- 
dependent nuclease, destroyed almost all messenger activity by "nicking" 
whilst leaving most transfer RNA and ribosomes essentially intact 
functionally. The nuclease action was stopped by the addition of 
5yl of solution H, which chelated calcium ions present in the solution 
and hence inactivated the calcium-dependent nuclease.
The M.D.L. thus prepared could either be used immediately or 
stored for several weeks at -7o°C without appreciable loss of activity.
7.2. M.D.L. cell-free protein synthesis assays.
Unless otherwise stated, the following conditions were used in 
cell-free protein synthesizing assays carried out using M.D.L,
Assays were performed in Eppendorf 1.5ml micro test tubes. Additions 
to the system (polysomes, poly(A)(+) RNA, etc.), excluding radio­
actively labelled amino-acids, were never greater than 20%, and 
normally 10%, by volume. In assays in which no additions or varying 
volumes of additions were made to the system (e.g. assays to determine 
endogeneous incorporation of radioactive amino acids) all assays were 
adjusted to the same volume with deionised water. Radioactive amino 
acids were added in a volume of 5yl. The amount of radioactivity 
added depended on the specific activity of the supplied solutions of 
amino/
35
amino acids and, in the case of L-( S) methionine, on the age of the 
batch used. In all cases, the number of pmoles of radioactive amino 
acid added was at least an order of magnitude lower than the endogenous 
pool size of that amino acid. The volume of M.D.L. normally used in 
assays was SOyl. This volume could be scaled up or down proportionally 
if desirable.
Assays were carried out at 30°C in a water bath heated by a 
Haake E52 Constant Temperature Circulator and the incubation time was 
either 40 minutes (using leucine as the labelled amino acid) or 120 min 
(using methionine as the labelled amino acid), Reactions were stopped 
by chilling the tubes rapidly to 4°C and storing the sample either at 
4°C or frozen at -70°C. The former method of storage was used to 
prevent artefacts of freezing and thawing, such as aggregation of proteins, 
but led to an apparent oxidation of the M.D.L., as shown by the change 
in colour of the sample, after periods of two weeks or greater.
8. Detection of Radioactive Incorporation.
Incorporation of radioactively labelled compounds by cells or by 
cell-free systems was detected by liquid scintillation counting using a 
Beckman LS-333 Liquid Scintillation Counter.
8.1. General Methods of Preparing samples for Scintillation Spectrometry,
8.1.1. Samples on paper discs.
Samples prepared by precipitation on paper discs were counted in 
glass or plastic scintillation vials, containing 5ml of 0.4% (w/v)
2/
2,5 diphenyloxazole (PPO) in toluene. Efficiency of counting by 
this method was measured as '\/9% for (^H)-labelled material and 
for (^^S)- and (^^C)-labelled material.
8.1.2. Liquid samples.
Liquid samples, such as redissolved immune precipitates or 
TCA precipitates were adjusted to a volume of 500yl with water and 
counted.in glass or plastic scintillation vials containing 5ml of
0.4% (w/v) PPO in a toluene-triton solution (2:1 by volume). Under 
these conditions, measurement of the external standard gave a value 
of 0.318 ± O.Ol (n = 17). With this low but constant value, samples 
prepared by TCA precipitation and immune precipitation could be 
directly compared.
8.1.3. Gel slices.
a) Bisaerylamide crosslinked.
Individual gel slices, obtained as described in Section 9*l-5 
were placed in plastic scintillation vials, 0.5ml of"Protosol" was 
added, and the vials were heated at 60°C for 60 minutes to allow 
digestion to occur. After cooling, 5m1 of toluene:PPO solution 
was added to each vial and the vials examined for radioactivity by 
liquid scintillation counting.
b) Diallyltartardiamide crosslinked.
Gel slices were digested by addition of 0.3ml 2% periodic 
acid and incubated for >1 hour at room temperature. 5ml of triton/ 
toluene/
toluene/PPO solution was added to each vial and the vials examined 
for radioactivity by liquid scintillation counting.
8.2. Detection of incorporation of radioactivity by reticulocyte 
lysate assays or M.D.L.s.
8.2.1. Paper disc/toluene/PPO detection method.
For all estimates of incorporation of radioactively labelled 
amino acids into polypeptides by cell-free systems, where comparison 
with immunopre c ipi tate s was not carried out, the following protocol 
was used, adapted from the method of Bollum, 1958.
From each cell-free assay, duplicate 5yl aliquots were spotted 
on Whatman 3MM 2.5cm filter paper discs and dried at room temperature. 
The discs were placed in a perforated basket and processed successively 
through the following solutions:-
1. 10% (w/v) TCA at 4°C for several minutes to precipitate 
protein and RNA.
2. 5% (w/v) TCA at room temperature for 10 minutes to
wash out excess free labelled amino acid.
3. 5% (w/v) TCA at lOO^C for 10 minutes to discharge
amino acids from tRNA.
4. lO% (w/v) TCA: 98% formic acid: 30% (w/v) H^O^
(2:1:1) at room temperature for 50 minutes to 
bleach coloured components.
5. Ethanol:diethyl ether (1:1) at room temperature for
lO minutes followed by
5. Diethyl ether at room temperature for 10 minutes,
these last to dry the discs of water.
All/
All solutions, except 5 and 6, contained lOmM unlabelled amino acid. 
All solutions, except 3, were stirred continuously using a magnetic 
stirrer. After step 6, the discs were dried under a heat lamp, 
then placed in glass or plastic scintillation vials, each containing 
5m1 toluene:PPO and their radioactivity measured by scintillation 
counting as described in Section 8.1.1. Duplicate samples generally 
varied by 5% or less. Latterly, duplicate blank paper discs were 
included in the washing procedure to estimate free radioactive amino 
acids adhering non-specifically to the discs. Counts detected on 
these discs were subtracted from the assay disc results.
8.2.2. Triton/toluene/PPO detection method.
This method allowed direct comparison of total TCA precipitable 
and specifically precipitable material. 5yl aliquots of M.D.L. or 
reticulocyte lysate were treated with fresh acid-acetone solution (1% 
(v/v) HCl in acetone), to precipitate and decolourise protein.
The precipitated material was washed once with 5% (w/v) TCA, 
resuspended and boiled for 10 minutes in 5% (w/v) TCA, then washed 
with ethanol-diethyl ether (1:1 by volume) and ether. The dried 
precipitate was dissolved in 9M deionised urea and aliquots treated as 
described in Methods 8.1.2.
8.3. Fluorographic detection of radioactivity (Bonner and Laskey, 1974)
8.3.1. Polyacrylamide gels.
Detection of radioactively labelled proteins in polyacrylamide
slab/
M  g"
slab gels was both awkward and time consuming to perform using the 
slicing, solubilising and counting methods described for tube gels. 
Moreover, the advantages of increased resolution and comparability 
of adjacent gel wells were decreased using these methods.
Consequently, the PPO impregnation technique developed by Bonner 
and Laskey, 1974 was used.
Slab gels (approximately 40mls liquid volume) were soaked 
with gentle agitation in two successive 500ml volumes of dimethyl 
sulphoxide (DMSO) for 1 hour each. This replaced water present in 
the gel with DMSO, in which PPO is soluble. This differed slightly 
from the method of Bonner and Laskey in that the ratio of DMSO volume 
to gel volume is lower but the washing time is longer to compensate. 
The gel was then immersed in four volumes of a 20% (w/w) solution of 
PPO in DMSO and gently agitated for 1 hour. This step is shorter 
than in the published method since experience showed a longer time to 
be unnecessary and long washing times increased diffusion of proteins. 
To precipitate PPO within the gel, the last solution was decanted and 
the gel flushed continuously for 1 hour with H^O. Gels were dried 
on to Whatman 3MM paper under vacuum.
Fluorography was carried out using Kodak RP Royal "X-Omat" 
or, where stated, Kodak Xomatic H Medical X-ray film. The gel was 
held in contact with the X-ray film between two glass plates.
The gel, film and plates were placed in a light-safe bag and stored 
at -70°C . When exposed for the required period they were developed 
by standard methods.
8.3.2./
8.3.2. Thin layer chromatographic plates.
After separation of labelled species on thin layer 
chromatographic plates (either polyamide sheets for dansylation 
experiments or silica gel sheets for tryptic mapping), PPO was 
introduced into the dieets as follows. Ascending chromatography was 
performed in the same direction as used for the second dimension 
separations performed previously on the sheets, using a solution of 
7% (w/v) PPO in acetone or ether. The sheets were then dried at 
room temperature and fluorography carried out as described for dried 
polyacrylamide gels.
8.3.3. Quantitative analysis of Fluorographs.
Fluorographs of PAG's were quantitatively analysed by 
densitometry using a Joyce-Loebel scanning densitometer.
9._____5.D.5. polyacrylamide gel electrophoresis (PAGE).
9.1. Polyacrylamide tube gels.
The composition of polyacrylamide tube gels and buffers was that 
described by Summers et al., 1965 with some slight modifications.
9.1.1. Standard Solutions.
Components are shown with their final gel concentrations in 
parentheses, where appropriate.
a) Solution A: 0.334M (O.lM) sodium phosphate buffer pH 7.2:
0.166/
0.166% (v/v) (0.05% v/v) N N N'N' Tetramethylethylene
diamine (TEMED): 0.33% (w/v) (0.1% (w/v)) SDS;
6M (6M) urea.
b) Solution B: 16.6% (w/v) acrylamide: 0.45% (w/v) NN'
methylene bisacrylamide: 6M urea.
These solutions were filtered, stored in brown bottles at 
4°c and used within two months. Various proportions of these 
solutions were mixed with fresh 6M urea as described below to 
produce-gels containing different acrylamide concentrations.
% acrylamide in gel Solution A Solution B 6M urea
5 3 3 4
6.6 3 4 3
7.5 3 4.5 2.5
lO 3 6 1.0
Alternatively, in some experiments, diallyltartardiamide was 
used as crosslinking agent instead of bisacrylamide. Polymerisation 
was catalysed by the addition to the gel solution of 0.2% (w/v) 
ammonium persulphate.
c) Running buffer
O.lM sodium phosphate buffer pH 7.2 containing 0.1% (w/v)
SDS.
9.1.2. Pouring gels.
Polyacrylamide tube gels were formed in 7.5cm gel tubes (0.7cm 
internal diameter). The bottom of the tube was sealed with Parafilm, 
the gel solution carefully added to about 0.5cm from the top of the 
tube and a small volume of deionised water carefully layered on top 
of the gel solution to provide a flat surface to the gel and to 
exclude/
exclude oxygen. After polymerisation, the parafilm was removed 
and the water decanted. The gels were placed in a standard tube 
gel electrophoresis apparatus and the lower and upper chambers 
filled with running buffer.
9.1.3. Sample preparation.
Samples for electrophoresis were dissolved in 2% SDS, 
reduced at 37°C for 30 min by addition of Dithiothreitol (DTT) 
to 50mM, and alkylated at room temperature for 30 min by addition of 
iodoacetamide to 120mM. After boiling, the samples were mixed 
with a small volume of bromophenol blue dye solution in 50% (v/v) 
glycerol and carefully layered on top of the gel.
9.1.4. Electrophoresis conditions.
Tube gels were electrophoresed at 7.5mA/gel until bands formed 
by the bromophenol blue tracking dye had reached within 1cm of the 
end of the gel. Gels were removed from their tubes and either sliced 
immediately or stored frozen at -70°C, until required.
9.1.5. Gel slicing.
Gels were sliced by pressing through an array of 100 parallel 
razor blades arranged 1mm apart. The gels were best sliced whilst 
semi-frozen. Individual slices were then removed from the slicer 
and placed in glass or plastic scintillation vials.
9.2/
9.2. Polyacrylamide slab gels.
The composition of polyacrylamide slab gels and buffers was 
that described by Laemmli, 1970 for tube gels, with some slight 
modifications.
9.2.1. Standard solutions.
a) Separating gel solutions.
Solution 1; 30% (w/v) acrylamide: 0.8% (w/v) NN'methylene
bisacrylamide. Before use, the acrylamide was recrystallised from 
chloroform in order to remove impurities. After making solution 1, 
it was stirred slowly for one hour with 10% (w/v) "Amberlite" 
resin to deionise the solution, followed by filtration through Whatman 
No. 1 filter paper to remove the resin. The deionised solution was 
stored at 4°C in a brown, stoppered glass bottle for no longer than two 
months.
Solution 2 : 1.5M Tris HCl, pH 8.8: 0.13% (v/v) NNN'N' Tetramethylethylene
diamine (TEMED). This solution was stored at 4°C. The TEMED 
concentration is 30% higher than that described by Laemmli.
This ensured more rapid polymerisation of the gel.
Solution 3: 0.4% (w/v) sodium dodecyl sulphate (SDS). This
solution was stored at 4°C.
Solution 4 ; 15-20mg ammonium persulphate, per lOml of solution 3.
This solution was made immediately before use and was not stored.
b) Stacking gel solutions.
Solution 5: as solution 1 above
Solution 6 : 0.65M Tris pH 6.8 (adjusted with concentrated HCl)
Solution/
Solution 7; 10% (w/v) SDS.
c) Other solutions.
Solution 8 : Reservoir buffer: 0.125M Tris - 0.96M glycine pH 8.8;
5% (w/v) SDS. This solution was a five times concentrated stock 
solution. It was stored at room temperature and diluted immediately 
before use.
Solution 9 : Sample buffer; 0.08M Tris HCl, pH 6.8; 2% (w/v) SDSt O.lM
DL-Dithiothreitol (DTT); 10% (v/v) glycerol; 0.001% (w/v)
Bromophenol Blue dye. This solution was made in 50ml quantities and 
stored at -20°C, frozen as small aliquots. This solution differed 
from that of Laemmli in two respects. The molarity of Tris in the 
solution was 20% higher which improved buffering capacity. The 
reducing agent used in the solution was DTT instead of 2-mercaptoethanol; 
DTT was a more stable reducing agent.
9.2.2. Preparation of gel solutions,
a) Separating gel.
.Shown below .are • the proportions of Solutions 1,2 and 4 
required to make gels containing various percentages of acrylamide.
Percentage acrylamide
Solution 3% 5% 7.5% 10% 12.5% 15%
1. (acrylamide) 0.4 0. 66 1.0 1. 33 1.66 2.0
2. (Tris-TEMED) 1.0 1.0 1.0 1.0 1.0 1.0
4. (SDS-persulphate) 1.0 1.0 1.0 1.0 1.0 1.0
H2O 1.6 1.33 1.0 0.66 0.33 0
All/
bAll solutions were at room temperature when mixed. Solution 4
was added last and the complete gel solution was de-aerated for
approximately 60s in a stoppered side-arm flask attached to a water
pump. The solution was immediately poured into the gel apparatus and
kept oxygen-free as described below (Section 9.3.4.) until the solution
had polymerised.
b) Stacking gel.
Stacking gel (6% acrylamide) was prepared by mixing solutions
5,6 and 7 with H^O in the proportions 8:4:1:69. To this solution was
added TEMED to 0.1% (w/v) and ammonium persulphate to 0.1% - 0.2%
(w/v). After agitation to dissolve the ammonium persulphate, the gel
solution was poured into the apparatus as described below (Section 9.2.4.)
// 'and polymerised in the presence of a Teflon comb to produce wells for
loading samples.
9.2.3. Polyacrylamide slab gel apparatus.
The apparatus used for running of slab gels was designed by 
Dr. T.R. Mosmann with whose permission this description is given.
The apparatus (Fig. 5. ) consisted of two plastic reservoir chambers
A & B, separated by silicon rubber tubing held compressed in place by 
Bulldog clips. The first chamber (A) had a slit along its inner side
i.e. that side held clamped to the other chamber. This slit allowed 
the passage of current from a platinum electrode in the chamber into 
the gel. The second chamber (B) had a cut-away section at the top 
of its inner side providing access to the gel for current from a 
platinum electrode in this chamber. Thus a free gath for current 
existed/
Fig.5: Fbiyacrylamide slab gel apparatus.
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existed from the electrode in one chamber via the gel to the electrode 
in the other chamber. The silicon rubber tubing when compressed 
provided an enclosed space 1.5mm wide between the two reservoir chambers 
in which to pour the gel and also acted as an effective seal against 
leakage of the gel solution from between the two plates.
9.2.4. Pouring the gel.
The polyacrylamide slab gel was poured in several stages as
folbws:
a) The gel apparatus was set up with the silicon tubing in place.
The space enclosed by the silicon tubing was open at the top at the 
cutaway section of the reservoir chamber, B, and included the slot 
at the bottom of the other reservoir chamber, A.
b) The apparatus was tilted at approximately 30 degrees to the 
vertical with reservoir chamber A uppermost and about 40ml of 
separating gel solution was poured into chamber A. This formed a 
triangular wedge of liquid over the slot in chamber A, and a small 
volume of liquid was drawn up by capillary action into the gel space.
The solution was kept deoxygenated by continuously flushing chamber A 
with nitrogen until polymerisation had occurred.
c) The apparatus was returned to the vertical and, via the
cutaway section of chamber B, approximately 90ml of separating gel 
solution was poured into the gel space, taking care to avoid 
trapping bubbles of air in the solution between the plates. This 
solution (80-l00ml) reached to about 2 or 3cm below the cutaway 
section of chamber B, On top of this solution was inserted the reverse, 
flat/
oflat edge of the "comb" later used for forming wells in the stacking 
gel (see Fig. 5. ) in order to provide a smooth upper edge to this
gel solution and also in order to prevent contact with the atmosphere. 
After polymerisation, this comb was removed and the top of the gel 
flushed several times with reservoir buffer to remove unpolymerised 
gel solution.
d) About 20ml of stacking gel solution was made and some of this
solution used to fill the gap between the top of the separating gel 
and the. bottom edge of the cutaway section of chamber B . At this 
point, the "comb" was inserted with serrated edge downwards, taking 
care to avoid trapping air bubbles in the spaces between the "teeth" 
of the "comb". Polymerisation was allowed to occur and the "comb" 
removed. The spaces left were flushed several times with reservoir 
buffer to remove unpolymerised gel solution.
e) Both chambers were then filled with IX reservoir buffer, taking
care not to displace the gel wedge in chamber A. The gel apparatus 
was then ready for loading of samples and electrophoresis.
9.2.5. Preparation of samples.
Solution 9, the sample buffer was mixed with samples to be 
electrophoresed in a ratio of 9:1. Samples were in several forms. 
M.D.L. assays were either mixed untreated with sample buffer, or 
after initial precipitation with 5% (w/v) trichloroacetic acid (TCA). 
Immuno-precipitates were normally re-dissolved in 9M deionised urea 
before mixing with sample buffer.
After mixing samples with sample buffer, the resulting 
solutions were boiled for 1-2 minutes in order to completely dissolve 
and/
and dissociate the proteins. Even this procedure had difficulty 
in dissociating immune complexes. This often led to aggregated 
material remaining in sample wells and not entering the gel.
Final volumes of sample loaded were 30-50yl depending on the 
capacity of the wells produced by the "comb". The samples taken up into a 
length of thin nylon tubing (Portex) attached to a Finn pipette with 
tip, adjusted to the correct volume. Samples, expelled slowly at 
the bottom of the well, formed sharp well-defined layers due to the 
presence of glycerol in the sample buffer. The tubing was then 
carefully removed. In those wells in which no sample was being 
loaded, a volume of sample buffer, equal to the volume of the other 
samples, was added.
9.2.6. Electrophoresis conditions.
After loading all samples into their wells the gel and 
apparatus were placed in a 4^c cold-room and attached to a Shandon 
VOKAM SAE 2761 Power Pack. The samples were electrophoresed at a 
constant current of 15mA, generally overnight. The electrophoresis 
was carried out at 4°C to minimise overheating problems in the gel. 
The heat produced was nevertheless sufficient to prevent the SDS 
in the reservoir buffer from precipitating from solution.
9.2.7. Elution of polypeptides from polyacrylamide gels.
Fluorographs of dried, PPO-impregnated gels were matched with 
the appropriate gels and radioactively labelled bands of interest were 
marked/
■' . n p*
marked out on the gels. Such areas of the gel were then carefully 
excised, the backing paper removed and were chopped into small 
pieces. These pieces were then resuspended in 1 ml 0.1% (w/v) SDS, 
0.05M Tris, pH 8.2, O.OlM DTT and incubated overnight at 37°C.
The gel pieces swelled up and absorbed some of the buffer. The 
remaining buffer was removed and lyophilised. A small aliquot 
was set aside for estimation of the radioactivity released and was 
analysed in triton/toluene/PPO by scintillation counting as described 
in Section 8.1.2.
10. Preparation and use of dextran gel (Sephadex) columns.
10.1. Materials.
The following grades of Sephadex beads were used in this 
project:- G-lO fine, G-25 fine, G-25 coarse, G-lOO. Both home­
made and commercially manufactured columns were used. 
Commercially produced columns were supplied by Pharmacia (G.B.) 
Ltd. Where necessary and applicable, scrupulous ribonuclease 
precautions were employed, as described in Section 3.1.
Otherwise columns and attachments were thoroughly washed with 
deionised water before use.
10.2. Preparation and pouring of gels.
■i
For each grade of Sephadex used, the beads were swollen 
for the period recommended by the manufacturer either at room 
temperature or heated in a boiling water bath. The beads were 
swollen/
8swollen in deionised water. After swelling, the gel slurry was 
carefully poured into the column, so as to avoid trapping bubbles, 
and the gel allowed to settle. The gel was then equilibrated 
with the buffer required by passing several column volumes of 
buffer through the gel. The columns were then used immediately. 
Gravity flow was used with pressure heads recommended by the 
manufacturers.
10.3. Separation of Ig H and L chains on G-lOO Sephadex.
500ml G-lOO Sephadex, prepared as described in Section 10.2, 
was equilibrated with 6M deionised urea in 20% neutralised formate 
buffer (IN formic acid + 0.2N NaOH) under a constant pressure 
head of 15cm. Reduced and alkylated Ig in urea/formate buffer 
was loaded in the column by gravity feed and washed through the 
column with urea/formate buffer under a constant pressure head of 
15cm. Eluant was monitored continuously at 280nm by an LKB 
Spectrophotometrie scanner/recorder and collected in 3ml fractions.
A typical eluant profile is shown in Fig. 6, The first peak to
elute was H chain, and the second L chain. Appropriate fractions 
were pooled and protein precipitated, when required, by acetone 
precipitation. Recovery of A^^^ absorbing material varied between 
60 and 90% of loaded absorbance units. Radioactively labelled Ig 
was added in the presence of excess unlabelled Ig. This un­
labelled Ig was normally the immune complex by which the radio­
actively labelled Ig had been isolated. Recoveries of radioactively 
labelled Ig (by cpm) were generally lower than recoveries of A^g^ 
absorbing/
FIG, 6: Séparation of Ig H and L chains by Sephadex G-lQO
chromatography.
Ig was reduced and alkylated, as described in Methods 
9.1.3., then loaded on to a column of G-lOO Sephadex, pre­
equilibrated with 6m  urea/20% neutralised formate buffer 
(Methods 10.3.). The sample was loaded in this buffer. 
Eluant was continuously monitored for absorbance at 280nm,. 
and collected in 3ml fractions. The fractions were 
independently monitored at 280nm. H and L chain fractions 
were taken as indicated and pooled.
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oabsorbing material (30 ~ 50% cpm loaded).
Small aliquots of each eluant fraction were dissolved in 
triton/toluene/PPO as described in Section 8.1.2. and radio­
activity measured by scintillation spectrometry.
10.4. G-lO, G-25 Sephadex.
Use of these gels will be described in the appropriate 
section- of Results, (Results, Section 15).
11.____Immune precipitation techniques.
11.1. Antisera.
a) Antisera directed against mouse immunoglobulin.
Antisera directed against murine myeloma Ig species were
raised in rabbits by standard methods. Antisera were stored 
sterile at 4°C and centrifuged before use to remove aggregated 
material. Antisera against 5563 Ig and Pi Ig were prepared in 
this way.
b) Antiserum directed against rabbit immunoglobulin.
Antiserum directed against rabbit immunoglobulin was
raised in goats by standard methods. Antiserum was stored 
sterile at 4°C and centrifuged before use to remove aggregated 
material.
c) Normal rabbit serum (NRS).
Normal rabbit serum was obtained from whole rabbit blood, 
after removal of blood cells and fibrinogen by clotting. It was 
stored sterile at 4°C and centrifuged before use to remove 
aggregated material,
d) /
od) Other antisera.
Antisera raised against SAMM 368 H (a) chain, H (y) chain and 
L (k ) chain were
kindly donated by Dr. T.R. Mosmann.
11.2. Precipitation techniques.
11.2.1.Direct.
Techniques used here were adapted from those of Rhoads ejt al., 
1973. The sample which contained immunoprecipitable material was 
diluted fifty-fold in PBSA containing Triton X-lOO (1%(v/v))and NaDOC 
(l%(w/v)l. 5yl of rabbit anti-mouse antiserum (or an equal volume 
of normal rabbit serum) was added to the solution and interaction 
allowed to occur at 37°C for 30 minutes, followed by incubation 
overnight at 4°C. The solution was then layered over discontinuous 
layers of 0.5M sucrose and IM sucrose in PBSA/Triton/DOC in an 
Eppendorf micro test tube. The tube was centrifuged at 16,000 x g 
at 4°C for ten minutes in a Sorvall HB-4 rotor. Immune complexes 
were centrifuged to the bottom of the IM sucrose layer. The entire 
tube was frozen at -70°C and the tip of the tube, containing the 
immune complexes, was cut off using a hot scalpel blade. The 
tip was treated in one of two ways :-
(i) The tip was washed with several volumes of ice cold PBSA
to remove the immune complex pellet followed by centrifugation of 
the PBSA to re-pellet the material.
(ii) Alternatively, the tip was washed with a small volume 
(50yl) of deionised 9M urea to dissolve pelleted immune complexes 
and/
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and the urea solution was transferred to a fresh Eppendorf tube. 
This method involved fewer losses and was used latterly.
11.2.2. Indirect.
The sample was diluted fifty-fold as described for direct 
immune precipitation and 5yl of rabbit anti-mouse antiserum was 
added. Reaction was allowed to proceed at room temperature for 
30 minutes. A volume of goat anti-rabbit Ig sufficient to precipitate 
all rabbit-mouse Ig complexes was added (100 - 140yl) and incubation 
continued overnight at 4^c. The visible immune precipitates thus 
formed were treated in either of two ways :-
(i) as described for direct immune precipitation above
(ii) The assays were centrifuged to pellet the immune precipitates. 
Supernatant was removed by aspiration and the pelleted material 
disrupted. 1 ml of ice-cold PBSA (containing unlabelled amino acid 
where necessary) was added, the pellet resuspended and centrifuged 
once more to produce a pellet. The supernatant was removed by 
aspiration and this washing procedure repeated two times more. The 
final washed pellet was dissolved in O.lM NaOH, if optical density 
measurements were required, or in deionised 9M urea for all other 
purposes.
The rationale for the various volumes of antiserum, washings, 
etc. described above is described in Results.
12. N-terminal amino group analysis of proteins/
12. N-terminal amino group analysis of proteins.
12.1. Dansylation procedure.
Determination of the N-terminal residue of proteins was 
carried out following the procedure of Gray, 1972. 50 - 250yg
acetone- or TCA-precipitated proteins were dissolved, with boiling, 
in 50yl of 1% (w/v) SDS in a small glass test tube. To this 
solution was added 50yl of redistilled N-ethylmorpholine, followed by 
75yl of a freshly prepared solution of 1-dimethylaminonapthalene- 
5-sulphonyl chloride (d^nsyl chloride) (25mg/ml) in dimethyl 
formamide. The reaction was allowed to proceed at room temperature 
for one hour, or until the characteristic’ yellow colour of dansyl 
chloride had disappeared. The protein was then precipitated by 
the addition of 0.5ml of acetone, pelletedty centrifugation and dried. 
5N HCl (arISTArJ containing ImM DTT was used to redissolve the protein 
and the tube was then evacuated and sealed. Hydrolysis of peptide 
bonds was promoted by incubation for 12 hours at 105^0. Thereafter, 
the tube was opened and the HCl driven off under vacuum against 
sodium hydroxide pellets. The residue was redissolved in a small 
volume of ethanol (10 - 20yl) in preparation for analysis on polyamide 
layer sheets.
12.2. Chromatography of dansylated amino acids on polyamide layer sheets.
Separation of dansylated amino acids was carried out by 
chromatography in two dimensions on polyamide layer sheets after the 
method described by Woods and Wang,(1967), with some slight modifications, 
as described below. 0.5yl of a mixture of dansylated amino acids in 
ethanol was applied to one side of a 10cm x 10cm polyamide sheet in 
a/
a compact spot (approx.1mm in diameter) about 1cm from each edge.
To the reverse side, and at the same position as the spot containing 
marker amino acids, approximately 5yl of dansylated protein 
hydrolysate in ethanol was applied in a compact spot. Samples were 
applied with thin glass tubing drawn out, by heating, to capillary 
size. Chromatography in the first dimension was carried out using 
2% (v/v) formic acid as solvent. After allowing the solvent front 
to reach 0.5cm below the upper edge of the sheet, the sheet was 
thoroughly dried at room temperature, then chromatographed in the 
second dimension using toluene : glacial acetic acid (9:1 v/v) as 
solvent. Toluene was preferred to benzene because of benzene's 
known carcinogenic properties. No significant difference in 
mobility was observed between samples run with the two solvents.
The solvent front was allowed to reach 0.5cm below the 
upper edge of the sheet, then the sheet was dried in a fume hood, 
using a current of air, and examined under ultraviolet light.
Dansylated amino acids could be detected by their characteristic 
fluorescence and dansylated residues from the protein sample could 
be identified by comparison of their mobilities with the marker 
dansylated amino acids on the other side of the polyamide layer sheet. 
Radioactively labelled residues were detected as described in 
Section 8.3.2.
12.3. Non-N-terminal dansylated derivative^.
Three major types of fluorescent spot not resulting from 
N-terminal dansylation would be detected even with proteins known 
to/
to contain blocked'N~terminal residues.
1. Dansyl OH. This was the major breakdown product from the
decay of dansyl chloride and whilst much of it was removed at the 
acetone precipitation stage, a certain amount was carried over to 
the final separation on polyamide sheets. It separated as an 
extended spot with a mobility of 0.6 in the first dimension 
solvent and with little or no mobility in the second dimension 
solvent. It could easily be distinguished since it characteristically 
fluoresced with a light blue colour, whereas dansylated amino acids 
fluoresced light green.
2, Dansyl chloride reacts not only with free N-terminal NH^ groups 
but also to a greater or lesser extent with many of the amino acid 
side chains. The most reactive side groups are the e amino group
of lysine and the ionised phenolic group of tyrosine. Both these 
side chains are dansylated, if accessible, under the same conditions 
used for N-terminal dansylation and appear generally as much stronger 
fluorescing spots under ultraviolet light than the N-terminal 
dansylated amino acid due to the relatively high molar ratio of 
lysine and tyrosine residues to N-terminal amino acids in most 
proteins. Such side chain dansylated amino acids had characteristic 
mobilities quite different from the same amino acids dansylated at 
a free N-terminwa.
13. Proteolytic cleavage by trypsin.
13.1. Conditions for proteolysis.
Peptide mapping of Ig H and L chains and their putative 
precursors/
precursors was carried out using TPCK trypsin as cleavage enzyme. 
Standard techniques were employed. 50 - SOOyg of acetone or 
TCA-precipitated protein (including the appropriate carrier when 
dealing with small amounts of radioactively labelled protein eluted 
from gels) were redissolved or at least finely resuspended in 200yl 
0,5% (w/v) ammonium bicarbonate solution. To this was added 
sufficient of a Img/ml solution of trypsin in ImM HCl to give an 
enzyme : substrate ratio of 1:20. The digestion sample was incubated 
at 37°C for 4 hours, whereupon a further equal quantity of trypsin 
was added and the digestion continued at 37°c for 12 hours. The 
digested sample was then lyophilised and the residue redissolved in 
a small volume ('v20yl) of electrophoresis buffer, prior to separation 
of peptides as described below.
13.2. Separation of proteolytically generated peptides.
Peptides generated by trypsin cleavage were separated by a 
combination of high voltage electrophoresis, followed by ascending 
chromatography, on silica gel plates (Camlab Ltd., Cambridge).
Lyophilised tryptic cleavage products were re-dissolved in
0.5% (v/v) pyridine, 5% (v/v) glacial acetic acid in a volume 
sufficient to give a concentration of I00yg/5yl. 5yl of this 
solution was applied to a silica gel sheet approximately 2cm from 
each edge. The sample was applied in small amounts and dried 
after each addition. O.Syl methyl green tracking dye was applied 
close to one edge of the sheet. The sheet was then wetted care­
fully with electrophoresis buffer (0.5% (v/v) pyridine, 5% (v/v) 
glacial/
glacial acetic acid, as above) as follows. Two sheets of Whatman 
3MM paper were laid in parallel on the sheet, one on each side of 
the spots, with a 1cm gap between their edges and the sample and 
tracking gels. Electrophoresis buffer was then evenly applied 
across the paper and allowed to permeate the silica gel plate, 
approaching the spots from either side with the two solvent fronts 
finally flowing together at the positions of the sample and tracking 
spots. The silica gel plate was then placed in a high voltage 
electrophoresis tank and electrophoresed at 20mA for 5 hours.
Cotton gauze, soaked on electrophoresis buffer provided electrical 
contact between the plate and the buffer reservoirs. After 
electrophoresis, the plate was thoroughly dried and chromatographed 
at right angles to the direction of electrophoresis using butanol: 
acetic acid:water:pyridine (15:3:12:10), until the solvent front had 
reached within 0.5cm of the upper edge of the plate (approximately 
2 hours). The sheet was thoroughly dried and stained for peptides 
or further treated for fluorography, both described below.
13.3. Detection of peptides.
13.3.1. Ninhydrin - cadmium acetate.
a) Standard solutions.
Solution A: 1% (v/v) indanetrione hydrate (ninhydrin) in acetone 
Solution B: 1% (w/v) cadmium acetate in 30% (v/v) glacial 
acetic acid.
b) Detection/
95
b) Detection methods.
15ml of solution B and lOOml solution A were mixed 
immediately prior to use and the resulting solution was sprayed 
lightly and evenly over the sheet. The sprayed sheet was 
heated in an oven at 100°C for a few minutes during which time 
the N-terminal groups of the peptides react to impart colours 
varying from yellow to red to the peptide spots. The sheet was 
examined and the spots marked on the reverse side.
13.3.2. Fluorographic detection of radioactivity on cellulose sheets.
Radioactively labelled peptides were detected by application 
of techniques described in Section 8.3.2. After fluorography,
PPO impregnated cellulose sheets could be treated with ninhydrin 
-cadmium acetate as described above to visualise all tryptic products.
RESULTS
1.Polysome yields using the method of Bennett et al.
Extractions of polysomes from myeloma cells were made as 
required according to the procedures described (Methods Section 3).
The yields of these preparations are shown on Table 7. Polysome 
yields varied from extraction to extraction but several general 
points were observed.
a) The 260:280nm ratio of various polysome preparations was
found to have an average value of 1.61 ± 0.126(n=21). Variation in 
this value can be explained by the degree of contamination of polysome 
pellets by protein, DNA, etc.
t) The yield of polysomes extracted varied widely and had an
average of 57.8 ± 23.2(n = 10) Ag^^ units/lO cells. Variations 
depended on the state of the cells, and of the thoroughness of the 
extraction procedure. Yields by other workers are as follows
Palmiter, 1974
Schechter, 1974
Tissue A^^^/g wet wt* 260/280
Slime mold 18.2 1.69
Silk moth 30 1.71
Chicken Brain 33.5 1.55
Chicken Kidney 86 1.78
Chicken Liver 191 1.78
Chicken Oviduct 111 1.73
Rabbit reticulocytes 89 1.90
Murine myeloma cells 170-180 1.69
* Ig wet weight of tissue 
^  10^  cells
Hence/
TABLE 7: Polysome: yields using the method of Bennett et al.
Date
Cell
line
No. of 
cells
Polysome yield 
'*260
^260
A - A 
260 280
units/ 
10^ cells
10/2/76 Pi n.d. I
II
57
27
1.676
n.d. ?
6/4/76 PI 1.2 X 10^ I
II
72
43
1.64
1.74 96
31/3/76 5563
9
1.2 X 10 I
II
20
20
n.d.
n.d. 33.3
26/5/76 5563
9
2.7 X 10 I
II
110
65.5
1.47
1.64
65
PI
9
2.3 X 10 I
II
43
94.5
1.72
1.43 60
2/9/76 PI
9
4 X 10 I
II
182
140
1.46
1.555 80
5563
9
6 X 10 I
II
300
174
1.64
1.63 80
27/1/77 PI
9
4.2 X 10 I
II
94
25
1.51
1,66
28
5563
9
1.2 X lO I
II
38
31
1.49
1.55 60
12/2/77 PI
9
2.4 X lO I
II
42.5
33
1.33
1.78
31.5
5563
9
1.5 X 10 I
II
30
34
1.80
1.62 45
Legend: Polysomes; were prepared as described in Methods Section 3.
I and II refer to first and second extractions as described in
9
Methods 3.3, Yields of A__^ units/lO cells are based on the total
260
^260 of polysomes extracted.
Hence the yields obtained by this method are within the range 
obtained by other workers using similar extraction methods in a range 
of tissues. The average yield, however, is rather low compared to 
that found from the myeloma cell line used by Schechter (1974).
This may be due to a difference in synthetic capacity between Schechter's 
myeloma cells and those used in this project. More likely, in view 
of the variability in the polysome yields between different experiments 
in this work, it may be due to insufficiently vigorous attempts to 
extract the polysomes from the cells.
2.Translation of myeloma polysomes in the reticulocyte lysate.
Initial studies on cell-free translation using the reticulocyte 
lysate system were carried out. PI.17 polysomes, isolated as described 
in Methods Section 3, were initially donated by Dr. L. Fitzmaurice and 
Mrs. J, Bennett, although latterly. Pi.17 polysomes were prepared by 
the author. Several preparations of Pi polysomes were investigated 
for their ability to stimulate incorporation of radioactivity into 
antibody-precipitable material. Data obtained from these assays is 
collected in Table 8. Some of the polysomes used had been isolated 
by specific precipitation from a total myeloma polysome mixture.
This was done using antibodies directed against the nascent myeloma 
protein H and L chains present on the polysomes after the method 
of Schechter, 1974. Those polysomes remaining after such 
precipitation were also tested for activity. Several general 
observations were made.
Specifically precipitable radioactivity increased in a roughly
linear/
TABLE 8 ; Incorporation of L(^H) leucine by reticulocyte lysate 
containing various Pi.17 polysome fractions.
Legend;
Pi.17 polysomes, in the amounts shown,were incubated in 
80yl reticulocyte assays (Expts. 1 and 3) or 160^1,assays (Expt. 2) 
comprising polysomes, supplement and lysate in the ratio 5:5:5 
(by volume). Assays were incubated as described in Methods 6.2.2. 
Incorporation of radioactivity into TCA-precipitable material was 
measured as in Methods 8.1.2., while specific precipitations 
were carried out as in Methods 11.2.2.(a) and radioactivity 
measured as in 8.1.2. In some assays, various levels of pactamycin 
were present.
3
TABLE 8 : Incorporation of L( H) leucine by reticulocyte lysate
containing various Pi.17 polysome fractions.
Specific­
TCA- ally
precipi t- precipit­ % age
ug able able specific­
poly­ counts/ counts/ ally
somes assay assay precipit­
Description /assay (X10“ )^ (XIO'3) able Notes
Pi.17 total 1 0 404.7 1.68 0.41 1,2,3 refer to
polysomes 29 287.5 15.36 5.34 separate
(20/10/75) 88 412.6 27.58 6.68 experiments
146 385.0 22.16 5.75
2 0 256.4 1.26 0.49
293 487.1 ■ 16.83 3.45
3 88 55.1 0 0.0SyM pactamycir
88 272.6 4.8 1.76 O.OSyM pactamycir
Pi.17 total 1 0 349.8 1.68 0.48
polysomes 13 118.4 4.44 3.75
(22/10/75) 39 202.7 14.54 7.17
65 277.0 29.52 10.65
2 0 256.4 1.26 0.49
124 357.2 18.85 5.28
PI.17 0 404.7 1.68 0.41
specifically 10* 157.2 8.58 5.46
precipitated 30* 246.8 26.52 10.74
polysomes 50* 279.7 28.14 10.06
(22/10/75)
Pi.17 non- 1 0 349.8 1.68 0.48
precipitated 18 131.4 7.08 5.4
polysomes 54 236.4 13.68 5.78
(22/10/75) 90 231.6 21.6 9.3
2 0 256.4 1.26 0.49
178 507.8 16.1 3.17
Pi.17 total 0 990.72 3.5 0.35
polysomes 61.7 234.7 13.4 5.7
(10/2/76) 29.3 289.4 12.07 4.15
estimate
A O
linear manner in response to increased amounts of polysomes added 
to the system (Fig. 7). Only in one case (Fig. 7A) did an increase 
in the amount of polysomes added lead to a decrease in specifically 
precipitable radioactivity. This may have been due to the 
saturation of the system with polysomes. The amount of radioactivity 
specifically precipitated/yg polysomes added showed evidence in some 
cases of being constant. It was clear, however, that higher levels 
of polysomes decreased the net specific incorporation/yg polysomes 
added,possibly due to limiting availability of substrate.
Another phenomenon observed in the reticulocyte lysate was 
the tendency for total incorporation of radioactivity into TCA- 
precipitable material to be reduced by the addition of exogenous 
polysomes. Two possible explanations presented themselves. The 
polysomes could have contained traces of inhibitory substances,(e.g. 
cyclohexmide, heparin),from the polysome isolation stage. This 
was thought unlikely since the inhibition of total incorporation 
seemed to be alleviated as the amount of polysomes (and hence also 
the amount of"inhibitory"material) added to the system was increased. 
Total TCA-precipitable incorporation of radioactivity, however, seldom 
reached the level of incorporation achieved by reticulocyte lysate 
alone. The alternative explanation was that the presence of large 
quantities of exogenous polysomes in the reticulocyte lysate inhibited 
the incorporation of radioactivity by the lysate due to competition 
between endogenous and exogenous polysomes for limiting substrate or 
factors. Such competition might inhibit processes such as re­
initiation of translation of messages. Addition of increasing 
quantities of polysomes might increase incorporation caused by "run­
off"/
FIG. 7; Immunoprecipitable and total incorporation of 
Ir<^ H) leucine by reticulocyte lysate in 
response to the addition of PI.17 polysomes.
Reticulocyte lysate, supplemented as described in 
Methods 6.2.1. was incubated with 5yCi L-(^H) leucine and 
varying amounts of Pi.17 polysomes of 20/10/75 or 22/10/75 
(Methods 3.3.). Total TCA-precipitable incorporation of 
radioactivity was measured as described in Methods 8.2. 
Specific immunoprécipitations were performed as described in 
Methods 11.2.2., and the immunoprecipitates isolated (Methods
11.2.2.). No normal rabbit serum control precipitations 
were used. For explanation of the specific precipitation 
of Pi mRNA-containing polysomes see text (Results 2).
a) Total and antibody precipitable incorporation with
PI.17 total polysomes (20/10/75).
b) Total and antibody precipitable incorporation with
Pi.17 total polysomes (22/10/75).
c) Total and antibody precipitable incorporation with
Pi.17 specifically precipitated polysomes (22/10/75).
d) Total and antibody precipitable incorporation with
Pi.17 non-precipitated polysomes (22/10/75).
Total incorporation of radioactivity 
Specifically precipitable incorporation of 
radioactivi ty.
C O u n t s /m in /5 ^ !  
( X 10"2 j sp.
30
25
20
15
10
29 38 146
poly so me 6 /assay
as A
33
as A as A
to 18. 54 90
off" of existing message-attached ribosomes without necessarily 
removing blocks on processes such as initiation. A similar effect 
has been noted by other workers (e.g. Milstein et al., 1972,using 
polysoraal RNA).
The effect of the initiation inhibitor pactamycin was 
investigated. A high concentration of pactamycin (O.SyM) inhibited TCA-P&e- 
cipitable incorporation of radioactivity by 87%. It also reduced 
specifically precipitable radioactivity to background levels.
This was in agreement with the known effects of pactamycin. At 
high concentrations, it inhibits both initiation events and elongation 
reactions. (Goldberg ^  ad., 1973).
At tenfold lower concentrations of pactamycin, incorporation of 
radioactivity into TCA precipitable material in the presence of 
exogenous polysomes was found to be 34% less than the levels of 
incorporation found in the absence of pactamycin. The incorporation 
of radioactivity into specifically precipitable material fell to 20% 
of levels found in similar assays with no pactamycin present.
These results suggested that initiation and re-initiation 
of protein synthesis accounted for a substantial proportion of the 
cell-free products in the reticulocyte lysate, particularly those 
directed by exogenous polysomes.
Polyacrylamide gel analysis of both total products and 
specifically precipitable material from these,and subsequent, assays 
was carried out. As the data in Fig. 8 demonstrated, specifically 
precipitable material was separated on gels mainly into two peaks 
of radioactivity. These peaks had the approximate mobilities of 
Pi Ig H and L chains, as judged by comparison with both internal 
markers/
FIG. 8; PAGE analysis of immunoprecipitable material from 
reticulocyte lysate assays containing Pi.17 
polysome fractions - identification of H and 
L chain products.
Samples of immunoprecipitates of the L{^H) leucine- 
labelled products of assays containing various Pi.17 polysome 
fractions were dissolved in 8m urea:2% (w/v) SDS, containing 
'Vioooc.p-.m. of L(^^S) methionine-labelled Pi. 17 protein and 
reduced and alkylated as described in Methods 9.1.3. The 
samples were applied to 10% (w/v) SDS-phosphate polyacrylamide 
tube gels, using Nw' methylene bisacrylamide as cross-linker 
(Methods 9.4.) . P A Œ  was carried out as described in
Methods 9.1.4. Gels were then sliced (Methods 9.1.5.) and
solubilised (Methods 8.1.3.) and radioactivity detected as 
described in Methods 8.1.3. channel settings in the liquid
3
scintillation spectrophotometer were adjusted to exclude H
energy range counts from one channel, and to cover the
35energy spectrum in the other. Spill-over of s counts into 
3
the " H only" channel was measured as X2 the counts detected 
14in the " C only" channel and subtracted from the counts in
3 3
the " H only" channel. The graphs show only the H counts
35detected. The positions of ( s)-labelled H and L chains 
are indicated by arrows.
A. Total Pi.17 polysome fraction - specifically 
precipitable products.
B. Specifically-precipitated Pi.17 polysome fraction
specifically precipitable products.
C. Non-precipitated PI.17 polysome fraction - 
specifically precipitable products.
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markers and external markers, radioactively labelled with Lr( S) 
methionine. Relative mobilities of marker H and L chains and 
precipitated putative H and L chains were as follows:-
Chain Rm S.D. = a n
Hm 0.355 ± 0.026 - 5
H ^ 0.380 ± 0.035 8c-f
L 0.524 ± 0.018 5m .
L ^ 0.535 ± 0.032 8
c-f
On gels with diallyltartardiamide (DATD)as cross linker (data not shown) 
the relative mobilities of marker and cell-free putative H and L chains 
were as follows:-
Chain Rm 5.D. = a  ri
H 0.475 - 2
m
H ^ 0.509 ± 0.016 3
c-f
L 0.625 - 2
m
L ^ 0.635 ± 0.033 3
c-f
These figures suggested that the material specifically precipitated by 
anti-Pl antiserum from the cell-free system was Pi heavy and light 
chain or their cell-free precursors. No direct controls were used 
in the assays in question to determine non-specific precipitation, 
e.g. replacing anti-Pl antiserum with normal rabbit serum. Two 
pieces of evidence, however, suggest that background precipitation was 
low. Firstly, in reticulocyte lysate assays containing no added 
polysomes/
polysomes, total incorporation of radioactivity into TCA- 
precipitable material was often up to two times the total incorpor­
ation in the presence of polysomes. In both these assays and in 
assays containing exogenous polysomes a major proportion of synthetic 
activity was devoted to translation of endogenous reticulocyte mRNA's. 
Nevertheless, specific antiserum precipitated at least 3 times as 
much radioactivity and usually about 15 times as much radioactivity 
from assays containing exogenous polysomes as from assays containing 
only reticulocyte polysomes. Moreover, polyacrylamide gel analysis 
of samples of these reticulocyte lysate background precipitates yielded 
no detectable peaks of radioactivity (data not shown).
Secondly, it could be argued that exogenous polysomes themselves 
promote some non-specific aggregation resulting in trapping of radio­
activity in immune precipitates. In one assay of exogenous polysomes, 
however, the presence of pactamycin allowed total incorporation of 
radioactivity similar to another control assay. While the pactamycin 
assay contained 2 x as many exogenous polysomes as the control, 
specifically precipitable radioactivity was only 30% of the control. 
Samples of the pactamycin precipitate, moreover, gave no peaks of 
radioactivity corresponding to H and L chain markers on a poly­
acrylamide gel (data not shown).
The ratio of radioactivity in H and L chain-like material varied 
from gel to gel and from assay to assay. Using only information from 
assays invdving total polysomes, the following ratios were obtained:-
Ave S . D. =g ri
H:L 1.50 ±0.26 4
m
H:L 1.05 ± 0.11 6c-f
(H:L ratio based on known amino acid composition (Parkhouse, 1969)
35 3
would be 2.28 using L-( S) methionine as label and 2.19 using L-( H)
leucine as label.)
This suggested that the ratio of synthesis of cell-free putative
H and L chains was different from the ratio of the secreted H and L
chains used for markers. These more closely approximated the '\;2:1
ratio of radioactivity in H and L chains expected from amino acid
composition data. This expected ratio assumes that either
i) Both chains are synthesized from the same amino acid pool, or
ii) their separate amino acid pools rapidly equilibrate with 
added radioactive amino acids to the same specific activity.
It also assumes that H and L chains are secreted in equal 
numbers, i.e. only as molecules.
The rather large variation in H:L ratio between apparently 
identical samples could have arisen from the relatively small but 
persistent problem of aggregation of radioactive material at the top 
of the gels. This could randomly affect how much each of H and L 
chains were electrophoresed into the gel. The difference in the H:L 
ratio between secreted marker Ig and cell-free system-produced putative 
H and L chain material was, however, significant.
When total TCA-precipitable material from reticulocyte lysate 
assays containing or lacking PI.17 polysomes was analysed by PAGE, 
striking differences were observed (Fig, 9). TCA precipitates of 
reticulocyte lysate alone displayed one broad major peak of radio­
activity/
FIG. 9 : PAGE analysis of TCA-precipi tab le products from
reticulocyte lysate assays containing various 
Pi.17 polysome fractions.
5yl aliquots of reticulocyte lysate assays containing 
various Pi.17 polysome fractions were precipitated as described 
in Methods 8.2. The precipitates were re-dissolved in 20yl 
8M urea:2% (w/v) SDS and reduced and alkylated (Methods 9.1.3.).
The samples were applied to 10% (w/v) SDS-phosphate poly­
acrylamide tube gels with NN* methylene bisacrylamide as cross­
linker (Methods 9.1.1.) and electrophoresed as described in 
Methods 9.1.4. Gels were sliced (Methods 9.1.5.), then 
solubilised and radioactivity measured by liquid scintillation 
spectrophotometry (Methods 8.1.3.). The positions of marker 
Pi.17 H and L chains and of globin are indicated by arrows.
A. Endogenous products of reticulocyte lysate.
B. Products of Pi.17 total polysomes in reticulocyte lysate
C. Products of Pi.17 non-precipitated polysomes in
reticulocyte lysate.
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activity with a mobility of 0.87 - 0.89. This was assumed to be 
globin, the major protein product of reticulocytes (see Fig. 9A) ,
It will be shown later (Fig. 2.3 ) that reticulocyte lysates synthesize 
other proteins in addition to globin. In contrast, PAGE of assays 
containing exogenous polysomes revealed much more complex radio­
active profiles (see Figs. 9B,C). Radioactive material was found 
across the entire gel. The globin peak was generally much reduced 
in terms of actual counts and as a proportion of total counts.
This suggested that added myeloma polysomes were being translated in 
competition with, and in addition to, endogenous reticulocyte material. 
Nothing could be clearly stated about the polypeptides synthesized 
since the resolving power of the method used to analyse the gels 
(slicing) was insufficiently great.
These gels illustrated the major disadvantage of the reticulocyte 
lysate cell-free system, viz. the non-quantifiability of the effect of 
exogenous mRNA due to competing endogenous mRNA.
Methods of removing the effect of endogenous mRNA were 
considered.
3. Polysome-depleted reticulocyte lysate.
Reticulocyte lysate was centrifuged in the presence of 25yM 
haemin at 40,000 rpm for 120 min at 4°C. This step led to the 
formation of a polysome pellet which was separated from the super­
natant and resuspended, as for myeloma polysomes, in 0.25M sucrose. 
When the effect of adding various polysome fractions to the polysome 
depleted reticulocyte lysate was investigated the results shown in 
Table 9 were obtained. These results demonstrated several points. 
Firstly/
TABLE 9 : Incorporation of radioactivity by polysome-depleted
reticulocyte lysate in the presence of Pi.17 polysomes.
Polysome fraction Specific
 added ______  Nature of lysate counts/assay
O
O
1.42 Ag Q
PI I polysomes
1-42 *260
PI I polysomes
0-G75 *260
PI II polysomes
0.67S *260 
PI II polysomes
Reticulocyte 
polysomes 
(5% of pellet)
Normal
Depleted
Normal
Depleted
Normal
Depleted
Depleted
1331
1363
13392
1849
12072
2507
2271
TCA precipitated 
counts/assay
912736
337920
234744
336384
289416
288576
1231104
Legend:
13ml of reticulocyte lysate, containing 25yM haemin was 
centrifuged at 40,000 rpm in a Beckman L5-65 ultracentrifuge, 
using a Beckman SW41 rotor. Centrifugation was for 120 min 
at 4^c. The polysome depleted supernatant was decanted and 
stored at -70^C until use. The polysome pellet was re­
suspended in 500yl 0.25M sucrose and stored at -70°C until 
use. Assays with depleted lysate were performed as with 
normal lysate (Methods 6.2.2.). Total TCA precipitable 
radioactivity and specifically immunoprecipitable radioactivity 
were measured by standard methods (Methods 8.1.2. and 8.2.2.).
Firstly, the polysome removal step had been partially successful in 
that activity (incorporation of radioactivity)had decreased by 63%, 
Background specific precipitation of normal and depleted reticulocyte 
lysate remained approximately constant. Addition of exogenous 
polysomes to depleted lysate led to no significant change in total 
incorporation by the lysates. Addition of exogenous polysomes to 
normal lysate, on the other hand, led to an inhibition of total 
incorporation of 68 - 75%. Specific precipitation of radioactivity 
from depleted lysates suggested that only a low level of myeloma 
polysome translation was occurring. By comparison, specifically 
precipitable material from normal lysates containing myeloma polysomes 
contained 9 X and 10 X as much radioactivity as the appropriate 
background precipitation. That the depleted lysate could respond to- 
added polysomes was demonstrated by the recovery in -the total TCA- 
precipi tab le incorporation of radioactivity upon addition of a fraction 
of -the reticulocyte polysomes removed from the lysate by centrifugation.
4. Messenger dependent lysate (M.D.L.)-optimisation of conditions.
4.1. Incorporation of radioactivity.
The M.D.L. was developed by Pelham and Jackson (1976) as 
a cell-free system which combined a high level of stimulation by 
exogenous messenger RNA with low levels of endogenous incorporation. 
Moreover, the reticulocyte lysate cell-free system, from which it was 
developed, has been shown to exhibit a high degree of fidelity in 
translating exogenous message. The system must nevertheless be tested 
wi-th each new species of message added, in order to ensure optimal 
translation/
71 E'
translation conditions.
M.D.L. was first tested for incorporation with exogenous mRNA.
Reticulocyte lysate was treated with ribonuclease, subsequently
35inactivated, as described in Methods 7.1.2. Using L-( S) methionine 
as label, a comparison was made of the incorporation characteristics 
of reticulocyte lysate, of M.D.L. and of M.D.L. containing tobacco 
mosaic virus (TMV) RNA. TMV RNA was kindly donated by Dr. R.T. Hunt. 
Incorporation of radioactivity into TCA-precipitable material was 
measured- over a time course. As the data in Fig. 10 demonstrated, 
M.D.L, alone showed only a low level of background incorporation 
(approximately 9% of the incorporation by reticulocyte lysate after 
40 min incubation). Reticulocyte lysate, in contrast, gave a steady, 
almost linear increase in incorporation of radioactivity over the time 
course of the experiment, M.D.L. containing TMV RNA showed a steady 
increase in incorporation over most of the time course of the 
experiment although the increase in incorporation deviated from 
linearity after 25 min. This was possibly due to limiting factors, 
such as availability of amino acids. Over the first 25 minutes 
of the assay the rate of incorporation stimulated by TMV RNA in M.D.L. 
was twice as great as the rate of incorporation in the reticulocyte 
lysate. This suggested that the M.D.L. was a very efficient system 
for translating exogenous mRNA. A comparison of M.D.L. and 
reticulocyte endogenous products separated by PAGE is shown in Fig. 20.
4.2. Determination of optimal conditions for translation of
myeloma mRNA.
35L-( S) methionine was used as the radioactively labelled amino
acid/
FIG. 10: Time course of incorporation of radioactivity by
reticulocyte lysate and M.D.L.
Supplemented reticulocyte lysate, prepared as described
in Methods 7.1.2., was divided into two portions, one of which
was nuclease-treated to prepare M.D.L. (Methods 7,1.2.).
SOyl assays of either reticulocyte lysate or M.D.L. were
6 35
incubated in the presence of lO cpm L-( S) methionine at 
30°C for 40 minutes. One assay contained in addition 2yg TMV 
RNA. 5yl aliquots were removed at various times during the 
incorporation and treated to allow measurement of total radio­
activity incorporated into TCA-precipitable material as 
follows:- each 5yl aliquot was diluted to 1.5ml with 1ml 
distilled H^O + 0.5ml 0.5N NaOH: 10% (w/v) lOmM un­
labelled methionine. This was incubated at 37°C for 15 min.
1 ml of 25% (w/v) TCA was added and precipitation allowed to 
occur for > 30 min. This solution was then Millipore filtered 
and washed £  8% (w/v) TCA. The filters were dried and counted 
for radioactivity in toluene/PPO.
35
FIG. 11: Time course of incorporation of L-( S) methionine by
M.D.L. containing Pi.17 polysomes in the absence and 
presence of unlabelled methionine.
SOyl assays,prepared as described in Methods 7.1.2.,
were incubated with 29yg Pi.17 polysomes in the presence of 
35
3yCi L-( S) methionine. Incubation took place either in the 
absence or presence of 50 pmoles unlabelled methionine.
Single 5yl aliquots were removed at intervals and treated on 
paper discs as described in Methods 8.2.1. M.D.L. assays, 
containing no added polysomes were incubated under otherwise 
identical conditions to the above assays. Radioactivity 
incorporated by these assays remained almost constant at 
4500 ± 500 counts/min/5yl (no added methionine) or 3950 ± 380 
counts/min/5yl (50 pmoles unlabelled methionine). These 
figures were subtracted from each time point as appropriate.
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acid of preference in M.D.L, studies. In assays where other amino
acids (L-(^H) leucine, L-(^H) methionine, L-(^^C) isoleucine, (^ H)
amino acid mixture) were used, their use will be noted in the text
or figure legends.
35L-( S) methionine offered several advantages as a labelling 
amino acid:-
i) High specific activity of the radioactively labelled 
amino acid
ii) Higher for 3-particle emission made fluorography
more sensitive
iii) The relatively small number of methionine residues in the Ig
molecules under study provided the possibility of simple
unambiguous peptide mapping
35
The incorporation of L( S) methionine by the M.D.L., stimulated 
by myeloma polysomes,was investigated over a time course of 120 min. 
(see Fig. 11). This data suggested that incorporation was continuous 
with methionine as the labelled amino acid over the time course 
studied. The rate of incorporation, however, decreased steadily after 
20-40 min. Assays were generally incubated for 120 min. The 
inclusion of 50 pmoles of unlabelled methionine in the assay reduced 
overall incorporation by only 2o% on average, suggesting that a 
substantial pool of endogenous methionine existed in the M.D.L.
(see Results 4.5).
The concentration of K ions required for optimal translation 
of either myeloma poly(A) RNA or myeloma polysomes was found to be 
between 90 and lOOmM (Fig. 12). Subsequent assays were carried 
out at this level of ions.
The/
FIG. 12; (K^ ) optima for incorporation of L-(^^S) methionine
in M.D.L.*s containing Pi.17 polysomes 
or PI.17 poly(A) RNA.
(i) Poly (A) RNA. To normal 50)j1 M.D.L. assays (Methods
7.2.1.) various concentrations of KCl solution were added in
volumes of 5|il. lyg Pi. 17 poly (A) RNA, 50 pmoles unlabelled
35methionine + 2.5yCi L-( S) methionine were-then added (lOyl) 
and incubations carried out as in Methods 7.2. 5yl aliquots 
were removed from each assay in duplicate after incubation 
and TCA-precipitable radioactivity determined as in Methods
8.2.1. The average counts/min/5yl were plotted. Assays 
containing no added poly(A) RNA (but otherwise identical) 
were run simultaneously and TCA-precipitable radioactivity was 
measured.
(ii) Polysomes. M.D.L. was prepared containing no added KCl
Various concentrations of KCl solution were added to 50yl
aliquots of M.D.L. in a volume of 5yl. Pi.17 polysomes and 
35L-( S) methionine were added in a volume of lOyl and assays 
incubated as described in Methods 7.2. TCA-precipitable 
radioactivity in 5yl duplicate aliquots was measured as 
described in Methods 8.2.1.
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FIG. 13: Temperature optimum for incorporation of L-( S)
methionine in M.D.L. containing Pi.17 polysomes.
M.D.L. assays, containing Pi.17 polysomes were incubated 
35with liCi L-( S) methionine at various temperatures for 120 min. 
(Methods 7.2.). 5yl duplicate aliquots were removed from 
each assay and radioactivity incorporated into TCA-precipitable 
material was measured as described in Methods 8.2.1.
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The optimum temperature for incubation of M.D.L. assays was 
found to be 30°C, as shown in Fig. 13.
4.3. Endogenous levels of methionine.
The endogenous pool size of methionine was of interest since 
this knowledge was required for meaningful calculations of the number 
of rounds of translation occurring in the M.D.L,
Two methods of calculating this number were used. Firstly, 
a sample of M.D.L. was analysed on a JLC-5AH Amino Acid Analyser 
(this work was carried out by Mr, Robert Blackie). The appropriate 
section of the analyser trace indicated that the endogenous methionine 
pool size was 400 pmoles/50yl assay (Fig. 14). This value was 
calculated as follows, using the HW method recommended by the 
manufacturers of the analyser (Japan Electron Optics Laboratory).
a) Standard.
Snmoles of each amino acid. Peaks were analysed as follows.
Base line
H= Ho-"b
H%W= c
a
0-P
S
-W
rH
<t)
O
uoTq.ouTq.xa;
FIG. 14: Comparison of amino acid analyses of normal
reticulocyte lysate and reticulocyte lysate 
passed over G-25 Sephadex.
In each case 1 ml of reticulocyte lysate was precipitated 
by the addition of concentrated TCA solution to a final concen­
tration of lO% (w/v). Ihe precipitated material was centrifuged 
to a pellet and the supernatant analysed by a JLC-5AH amino 
acid analyser (this work was performed by Mr. R. Blackie).
The number of pmoles of methionine preserlt was calculated as 
described in Results 4.3.
Only the portion of the amino acid analyser trace containing 
the methionine peak is shown.
b) Unknown
Calculate HXW as above. HXW = No. of nmoles of amino acid
C
in sample.
A second method of detecting the methionine pool size was used. 
This involved dilution of the radioactively labelled methionine in 
the assay by the addition of known amounts of unlabelled methionine. 
When sufficient unlabelled methionine has been added to reduce the 
incorporation of radioactivity in the assay by 50%, this amount of 
unlabelled methionine should equal the endogenous pool plus radio­
active methionine. In this'experiment, the incorporation of a 
second amino acid, labelled with a different radioactive isotope was 
measured to ensure that the decrease in incorporation of radioactivity 
was not due to a decrease in protein synthesis. L-(^^C) isoleucine 
was used for this purpose. This experiment (see Pig.15) suggested 
that the endogenous methionine pool was about 700 pmoles/50yl assay 
calculated as follows
No, of pmoles L-(^H) methionine required 
to reduce incorporation by 50% = 1540
= X + y
3
where x = added L-( H) methionine = 830 pmoles
y = endogenous methionine 
1540 = 830 + y 
. . y = 710 pmoles
Note :
3
L-( H)-methionine was used in order that the higher energy emitter 
(L-^^C)ile) could be used as an unambiguous indication of the amount 
of protein synthesis. (By selection of channels on the scintillation 
counter, all energy range counts were excluded from counting of ^^C)
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FIG. 15: Estimation of i±te size of the endogenous unlabelled
methionine pool in M.D.L. assays by double-labelling.
To normal reticulocyte lysate assays, prepared as Methods 7.1.2.,
containing 5yCi L-(^H) methionine and 0.25pCi isoleucine
were added serial dilutions of unlabelled methionine, initially
at a concentration of 2000 pmoles/5yl, in a volume of 5yl.
Each assay was performed in duplicate. Incubation conditions were
as described in Methods 7.2. After incubation, duplicate 5yl
aliquots from each assay were prepared for liquid scintillation
counting as described in Methods 8.2.1. Counting channels were
selected to exclude all energy range counts from one
channel, and to include both and energy range counts
14
in the other channel. The level of C counts in the wide
channel was estimated by measurements of radioactivity in an
assay containing only L-(^^C) isoleucine as label. 30% of
counts were detected in the restricted channel. Therefore,
assuming quenching to be constant, the number of counts
detectable in the and channel attributable to '^^ C was
14
approximately 2 x the number of counts detectable in the C-only
channel. This correction was made when arriving at the number
3
of counts detected due to the incorporation of L-( H) methionine. 
The endogenous pool size was calculated as described in Results 4.3,
This figure was of the same order of magnitude as that determined by 
amino acid analysis but varied significantly enough to require 
explanation. The following explanations for the difference can be made.
a) Amino acid analysis detects only free amino acids; tRNA-bound
amino acids are precipitated from solution before analysis. The 
double-label dilution experiment theoretically measures both free and 
bound amino acids.
b) Amino acid analysis results may also be low due to oxidation
of methionine to methionine sulphone,which' appears elsewhere on the
amino acid analysis trace.
3
c) The use of L-( H) methionine for measurement of the endogenous
methionine pool size in the dilution experiment introduced a source
3
of error. Inaccuracy of measurement of the volume of L-( H) methionine
added (5yl) by for example 10% (O.Syl) would result in an under- or
over-estimation of the endogenous pool size by ± 8o pmoles.
As a result of these qualifications, the figure of 700 pmoles
methionine/50yl was taken as the more accurate and used in all
subsequent calculations. This generally involved a correction of
2
the specific activity of the added methionine by a factor of ^ 10 - 
fold, using the equation
Specific activity  ____ 700  Assay volume specific activity
in assay no.of pmoles ^ 50 L-( S)
L-(^^S)met methionine
added
4.4./
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4.4. Dose response to myeloma inRNA.
The M.D.L. was tested with serial dilutiors of both polysomes 
and poly(A) RNA to determine the effect of increasing amounts of mRNA 
being added to the system. This could be used to discover whether
levels of polysomes and poly(A) RNA added to the system were saturating.
As can be seen from Fig. 1 6 ,  5563 pd^somes showed no saturation over 
the range examined (0.5 - 4,3 yg/assay), the effect of increasing 
quantities of polysomes added being a linear increase in incorporation 
of radioactivity (10^ cpra added/assay). The level of incorporation/yg 
polysomes added remained fairly constant over the range of concentrations 
studied. Pi.17 polysomes, however, showed a rather pronounced levelling 
off of incorporation at higher concentrations and even at the lower end 
of the concentration range studied (2.0 - 15.6yg/assay), the level of 
incorporation/yg polysomes was not constant. In this experiment, 
maximum stimulation by polysomes msulted in incorporation of 83% of 
the added radioactivity. The plateau effect could therefore be 
attributed to lack of substrate rather than saturation by mRNA.
Consequently, within the concentration ranges studied there was found 
no saturation of the M.D.L. by myeloma polysomes, except at the highest levels.
Using poly(A)-containing RNA from two cell lines, increasing 
concentrations of RNA again produced a linear increase in incorporation 
of radioactivity, with a constant level of incorporation/yg poly(A)
RNA added (see Fig. 17) . The incorporation of radioactively labelled 
substrate/yg added RNA varied by a factor of 20 - lOO between polysomes 
and poly(A) containing RNA. Since poly(A) containing RNA is generally 
accepted to constitute a small fraction (1-5%) of the RNA in 
polyribosomes (see Methods), this was not unexpected. Incorporation 
by polysomes, although showing marked variations, due to differences 
in/
FIG. 16; Dose response of M.D.L. with various polysome
fractions.
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5yl M.D.L. assays containing lO counts/min of L-( S)
methionine, were incubated with serial dilutions of Pi.171, or 5563
II polysomes, for 40 min at 30°C. Incorporation of radioactivity
into TCA-precipitable material was measured as described in the
Legend to Fig. lO. Incorporation of radioactivity in the
absence of added polysomes is shown as a straight line parallel
to the abscissa. Calculations of counts/min incorporated/yg
polysomes added were based on the net incorporation in the
presence of polysomes.
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FIG. 17: Dose response of M^D.L. to the addition of Pi.17
or 5563 poly(A) RNA.
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SOyl M.D.L. assays, containing lOyCi L( S) 
methionine (Syl) were incubated in the presence of serial 
dilutions of either Pi.17 poly(A) RNA or 5563 poly(A) RNA 
under standard conditions (Methods 7.2.). Duplicate 5yl 
aliquots were treated and measured for radioactivity incor­
porated into TCA-precipitable material as described in Methods
8.2.1. Background incorporation of 740Ô counts/min was 
subtracted from each assay. The calculation of incorporation/ 
yg poly(A) RNA added is based on the incorporation with 
background incorporation subtracted.
A: PI. 17 poly (A) PiïA 
B: 5563 poly(A) RKA
V o
2 0 "
0-5
/*9 poty{A)RNA
0-4
Ill
in incubation time, volume of assay, amount of radioactive substrate
4 5added, gave incorporation in the range lO - 10 cpm/yg polysomes 
added. Incorporation by poly(A) RNA was in the range 10^ - 10^ 
cpm/yg poly(A) RNA added. Assays of polysomes contained 10 - 30 
yg polysomes/50yl M.D.L,, whilst assays of poly(A) RNA contained
0.1 - l.Syg poly(A) RNA/50yl M.D.L.
4.5. .Myeloma mRNA in the M.D.L. - rounds of translation.
Several calculations were made on the number of rounds of 
translation of poly(A) RNA, occurring in the M.D.L. Calculations 
involved several assumptions which are listed below
(i) Endogenous methionine levels were 700 pmoles/SOyl 
(see Section 4 «. 3)
35(ii) Efficiency of detection of L( S) methionine by 
scintillation counting was 60%.
(iii) The poly(A) RNA used in the M.D.L. was essentially free
from non-translatable RNA, e.g. ribosoraal RNA.
(iv) All mRNA molecules present in poly(A) RNA were 
undamaged and capable of translation.
5
(v) The average MW of mRNA molecules present was 4.5 x 10 .
(vi) The average protein contained 6 methionine residues ( Parkiicuse p 1969 ) 
Of these assumptions, (i) is based on experiments described in
35Section 4.3. Assumption (ii) was based on experiments with L( S)
methionine on paper discs in toluene/PPO scintillation fluid.
Assumptions (iii) and (iv) are both idealised cases which would tend 
to underestimate the number of rounds of translation/active mRNA 
molecule. Assumption (v) is based on an average of an L chain 
mRNA/
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mRNA 1150 - 1200 nucleotides long (750 coding nucleotides, 200 non­
translated nucleotides, 200 nucleotides in the 3' poly(A) tail) and 
an H chain mRNA 1750 - 1800 nucleotides long (1350, 200, 200 
nucleotides as before). These mRNA's represent medium length mRNA's, 
hence giving a reasonable average MW. They should also constitute 
a significant proportion of the cellular mRNA species. Assumption (vi) 
is based on an average of the number of methionine residues found in 
several IgG H and L chains since these are major proteins synthesized 
in the system.
With these assumptiors, the following calculations were made,
35
using the assays giving highest incorporation of L( S) methionine.
1. 0.31yg Pi.17 poly(A) RNA, translated in 50yl M.D.L.,
35
containing 4.73yCi L ( S) methionine.
Counts/min incorporated/assay with Pi.17 poly(A) RNA = 3.56 x lO^
" " " " no additions = 0.397 x 10^
Net incorporation directed by PI.17 poly(A) RNA= 3.16 x 10^ cpm/assay
Assuming 60% efficiency of detection of radioactivity.
Actual net incorporation by Pi.17 poly(A) RNA = 5.27 x lO^
dpra/assay
Specific activity of L(^^S) methionine = 500Ci/mmole
= 1.1 X 10^
dpm/pmole
,35 ,  ^ 5.27 X 10^
pmoles L( S) methionine incorporated/assay = -----
1.1 X 10^
= 4.79 pmoles
35
Also, pmoles L ( S) methionine added = 9.46 
and pmoles unlabelled endogenous methionine/assay = 700 
Ratio of (32g) : (35g) =
.•./ = 7 4
i  i 3
.°. Total pmoles methionine incorporated/assay = 74 x 4.79
= 354.46
Assuming 6 methionine/average protein
No. of pmoles protein made = 59.08
Now, No. of yg poly(A) RNA added/assay =0.35
Ave. MW of mRNA = 4.5 x 10^
-7
.’ . No. of pmoles mRNA/assay = — -—  ---
4.5 X 10
= 0.77
No. of pmoles protein synthesized/pmole mRNA added = 76 
= No. of rounds of translation/mRNA molecule
2. Using 5563 poly(A) RNA, the best figure obtained was
43.6 rounds of translation/mRNA molecule.
The best and worst Pi.17 results varied by about a factor of 
4 whilst those of 5563 varied by a factor of 7, It should be 
emphasised that although the figures quoted above are the best 
results obtained, they are probably underestimates. As such, they 
nevertheless indicate the high activity of the system in re-initiation 
of protein synthesis. The most comparable results published are those 
of Palraiter (1974) who obtained values of between 56 and 110 rounds 
of translation of globin mRNA and between 18 and 45 rounds of 
translation for ovalbumin mRNA in reticulocyte lysate (16 using the 
above method).
5. Ce11-labelling experiments/.
1 1 4 .
5._____ Cell-labelling experiments.
An accurate knowledge of the percentage of the protein synthetic 
capacity of myeloma cells devoted to Ig production was essential in 
order to assess the significance of the level of immunoreactive material 
synthesized by the M.D.L. cell-free protein synthesizing system in 
response to exogenous messenger-containing material (polysomes or 
poly(A) RNA).
5.1.1. Pi.17 cells labelled with L-(^H) leucine.
Pi.17 cells were incubated in RPMI medium lacking leucine with 
250yCi L-(^H) leucine and lysed as described in Methods, Section 2.3. 
Percentage Ig production was measured as 16.27% after labelling for 5 
minutes and 14.6% after labelling for 90 minutes. Second immune 
precipitations indicated that almost all immunoprecipitable material 
was removed by a single immunoprécipitation. The results are shown 
on Table 10 together with results of a labelling of 5563 cells 
carried out simultaneously. Total products and specific precipitates 
separated by PAGE are shown in Fig, 18.
355 .1 .2 . Pi.17 cells labelled with L-( s ) methionine.
Pi.17 cells were incubated in RPMI medium lacking methionine 
35
with L-( S) methionine and lysed as described in Methods,Section 2 .3 , 
Percentage Ig production was measured as 17.4% after incubation for 
60 minutes (compare with figures using L-(^H) leucine). Results are 
shown in Table Ibtogether with results of a labelling of 5563 cells 
carried out simultaneously. Total products and immunopre c ipi ta te s 
are shown in Fig. 19 .
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TABLE 10: Radioactive labelling of Pi,17 & 5563 cells
3
with L-( H) leucine
Legend:
7
2 X 10 Pi.17 or 5563 cells (>90% viable) were 
incubated with 200yCi L-(^H) leucine as described in Methods 
for 5 min or 90 min. After incubation, cell lysate was 
prepared from both incubations of each cell line and supernatant 
retained from the 90 min labelling of both cell lines.
Duplicate immunoprécipitation reactions, using 5yl anti-5563 
antiserum (or 5yl normal rabbit serum), followed by lOOyl 
anti-rabbit Ig antiserum were performed on duplicate aliquots 
of the various fractions, and the immunoprecipitates isolated 
(Methods 11.2.2(b)). After the first immunoprécipitation, 
a second immunoprécipitation was carried out on the supernatant 
remaining and the immunoprecipitate isolated as before.
Total TCA-precipitable material was obtained as described in 
Methods 8.2.2. Samples of both TCA- and immuno-precipitates 
were measured for radioactivity as described in Methods 8.1.2. 
Percentage production was calculated as
Total Specific counts/min - total MRS counts/min 
TCA counts/min X 100
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FIG. 18: PAGE analysis of 5563 and Pi.17 cellular products,
3
radioactively labelled with L-( H) leucine.
(see Table 10).
7
5563 or Pi.17 cells (10 cells/labelling) were labelled
3
with L-( H) leucine as described in Table lo. Aliquots were 
subjected to indirect immunoprécipitation as described in Methods
11.2.2.(b). Immunoprecipitates were washed, re-dissolved in 9M 
urea, and small aliquots were analysed by PAGE and fluorography 
(Methods 9.2.5. and 8.3.1.). Equivalent amounts of both cell 
lysate and cell supernatant fractions were similarly analysed.
In some wells, samples were lost at TCA precipitation. Normal 
rabbit serum controls were performed to measure non-specific 
precipitation.
Well Description
1 PI. 17 5' cell lysate - total T C A  products
2 P I . 17 5' cell lysate - 1st specific ppn.
3 P I .17 5' cell lysate - 2nd specific ppn.
4 P I .17 5' cell lysate - NRS ppn.
5 P I . 17 90’ cell lysate - total T C A  products
6 PI. 17 90'' cell lysate - 1st specific ppn.
7 P i . 17 90'' cell lysate - 2nd specific ppn.
8 P I . 17 90'' cell lysate - NRS ppn.
9 P I . 17 90'' secreted - total T C A  products
10 P i . 17 90'' secreted - 1st specific ppn.
11 P I . 17 90'' secreted - 2nd specific ppn.
12 P i . 17 90'' secreted - NRS ppn.
13/
Well Description
13 5563 5' cell lysate - total TCA products
14 5563 5' cell lysate - 1st specific ppn.
15 5563 5' cell lysate - 2nd specific ppn.
16 5563 5' cell lysate - NRS ppn.
17 5563 90' cell lysate - total TCA products
18 5563 90' cell lysate - 1st specific ppn.
19 5563 90' cell lysate - 2nd specific ppn.
20 5553 90' cel^ lysate - NRS ppn.
21 5563 90' secreted - total TCA product
22 5563 90' secreted - 1st specific ppn.
23 5563 90' secreted - 2nd specific ppn.
24 5563 90' secreted - NRS ppn.
5.2.1. 5563 cells labelled with L-(^H) leucine.
5563 cells were incubated in RPMI medium lacking leucine with 
L-(^H) leucine and lysed as described in Methods Section 2.3. 
Percentage Ig production was measured as 7.6% after labelling for 
5 minutes and as 6.4% after labelling for 90 minutes. Second 
precipitations indicated that almost all immunoprecipitable material 
was removed by a single immunoprécipitation. The results are shown 
on Table 10. (see also Fig. 18) .
35
5.2.2. 5563 cells labelled with L-( S) methionine.
355563 cells were incubated with L-( s) methionine and lysed 
as described in Methods, Section 2.3. Percentage Ig production 
was measured as 10.73% after labelling for 6o minutes (compare with 
figures for L(^H) leucine labelling). Results are shown in Table 11, 
(see also Fig, 19) .
35
5.2.3. 5563 cells labelled with L-( S) methionine in the presence of 
varying concentrations of 2-deoxyglucose.
35
5563 cells were incubated with L-( S) methionine in PBSA 
in the presence of varying concentrations of 2-deoxyglucose as
described in Methods,2.4. Percentage Ig production in the absence
of 2-deoxyglucose was measured as 7%. The percentage Ig production 
in the presence of varying concentrations of 2-deoxyglucose is shown
in Table$2 (see also Fig. 35).
' ■ f
Incorporation of radioactiviincbo total TCA, ptble.
material decreased to a const iant level of 2Qfo of
uninhibited v a l u e whilst sp jecifically pptble. 
radioactivity levels continuedto decrease*as the
concentration of 2-deoxyglucose increased.
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FIG. 19: PAGE analysis of 5563 and Pi.17 cellular products
35
radioactively labelled with L-( S) methionine 
(see Table 11).
35
5563 and Pi. 17 cells were labelled with L-( S) methionine 
as described in Table 11. Direct and indirect immuno­
précipitation was carried out on cell lysates and cell super­
natant material as described in Methods 11.2.1. and 11.2.2(b), 
respectively. Total labelled material and fractions of 
immunoprecipitable material were analysed by PAGE and fluorography 
as described in Methods 9.2.5. and 8.3.1.', respectively.
Well Description
L Pi.17 5' cell lysate - total products
2 Pi.17 90’ cell lysate - total products
3 Pi.17 90' secreted - total products
4 PI.17 90' cell lysate - indirect ppte. (1/25 ppte).
5 Pi.17 90' cell lysate - NRS ppte. (1/25 ppte).
6 Pi.17 90' cell lysate - direct ppte. + Oyl 5563 (1/2 ppte).
7 Pi.17 90' cell lysate - NRS ppte. + Oyl 5563 (1/2 ppte).
8 Pi.17 90' cell lysate - direct ppte. + 2.5yl 5563 (1/2 ppte)
9 Pi.17 90' cell lysate ; NRS ppte. + 2.5yl 5563 (1/2 ppte).
10 Pi.17 90' cell lysate - direct ppte. + 5yl 5563 (1/2 ppte)
11 Pi.17 90' cell lysate - NRS ppte. + 5yl 5563 (1/2 ppte).
12 Pi.17 90' secreted - total products
13 5563 90' secreted - total products
14 5563 90' cell lysate - indirect ppte (1/25 ppte).
15 5563 90' cell lysate - NRS ppte (1/25 ppte).
16 5563 90' cell lysate - direct ppte + 5yl 5563 (1/2 ppte).
17/
Well Description
17 5563 90' cell lysate - NRS ppte + 5yl 5563 (1/2 ppte).
18 5563 90' cell lysate - direct ppte + 2,5yl 5563 (1/2 ppte).
19 5563 90' cell lysate - NRS ppte i 2.5yl 5563 (1/2 ppte).
20 5563 90' cell lysate - direct ppte Oyl (1/2 ppte).
21 5563 90' cell lysate - NRS ppte Oyl 5563 (1/2 ppte),
22 5563 90’ secreted - ■total products
23 5563 90' cell lysate - total products
24 5563 5' cell lysate ■- total products
I D
35
5.3. SAMM 368 cells labelled with L-( S) methionine.
35
SAMM 368 cells were incubated with L-( S) methionine and 
lysed as described in Methods,Section 2. Percentage Ig production 
after 15 minutes and 90 minutes was measured using three specific 
rabbit antisera directed against SAMM 368 a-heavy chains, y-heavy 
chains and K-light chains respectively. The anti-a antiserum showed 
some cross-reactivity with y-heavy chains (Dr. T.R. Mosmann, personal 
communication). The precipitation with anti-K antiserum was not 
complete. Results are shown in Table 13. Total products and 
specific precipitates are shown in Fig. 2o.
6. Relative production of H and L chains in cultured cells.
6.1. Introduction.
Comparison of cell-free synthesized putative H and L chains 
with cellularly secreted H and L chains of Pi.17 had revealed 
significant differences in the relative production of H and L chains. 
This conclusion was based on the relative amounts of radioactivity 
detected in H and L-chain like material separated by PAGE (Results 
Section 2) . This difference might reflect a difference in
H:L chain ratio between intracellular and secreted material under 
normal culture conditions. Alternatively, it may have been an 
artefact caused by trapping of material at the top of polyacrylamide 
gels. Both these possibilities were investigated.
The H:L chain ratio, both intra- and extracellular in Pi.17 
myeloma cell cultures was investigated. Several different methods 
of solubilisation of immune precipitates were also used to test 
whether/
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FIG. 20; PAGE analysis of SAMM 368 cellular products
radioactively labelled with L-(^^S) methionine 
(see Table 13).
35
SAMM 368 cells were labelled with L-( S) methionine 
as described in Table 13. Indirect immunoprécipitation was 
carried out on cell lysate aliquots as described in Methods 
11.2.2(b). Total labelled material and equivalent fractions 
of immunoprecipitable material were analysed by PAGE and 
fluorography, as described in Methods 9.2.5. and 8.3.1., 
respectively.
Well Description
1 SAMM 368 15' cell lysate - total products
2 SAMM 368 60' cell lysate - total products
3 SAMM 368 15' cell lysate - anti a indirect ppte.
4 SAMM 368 60' cell lysate - anti a indirect ppte.
5 SAMM 368 15' cell lysate - anti y indirect ppte.
6 SAMM 368 60' cell lysate - anti y indirect ppte.
7 SAMM 368 15' cell lysate - anti k indirect ppte.
8 SAMM 368 60' cell lysate - anti k indirect ppte.
9 SAMM 368 15' cell lysate - NRS indirect ppte.
10 SAMM 368 60' cell lysate - NRS indirect ppte.
< -CK
• •
.d I) m
whether the problem of trapped radioactivity could be improved by
better solubilisation. The possibility that a pool of light chain existed,
not totally precipitable with antiserum directed against whole
Pi Ig molecules^ was investigated using an antiserum directed against
L(k ) chains. Finally, conditions of both normal growth and growth
under the inhibiting effect of cycloheximide were investigated.
Cells were labelled for a long period (4.5 hours) to allow a 
substantial amount of secretion of Ig and also to ensure steady-state 
synthesis of Ig. Viability of cells was measured at appropriate 
points. Cells remained 100% viable during pelleting and resuspension 
and until the addition of radioactively labelled methionine. After 
incubation, cell viability had dropped to 70%.
Labelling of cells was followed by preparation of cell lysates 
and cell supernatant as described in Methods 2.2. and 2.3.
Immune precipitate reactions were carried out on small volumes of cell 
lysate (60yl) and on lOfold greater volumes of œil supernatant (600yl) 
as described in Methods 11,2.2. Radioactivity in each precipitate 
was detected by liquid scintillation spectrometry using triton/ 
toluene/PPO as the solvent/fluor system. Results are shown in Table 
14.
35
6.2. Incorporation of L-( S) methionine into specifically 
precipitable material.
Antiserum (5yl), directed against PI Ig precipitated all 
immunoreactive material from cell lysate samples, both in the absence 
and presence of cycloheximide. This was suggested by graphical methods 
(data not shown)
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TABLE 14 ; Comparison of incorporation of radioactivity into 
specifically immunoprecipitable material by 
cultured cells in the absence and presence 
of cycloheximide.
Legend:
7 35
2 X lo cells were incubated with 170yCi L-( S)
methionine in either the absence or presence of cycloheximide
(200yg/ml) for 4.5 hours, as described in Methods 2.2. and 2.3.
After incubation, viability was v70%. Triplicate or duplicate
indirect immunoprecipitates, using the antisera noted, were
performed as described in Methods 11.2.2. 60yl aliquots
of cell lysate and 600yl aliquots of cell supernatant were
immunoprecipitated.
Abbrevi ations:
NRS = Normal Rabbit Serum
aPl = Rabbit antiserum against Pi.17 Ig
aK = Rabbit antiserum against mouse K L chains
, plotting radioactivity precipitated against volume of 
antiserum added, and corroborated by the much higher level of 
radioactivity in specifically precipitated material from cell medium 
using the same amount of antiserum. Both intra- and extracellular 
Ig would be expected to have similar specific activity, implying 
that the higher level of radioactivity precipitated extracellularly 
was due to the presence of more protein. Extracellular precipitation 
was not necessarily quantitative but must have been approaching 
complete precipitation of immunoreactive material, as judged by the 
shape of the titration curve obtained
6.3. Effect of cycloheximide on incorporation into specifically 
precipitable material.
Cycloheximide (0.2yg/ml) lowered the level of incorporation 
of radioactivity into specifically precipitable material by
approximately 25% in extracellular material and by 40% in intra-
(Table 14)
cellular material in this experiment.^ The only major exception 
to this was the reduction of anti-K precipitable material by 60% 
intracellularly but by only 10% extracellularly. The difference 
between intra-and extracellular inhibition may not be significant. 
Cycloheximide at the level used, however, did not block protein 
synthesis or secretion completely.
6.4. Comparison of precipitation by gPl and aK antisera.
As Table 14 demonstrated, anti-K antiserum precipitated 
considerably/
i î "
considerably less secreted material than did anti-PI antiserum, 
approximately by a factor of 3, both in the presence & absence of 
cycloheximide. The presence of cycloheximide reduced the relative 
difference in precipitable radioactivity by approximately 20%.
With intracellular material, anti-K antiserum precipitated more 
material than anti-Pl antiserum in cells grown under normal conditions, 
but in the presence of cycloheximide, this was reversed.
6.5. Methods of solubilisation of immune precipitates.
Samples of immune precipitates of intra- and extracellular 
material from cells grown normally were reduced and alkylated in 
each of the following buffers before separation by PAGE
1. 8m urea in 0.2m Tris HCl pH 8.5
2. 8M urea, 2% (w/v) SDS in 0.2M Tris HCl pH 8.5
3. 2% (w/v) SDS in 0.2M Tris HCl pH 8.5
Samples were reduced and alkylated as described in Methods, 9.1.3., 
acetone precipitated and redissolved in lOM urea before loading on 
the gels. As can be seen from Figs. 22 A-F, secreted material 
was resolved with least trapping using 8M urea/0.2M Tris pH 8.5 
for reduction and alkylation, although of the three solvents, only 
8M urea/2% (w/v) SDS/0.2M Tris pH 8.5 showed significant trapping 
of material. Intracellular specific precipitates were resolved 
with least trapping using 2% (w/v) SDS in 0.2M Tris HCl pH 8.5, 
although none of the three solutions eliminated trapping problems 
completely. Estimations of H:L chain radioactivity in extra­
cellular material varied from 2.54 to 2.79. Estimates of the ratio 
of/
FIG. 22; PAGE analysis of immunoprecipitatés of intra- and
extracellular material from Pi.17 cells,
35
radioactively labelled with L-( 5) methionine.
35
Cells were incubated with 170viCi L-( S) methionine as 
described in Methods 2.2., for 4.5 hours. Cell lysates and 
cell supernatant were prepared (Methods 2.3.) and immuno­
précipitation was carried out (Methods 11.2.2.), The 
immunoprecipitates were re-dissolved, after 3 washes with 0.7% 
(v/v) NP-40 in PBS, in several Tris HCl buffer solutions (see 
below). Reduction and alkylation (Methods 9.1,3 preceded 
application to 7.5% SDS-phosphate polyacrylamide tube gels 
with NN' methylene bisacrylamide as cross-linker (Methods 9.1.1.). 
Electrophoresis, gel slicing and liquid scintillation counting 
were carried out (Methods 9.1.4., 9.1.5, 8.1.3., respectively).
A: Secreted immunoprecipitable material in 2% SDS: 0.2M
Tris HCl pH 8.5
B: Intracellular immunoprecipi table material in 2% SDS: 0.2m
Tris HCl pH 8.5 
C: Secreted immunoprecipitable material in 8m urea:
0.2m Tris HCl pH 8.5 
D: Intracellular immunoprecipitable material in 8m urea:
0.2m Tris HCl pH 8.5 
E : Secreted immunoprecipitable material in 8M urea:2% SDS:
0.2M Tris HCl pH 8.5 
F: Intracellular immunoprecipitable material in 8M urea:
2%SDS: 0.2M Tris HCl pH 8.5
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1of H;L chain radioactivity intracellularly may be more affected by
trapping problems, but an average of 0.99 was obtained.
35
The cells were radioactively labelled with L-( S) methionine. 
Previous studies by other workers (Parkhouse, 1969) have shown the 
H chain of Pi to contain 8 methionines whilst the L chain contained 
3.5 methionines. Hence on a molar basis, the ratio of radioactivity 
in H and L chains (assuming balanced production) would be 2.66 
(assuming 3 L chain methionine residues) or 2 (assuming 4 L chain 
methionine residues). This former figure was in agreement with the 
ratio found on gels of secreted Pi Ig. 'Intracellular Ig, however, showed 
a much lower H:L chain ratio suggesting the presence of a large intra­
cellular pool of L chain. This pool may be produced either by 
unbalanced production of H and L chains or by selective degradation 
of H chains. The pool was estimated, on a molar basis to be B0% 
above the level for balanced H and L chain production. Such imbalances 
in H and L chain production have been described by other workers 
(Stevens and Williamson,1974). Similar findings with specifically 
precipitable material from reticulocyte lysate containing myeloma 
polysomes(although using a different labelled amino acid) suggested 
that cell-free translation was representative of cellular events 
(see Section 2) .
6.6. Effect of cycloheximide on Ig synthesis relative to total 
protein synthesis.
The effect of cycloheximide on the synthesis of Ig relative 
to total protein synthesis was investigated. Pi.17 cells were 
labelled/
labelled for either 30 min or 180 min with 250yCi leucine in
the presence or absence of cycloheximide at 0.2yg/ml. Lysates were 
prepared and both TCA precipitable and specifically precipitable 
material was measured for radioactivity. As the results in Table 15 
show, the synthesis of antigenically active material was inhibited 
to approximately the same extent as total protein synthesis by 
cycloheximide. This is in agreement with the results of other 
workers (Nuss and Koch, 1976; Stevens and Williamson, 1974, both 
using emetine) .
7._____ Translation in Messenger-Dependent Lysate.
After optimisation of the M.D.L, system for translation of 
myeloma mRNA, investigation of the products of translation in M.D.L. 
was carried out. This was done mainly by electrophoretic analysis 
on polyacrylamide slab gels.
7.1. Comparison of endogenous products of reticulocyte lysate 
and M.D.L.
Samples of radioactively labelled reticulocyte lysate assays 
and M.D.L. assays were analysed by PAGE in order to investigate the 
effect of nuclease action on reticulocyte lysate. They were also 
used to look for endogenous radioactively labelled species present 
in the M.D.L. Such species might interfere with interpretation of 
results obtained using myeloma polysomes or poly(A) RNA. As Fig. 23 
shows, the reticulocyte lysate made several proteins (Well2^), the 
most prominent of which being proteins of apparent MW 64^000,and 
18,000/
o
1—1
$
A
•H
CJ
0)
u
A
>t
H
1—1
OJ
Ü
•H
m
•H
o
<u
A
in
1
m
1—1
t
•H
A
•H
O
0)
U
A in
t r4
rH
Ü (U
U
0 rH
in rH
•H A
in
(D Ü
è •H
a rH
>i (ti
in •H
U
(U <D
> ■P
H (ti
■0 a
«J
r4
<U
u
ü
0
(U
'H
a
•H
X
(Ü
b
o
H
Ü
>1
U
IH
0
4->
Ü
Q)
m
kH
M
in
I—1
g
;
(U
0) A
A Ü
(iJ ro
XÎ
o'? Ü
ro
to i« O
1—!
Ü 'a
*H
iH
•H
U in
0) +J
A
to
0
Ü
(Dcn
r§
A C 
% -M
i  I
i  «tn 0) 
* r4
O
rn
OD
<M
'=ÿ
O
CN
kO
00in
I
CN
ro^
OJ O
rH rH
b  X
ro+j a
00 CO o
to A  a kO r' ro
«  -H \
% u in o rH rH0) -P
U Ü
A  3
o
o
ro~'>1 0) 1
rH rH O
iH n  r— t
ro ro —'
Ü 4-> p
•H "r-1 "H kO CNMH A a kO
•H -H ' \
o Ü in CN ro0) 0) -M rH
A  P g
to A  3ou
ro
ro A
A  g A
ro ro O
rCu 1
I—Ir-'
I
00
k£)
CN
CN
LO
on
rH
I>
m
ID
CO
kO
I
O
CTi
kO
kO
in
kO
I—I
kO
I
m  1—I
m
m
ro
kOm
CTi
00
o
CN
CÎ ro ro ro ro
O +j p +j p
-H ro ro ro c ro p _  d d
-P in 0 in p in H in 'H b  -H t J ■H
A >t -H !>i H >1 a >1  a ro a ro a•H iH n rH a rH rH •p •p
U o o ro o ro o
Ü rH O rH o rH 00 rH 00 P  00 p CO
in iH CO rH ro rH rH 1- - 1 I- - 1 U .H u 1—1
ro ro ro ro ro ro ro
p u o U O to to
TABLE 15; Effect of cycloheximide on relative synthesis of 
TCA-precipitable and specifically precipitable 
material in Pi.17 cells.
Legend:
7
Aliquots of 4 X 10 Pi.17 cells were incubated as 
described in Methods 2.2. for either 30 min or 180 min.
250yCi L-(^H) leucine was present in each incubation.
Incubation was performed in either thé presence or absence of
0.2]jg/ml cycloheximide. Cell lysates and cell supernatant 
were prepared (Methods 2,3.) and both TCA-precipitable and 
specifically precipitable material isolated (Methods 1.2.2.), 
from lOyl (cell lysate) or lOOyl (cell superantant) aliquots. 
Radioactivity incorporated was measured by liquid scintillation 
counting (Methods 8.1.2.).
FIG. 23: PAGE analysis of reticulocyte lysate and M.D.L.
endogenous radioactively labelled products; 
analysis of radioactively labelled products 
synthesized in M.D.L. in response to the 
addition of polysomes or poly(A) RNA from 
myeloma cells.
Standard 50yl M.D.L. assays containing 5yci L-(^H) 
leucine were incubated as described in Methods 7.2., with the 
additions noted below. After incubation, 5yl aliquots were 
prepared for electrophoresis as described in Methods 9.2.5., 
and PAGE was carried out at 15mA/gel for 8 hours. The gel 
was processed and fluorography performed as described in Methods
8.3.1., except that the X-ray film was briefly exposed to light 
to improve sensitivity (Bonner and Laskey, 1974). Exposure 
was for four days. Numbers of counts/min loaded per gel well 
were measured in duplicate 5yl aliquots as described in Methods 
8 .2 .1 .
Key Well Description
1
2 Reticulocyte lysate
3 M.D.L,
4 M.D.L. + 0.2yg reticulocyte poly(A)
5 M.D.L.
6
7 M.D.L. + lyg P i . 17 I polysomes
8 M.D.L. + yg P i . 17 I poly(A) RNA
9 °»
10 M.D.L. + yg P I . 17 II polysomes
11 M.D.L. + yg P i . 17 II poly(A) RNA
12 -
13 M.D.L. + yg 5563 I polysomes
14 M.D.L. + yg 5563 I poly(A) RNA
15
16 M.D.L, + yg 5563 II polysomes
17 M.D.L. + yg 5563 II poly(A) RNA
18
(countd/min 
loaded)
(34.000)
( 330)
(10.000)
( 367)
( ” )
( 7,235)
( 6,430)
( “ )
(14,100)
( 6,300)
( - )
(17,000) 
(10,650)
( - )
( 5,660)
( 2,980)
( - )
 ^  ^ 5 6 7 8 9 10 11 12 13 1^  15 16 17 1&
64K"
18K<
I
FIG. 23a: Densitoraetric analysis of Wells 13 and 14.
Wells 13 and 14 were scanned by a Joyce-Loebel
densitometer to determine quantitatively the distribution 
of radioactivity. Comparisons between polysomal and poly(A) 
RNA-containing wells were made.
A. 5563 II polysomes and poly(A) RNA.
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18,000, although many minor bands were detectable to the naked eye. 
Lodish and Small, 1976, have reported the presence of a prominent
64.000 MW protein in rabbit reticulocytes. Treatment with micro- 
coccal nuclease (Wells 3/5) resulted in elimination of all 
reticulocyte proteins and the appearance of two fast-migrating 
species (mobilities 0.79 and 0.83). Addition to the system of 
reticulocyte poly (A) RNA restored the prominent globin band (Well 4-) . 
Treatment with micrococcal nuclease therefore removed most, but not 
all, endogenous protein synthetic activity. The remaining species 
described above were at variance with the results of Pelham and 
Jackson, 1976, who described proteins of approximate MW 22,000 and
42.000 in control M.D.L. assays, one of which appeared to be labelled 
by a non-ribosomal process. The mobilities of the labelled species 
observed were such that they did not interfere with interpretation
of myeloma products.
7.2. Comparison of translation of myeloma polysomes and myeloma 
poly(A) RNA.
During the extraction of RNA from polysomes and the subsequent 
purification of poly(A)-containing RNA on oligo dT cellulose, there 
were several steps at which selective loss of messenger species was 
conceivable. For example, during phenol extraction,trapping of messenger 
species with long poly(A) tails at the phenol-buffer interface has 
been reported (Lee et al., 1971). In addition, loss of non-poly(A) 
containing mRNA species could occur on passage over oligo dT 
cellulose. This possible translational capacity difference between 
polysomes/
polysomes and poly(A) RNA was investigated by translation in the 
M.D.L. Four polysome preparations, consisting of the first and 
second polysome extractions of Pi.17 and 5563 tissue culture cells,
i.e. Pi.171, P1.17II and 55631, 5563II polysomes were each divided 
into two portions. One of each was treated by phenol extraction 
and oligo dT cellulose purification to yield poly(A)-containing RNA. 
Aliquots of each polysome sample and the appropriate poly(A) RNA 
fraction were assayed in the M.D.L, The resulting products were 
analysed by PAGE. As Fig. 23 demonstrates, the products of each 
polysome sample and the appropriate poly(A) RNA fraction showed 
apparently compete qualitative homology. When analysed densito- 
metrically the poly(A) RNA products showed an apparent selective loss 
of very high MW species, which may have been artefactual, (see Fig,
23a) . The loss appeared to be confined to the very high MW species, 
and did not appear to include products with MW < H chain. Differences 
between the products of Pi polysomes/poly(A) RNA and 5563 polysomes/ 
poly(A) RNA at lower MW's were mainly seen in the faster-migrating 
products of both cell lines, where a prominent band in 5563 products 
was replaced in Pi products by another prominent band with lower 
mobility. These were later identified as the precursors to L chains 
produced by these cell-lines.
7.3. Comparison of poly(A) RNA products with cellular products.
A comparison of the cellular products of myeloma cells and the 
M.D.L, cell-free products of myeloma poly(A) RNA was carried out 
by PAGE (see Fig. 24r) . Several observations were made:-
a/
FIG. 24; PAGE analysis of Pi.17 and 5563 poly(A) RNA-directed
35
products from M.D.L., labelled with L-( S) methionine
35
and comparison with L-( S) methionine labelled
cellular products.
Serial dilutions of Pi.17 and 5563 poly(A) RNA were
35
incubated with M.D.L. containing 5iiCi L- ( S) methionine as 
described in Methods 7.2. 5yl aliquots of the assays were 
prepared for electrophoresis as described in Methods 9.2.5.
PAGE was performed at 15mA for 16 hours and the gel processed 
for fluorography as described in Methods 9.2.6. The processed 
gel was exposed to R.P. Royal X-Omat x-ray film.
Key Well Description (counts/min).
1 M.D.L. + 0.5yg Pi.17 poly(A) RNA (29,100)
2 " + 0.25yg " " " (19,200)
3 " + 0.125yg " " " ( 9,000)
4 " + 0.06yg " " " ( 4,900)
5 Pi.17 total cellular products
6 5563
7 M.D.L. + lyg 5563 poly(A) RNA (50,500)
8 " + 0.5yg " " " (24,160)
9 " + 0.25yg" " " ( 8,560)
10 " + 0.125yg " " " ( 5,725)
PI 17 
1 2  3 4
cell 
lysate  
5 6
5563 
7 a 9 0^
pL —
—  pL
1 & &
a) In cellular products of both PI and 5563, two prominent bands occur
in PAGE, identified by immunoprécipitation elsewhere as the H and L 
chains of the respective Ig. Despite having the same approximate
MW's, both the H and L chains of the two cell lines show distinct 
differences in mobility as shown below:-
Mobility
Cell-line H L
PI.17 0.34 0.76
5563 ■ 0.33 0.78
(see also Fig. 24),
This called into question the use of molecular weight markers 
as a means of distinguishing the molecular weight of precursors.
Instead, it was decided to use mobility as the identifying characteristic 
of H and L chains and their precursors. This allowed comparison of 
bands within the same gel but was less accurate for comparison between 
gels.
b) Apart from H and L chains, the proteins of the two cell lysates
showed great qualitative homology, although not quantitative homology 
(see Fig. 24a for densitoraetric analysis).
c) Homologies were observed between the cellular products and
the appropriate cell-free products, although there were also many 
differences. The most striking variations concerned the positions 
of the Ig chains. With both cell lines, comparison of cell lysate 
material and MDL-synthesized material showed the absence in M.D.L. 
products of the prominent band identified previously as L chain
in cell lysates (see Figs. 18 and 19). In its place, a prominent 
band with lower mobility was observed (see Fig. 24a). This concurs 
with the findings of other groups with other myeloma cell types 
(Milstein/
FIG. 24a; Densitometric comparison of radioactively labelled 
cell lysates from Pi.17 and 5563 cells.
Densitometric analyses of wells 5 and 6 from Fig. 24, performed 
on a Joyce Loebel scanning densitometer. Positions of the H 
and L chains from each cell line are indicated. The trace of 
PI.17 cellular products has been displaced vertically for clarity.
m
K D  _
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Milstein et al., 1972; Swan# Aviv and Leder, 1972) and with each cell 
line the lowered mobility band was tentatively identified as the 
precursor to L chain (pre L chain), Comparison of these bands' 
mobilities with those of the cellular L chains are shown below.
Mobility
Cell line L pre L %age decrease in mobility
PI.17 0.76 0.70 7.12
5563 0.78 0.74 4.64
d) ■ In the H chain size region of the products, many bands were 
found but only in 5563 cell-free products was there found a band 
as similarly prominent as cellular H chain. Pi.17 cell-free products 
seemed to show no band of appropriate prominence which could be 
tentatively identified as H chain or its precursor. The relative 
mobilities of cellular 5563 H chain and its tentatively identified 
cell-free product were 0.33 and 0.34 respectively, as accurately 
as could be determined. The increase in mobility of the putative 
5563 cell-free H chain could result from absence of carbohydrate 
sidechains in the cell-free product which could increase mobility 
and might mask the effect of a precursor sequence in H chain.
This will be discussed more fully in Section 11.
7.4. Methods for identification of Ig precursors.
Several methods were used to identify unambiguously, the cell- 
free synthesized H and L chain products from the M.D.L.
1. Inference from the prominence of the bands 
separated by PAGE.
2./
2. Inference of position from known properties 
of other precursors, e.g. lower mobility 
of pre L chains.
3. Inference of position from known effects of 
cell-free translation, e.g. absence of 
carbohydrate addition, for H chain.
4. Direct immune precipitation.
5. Indirect immune precipitation.
■ 6. Comparison between producing and non-producing 
cell lines.
7. Tryptic mapping.
Some of these criteria have been discussed already (1 and 2) . 
Of the others, immunoprécipitation and tryptic mapping offered 
the possibility of the most unambiguous identification of cell-free 
H and L chains.
8. Immunoprécipitation.
8.1. Optimisation of immunoprécipitation.
Immunoprécipitation is a powerful tool for identification 
of specific proteins or polypeptides. It offered one method of 
unambiguously identifying Ig-like products of cell-free systems 
which had been stimulated by .myeloma cell polysomes or poly(A) RNA.
The conditions of immunoprécipitation had, however, to be 
optimised to ensure that the maximum amount of antigenic material was 
precipitated. It could not be assumed that the cell-free product 
would have identical antigenic properties to the intracellular or 
secreted/
1secreted products. Reticulocyte lysate cell-free systems lack the 
mechanisms for translocation of synthesized H and L chains into the 
intra-cisternal space. They also lack mechanisms contained therein 
for assembly and processing of Ig molecules. This could result in 
the synthesis of Ig-like proteins in the cell-free system with 
affinities for antisera different to those of Ig synthesized ^  vivo.
It was considered nevertheless that cell lysates of myeloma cells 
provided a useful model system for optimisation of immune precipitation, 
whilst- recognising that conditions might well require adjusting for 
use with the cell-free systems.
Two methods of immunoprécipitation were considered. The first, 
direct precipitation, involved simple interaction between a specific 
antiserum and antigenic material. This resulted in the formation of 
small insoluble immune complexes which could be pelleted from the 
solution by centriËigation. The second method, indirect immune 
precipitation, initially involved interaction of a specific anti­
serum with the antigen as before. This was followed, however, by 
the addition of a more general antiserum whose specificity was directed 
against the Ig present in the first antiserum. This included the 
specific antibodies bound to the original antigen. This had the 
effect of producing larger, more easily isolated immune complexes and 
thereby improved the recovery of the antigenic material under study, 
as will be demonstrated {Section 8.2.3.).
8.1.1. Optimisation of indirect immunoprécipitation.
Immunoprécipitation was normally carried out in buffered 
saline solution to maintain protein integrity and to allow antibody 
antigen/
antigen interaction. Detergents (Triton X-lOO, sodium deoxycholate) were 
present to attempt to minimise non-specific aggregation. These 
detergents did not appear to prevent antigen - antibody interaction 
and the formation of specific immune complexes (Askonas & Williamson,
1967; Parkhouse & Crumpton, 1972).
Two antisera were used. The first was raised in rabbits 
using purified 5563 Ig and showed a specificity of interaction both 
with 5563 Ig and also with Pi Ig. The second antiserum was raised 
in goats against rabbit Ig and hence interacted with all the rabbit 
Ig present in the rabbit antiserum.
Several variables required to be optimised in order to ensure 
maximum precipitation of antigen from the sample.
The first variable investigated was the equivalence of goat 
antiserum with rabbit antiserum. This was determined indirectly 
by titrating the goat antiserum against a fixed volume of radio- 
actively labelled 5563 cell lysate (210,000 cpm/5yl TCA pptble) 
containing a fixed volume of rabbit antiserum. Increasing volumes 
of goat antiserum will precipitate increasing amounts of rabbit Ig- 
5563 complexes (and hence of radioactivity) until all such complexes 
have been removed from solution. Thereafter, larger volumes 
of goat antiserum will lead only to larger immune complexes being 
precipitated.
This did not require that the rabbit antiserum and 5563 Ig were 
at equivalence. As the data in Fig. 25 suggests, equivalence was 
reached at 20 volumes goat antiserum versus 1 volume rabbit antiserum. 
Below equivalence, the amount of radioactive material precipitated 
fell off sharply, indicating that not all rabbit Ig - 5553 Ig 
complexes were being precipitated. Above equivalence, radioactivity 
precipitated/
FIG. 25: Titration curve Goat anti-rabbit Ig antiserum
vs. Rabbit anti- 5563 protein/5563 complexes 
in cell lysate.
5yl aliquots ('v 180,000 counts/min) 5563 cell lysate,
35
radioactively labelled with L-( S) methionine were incubated in 
250yl PBSA containing 1% (v/v) Triton X-100, 1% (w/vj NaDOC, 
with 5yl rabbit anti-5563 antiserum. Incubation was for 30 min 
at room temperature. Subsequently, varying volumes (25yl-250yl) 
of goat anti-rabbit Ig antiserum was added (volumes equalised c_ 
PBSA) and the incubation was continued overnight at 4°C. The
precipitates were pelleted by centrifugation, resuspended in 
1 ml PBSA and this procedure repeated 2 more times. The washed 
precipitates were redissolved in 1 ml O.IN NaOH, and optical 
density at 280nm measured by a Unicam SPlBOO Ultraviolet 
Spectrophotometer. 0.5 ml of the solution was dissolved in 
6 ml Triton/toluene/PPO scintillation fluid (Methods 8.1.2.) 
and radioactivity measured by scintillation counting. Each 
assay point was performed in duplicate. In some assays, normal 
rabbit serum was used instead of antiserum to measure non­
specific precipitation.
FIG. 26; Titration curve!- Goat anti-rabbit Ig antiserum 
vs. rabbit anti-5563 antiserum/lg-like product 
complexes from M.D.L. containing Pi.17 poly(A) RNA.
5yl of M.D.L, assay,incubated with Pi.17 poly(A) RNA under 
standard conditions (TCA precipitable material - 186,000 counts/ 
min/5yl, background 18,770 counts/min/5yl), was incubated in 
250yl PBSA containing 1% (v/v) Triton X-lOO, 1% (w/vj NaDOC, with 
5yl rabbit anti-5563 antiserum. Incubation was for 30 min at 
room temperature. After this, various volumes (25yl-250yl) 
of goat anti-rabbit antiserum were added and the incubation 
continued overnight at 4°C. Volumes were adjusted with PBSA.
The precipitates were washed, and optical density and radioactivity 
measurements were carried out as described in Fig. 25. Each 
assay point was performed in duplicate. For some points normal 
rabbit serum control precipitations for background precipitation 
were performed.
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Àprecipitated remained level over a range of goat antiserum:rabbit 
antiserum ratios whilst the size of precipitate formed continued 
to increase. To ensure maximum precipitation of radioactivity from 
cell lysates, rabbit and goat antisera were subsequently used in a 
ratio of 1:20.
This experiment was also carried out using normal rabbit 
serum in place of the rabbit antiserum to test for non-specific 
precipitation of radioactivity. The non -specific precipitation level 
was < ^ 2 % of total TCA precipitable material and ^10% of the maximum 
specifically precipitable levels. Later experiments suggested 
that this non-specific precipitation resulted from non-specific 
trapping of radioactively labelled proteins and/or amino acids in the 
immune complexes as they formed.
This method was then used to check equivalence with a sample 
of radioactively labelled M.D.L. Conditions were similar to that 
used with the cell lysate. Fig. 26 demonstrates that equivalence of 
goat and rabbit antiserum occurred in a ratio of 25:1 (by volume).
This was slightly higher than was found using cell lysate, but not 
greatly so. The major difference noted was in the higher level 
of non-specific precipitation of radioactivity observed in control 
precipitations involving normal rabbit serum. This constituted 6.3% 
of total TCA precipitable radioactivity and approximately 50% of 
maximum specifically precipitable radioactivity. Such a level of 
non-specific precipitation was considered unacceptable. Several 
methods of reducing this level were investigated.
First to be investigated was the effect of repeated resuspension 
and pelleting of the precipitate in ice cold PBSA containing excess 
unlabelled methionine. As the data in Figure 27 shows, after 3 
washes/
FIG. 27: Effects of washing immunoprecipitates on the amount
of radioactivity detected.
Quintuplicate samples were set up, each containing 5yl 
Pi.17 M.D.L, assay (186,000 counts/min) and 5yl rabbit anti- 
5563 antiserum in PBSA containing 1% (v/v) Triton X-lOO and 
1% (w/v) NaDOC. After 45 min incubation at room temperature, 
lOOyl Goat anti-rabbit Ig antiserum was added and incubation 
was continued at 4°C for 2 hours. The precipitates were 
pelleted by centrifugation and washed from 1 - 5  times with 
PBSA. Each washed, pelleted precipitate was dissolved 400yl 
O.IN NaOH and duplicate lOOyl aliquots were measured for radio­
activity in Triton/toluene/PPO (Methods 8.1.2.) by scintillation 
counting.
Identical manipulations were carried out on samples 
containing normal rabbit serum in place of specific antiserum.
FIG, 29: Relationship between immunoprecipitate size and
amount of radioactivity precipitated.
Serial dilutions of rabbit anti-5563 antiserum were added 
to 5yl PI.17 M.D.L, (186,000 counts/min) in precipitation 
medium (Methods 11.2.2.). After the standard incubation period, 
goat anti-rabbit Ig antiserum in the ratio 30:1 (by volume) over 
rabbit antiserum was added and incubated at 4°C overnight. 
Precipitates were isolated by standard procedures (Methods 11.2.2.) 
and radioactivity measured by scintillation counting (Methods
8.1.2.). With some assay points, normal rabbit serum control 
precipitations were included.
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washes with PBSA, the level of radioactivity detected in immune 
precipitates from a sample of M.D.L., either specific or non­
specific, remained constant. After this treatment, non specific 
precipitates contain 31% of the amount of radioactivity contained in 
specific precipitates. Thus washing of precipitates reduced but did 
not eliminate non-specific precipitation. Two further possible 
methods were investigated:-
i) ribonuclease was used to destroy RNA present in the M.D.L. 
sample. This was used to prevent possible contamination of precipitates 
by non-specific adsorption of tRNA molecules charged with radio­
actively labelled amino acids,
ii) normal rabbit serum, followed by goat antiserum were used 
for the purpose of clearing non-specifically adhering material 
from the sample. After transfer of the resulting supernatants to 
fresh tubes, specific precipitation was carried out, theoretically
in the absence of non-specifically aShering species. As demonstrated 
by Table 16, addition of pancreatic ribonuclease to M.D.L. samples 
before immunoprécipitation increased rather than eliminated non­
specific precipitation. This problem has been found by other workers
(Sussman et al., 1976), Thus, nuclease treatment was concluded to be
ineffective in reducing non-specific precipitation. As shown by 
Fig, 28, the use of a clearing precipitate was also ineffective with 
regard to this problem. After the clearing precipitate, non-specific 
precipitation was reduced to approximately 5o% of the level found 
without a clearing precipitate. Specifically precipitable counts, 
however, fell to 40% of their previous level. An indication that 
interference with antibody-antigen interactions was occurring was 
found in the shape of the titration curve obtained after using the 
clearing/
TABLE 16: Effect of ribonuclease on non-specific trapping
of radioactivity in immune precipitates.
Legend:
Duplicate 50yl aliquots of M.D.L., stimulated by Pi.17 
poly(A) RNA, containing 1.8 x 10^ cpm/aliquot (as determined on 
paper discs) were treated as follows:-
Aliquot a) no additions, incubated @ 37°c for 3o minutes.
Aliquot b) made 15mM in EDTA pH 7.3, 25yg/ml pancreatic ribonucl­
ease: incubated @ 37°C for 30 minutes.
After this, 5yl samples were added to 250yl PBSA containing 
1% (v/v) Triton X-lOO, 1% (w/v) sodium deoxycholate. To 
these were added either 5yl of specific rabbit antiserum 
or 5yl of normal rabbit serum. This solution was incubated 
at room temperature for 30 minutes. Thereafter, various volumes 
of goat antiserum were added and sufficient PBSA to make the volumes 
of all assays equal. These solutions were incubated at room
temperature for 30 minutes, then overnight at 4°c. The 
precipitates were pelleted by centrifugation, then washed, 
dissolved and counted as described in Methods 11.2.2. and
8.1.2.
TABLE 16 : Effect of ribonuclease on non-specific trapping of
radioactivity in immune precipitates.
Treatment
Control
Pancreatic
ribo­
nuclease
Vol.of 
Volume of normal 
rabbit rabbit 
antiserum serum
(yl) (yl)
Volume of 
of goat 
antiserum 
(yl)
20
150
300
20
150 '
300
20
150
300
20
150
300
c.p.m./ cpm
precipitate -NRS ppte
1716
12326
8886
1232
2116
2586
2356
16622
9570
3984
9052
15618
384
10210
6300
not valid 
7570 
not valid
FIG. 28: Comparison of the effect of a pre-precipitation
step on titration curves and M.D.L.
Duplicate series of immunoprécipitation assays were 
performed using varying rabbit antiserum:goat antiserum ratios 
(1:5 to 1:50) by standard methods (see Fig. 25) and using Pi.17 
M.D.L. products as radioactive label. In some cases, normal 
rabbit serum replaced the specific rabbit antiserum. In one 
of the duplicate series, the assays had previously been 
subjected to a normal rabbit serum:goat anti-rabbit Ig antiserum 
precipitate (as a step to remove non-specifically binding 
material). The other duplicates had not been treated this way.
A. Titration curve without pre-precipitation with 
NRS/goat antiserum.
B. Titration curve after pre-precipitation with 
NRS/goat antiserum.
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clearing precipitate.
Neither of these two methods yielded appreciable improvements 
in the level of non-specific precipitation. Later work showed that 
the inclusion in the precipitation assays of 0.5% (w/v) SDs reduced the 
level of non-specific precipitation significantly (T.R. Mosmann, 
personal communication).
One disadvantage of indirect immunoprécipitation was that 
large quantities of unlabelled IgG were present in the immune 
precipitate. When immuneprecipitate samples were separated by PAGE, 
even quite small quantities of immuneprecipitate caused distortion 
of the gel tracks, and of the radioactively labelled products 
separated on them. This was because local concentrations of 
unlabelled IgG H and L chains caused local overloading of the gels.
This was not very important for cell-free synthesized L chains which, 
being synthesized as larger precursors, had mobilities lower than the 
area of L chain distortion. Nor was it a serious problem with a- and 
y-type H chains which migrate more slowly than the y H chain of IgG 
and hence avoid distortion. In the cases of 5563 and Pi.17 cells, 
both of which produce y-type H chains, gel distortion in the region 
of gel at which the cell-free product migrated was a serious problem, 
resulting in "bullet-shaped" fuzzy bands (see Fig.31) rather than 
sharp straight bands. One way of circumventing this problem was 
to investigate wtether less antiserum could precipitate the same amount 
of radioactivity. Consequently, the equivalence of cell-free system- 
produced antigenic material with rabbit antiserum was determined.
The ratio of rabbit antiserum to goat antiserum was kept constant 
while varying the volume of rabbit antiserum added to a system 
containing a constant volume of M,D.L,/containing 5563 cell-free 
products/
products. Figure 29 showed that, allowing for non-specific 
precipitation of radioactivity > 5yl of rabbit antiserum would 
precipitate a constant amount of radioactivity from 5yl of M.D.L. 
containing 5563 antigenic material,but that below 5yl of rabbit 
antiserum, the amount of radioactivity dropped sharply, indicating 
that equivalence had not been reached. Consequently, the size of 
immunoprecipitate could not be reduced to any advantage. The 
alternative precipitation method, direct precipitation, offered some 
advantages in terms of amount of protein precipitated and was 
therefore investigated.
8.1.2. Optimisation of direct precipitation.
Direct immune precipitation, relying on the primary antibody- 
antigen reaction to produce insoluble immune complexes large enough 
to be pelleted by centrifugation was investigated as an alternative 
to indirect immunoprécipitation, with its disadvantages.
Direct precipitates were performed as described in Methods
11.2.1. In view of the likely size of the immunoprecipitate, 
the sucrose layer method of isolating precipitates was used, followed 
by dissolving the precipitate in 9M deionised urea.
The relative effectiveness of direct precipitation and 
indirect precipitation was studied, by comparing the amount of 
radioactivity recovered by each method from a sample of cell lysate. 
Cell lysates and secreted material from two cell lines, 5563 and 
Pi.17, were used. As the data in Table 17 demonstrate,in general, 
directly immunoprecipitable radioactive material amounted to only
TABLE 17: Comparison of direct and indirect immuneprecipitatlon
from Pi.17 and 5563 cell lysate.
Legend:
Immunoprécipitations were carried out using conditions 
described in Methods 11,2.1. (direct) or Methods 11.2.2. 
(indirect). lOyl L(^H) leucine-labelled 5563 cell lysate 
(140,000 counts/min), lOyl L(^H) leucine-labelled Pi.17 cell 
lysate (175,000 counts/min) or SOyl L(^H) leucine-labelled 
Pi.17 cell supernatant (26,600 counts/min) were used. 
Immunoprecipitates were washed as described in Methods
11.2.1. (direct) or Methods 11.2.2.(b) (indirect) and 
dissolved in either lOOyl 9M urea (direct) or 500yl 9M urea 
(indirect). Radioactivity was measured by scintillation 
counting of samples dissolved in triton/toluene/PPO (Methods
8.1.2.)
Key:
I, indir.- indirect immunoprécipitation
D, dir. = direct immunoprécipitation
C = indicates normal rabbit serum control
precipitation
MRS = normal rabbit serum
ppte = precipitate
Sp = specific
n.a. = not applicable
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33% of the radioactive material precipitable by indirect 
immunoprécipitation. The possibility that the immune complexes 
being formed were too small to allow precipitation from solution was 
investigated. Varying amounts of purified antigen (in this case, 
pure 5563 protein) were added to the solution before the antiserum.
This was intended to provide more antigen material to allow formation 
of larger immune complexes.
The amount of radioactivity precipitated from 5563 cell lysate 
remained unchanged in the presence or absence of added 5563 Ig.
This indicated the possibility that limiting amounts of antiserum 
were not being used. It also suggested that there was no significant 
pool of soluble immune complexes containing radioactively labelled 
material. Alternatively, the data could be interpreted as suggesting 
that any pool existing contained only poorly interacting species.
In the presence of 5563 Ig, the amount of radioactivity detected 
in direct precipitates from Pi.17 cell lysates showed a marked 
decrease. This may have been due to competition between the radio­
actively labelled Pi Ig and the unlabelled 5563 Ig. The antiserum was 
raised against 5563 Ig and whilst showing cross-reactivity with 
Pi Ig might be expected to contain some antibodies having greater 
affinity for 5563 Ig.
Immunoprécipitations were carried out in the medium retained 
after labelling of Pi.17 cells. This medium contained radioactively 
labelled secreted Pi Ig. Both direct and indirect immuno­
précipitation techniques yielded the same amount of radioactivity 
precipitated. A hypothesis consistent with this and the above data 
was that strongest affinity was shown to L chains by the antiserum. 
Thus/
13&
Thus the larger immune complexes formed in direct immunoprécipitation 
contained a higher proportion of free L chain than that found in 
the cell. This was later confirmed by gel analysis of direct and 
indirect immunoprecipitates (see Fig. 19).
With direct immune precipitation the effect of varying the 
amount of antiserum used was investigated. The optimum volume of 
antiserum was found to be 5yl. At this volume, the amount of 
radioactivity precipitated levelled off.
•When direct precipitation was used on samples of M.D.L. 
assays, the results obtained were variable. Direct precipitation 
did not always yield more radioactivity than was precipitated in 
normal rabbit serum control precipitations. When, however, specific 
direct precipitation did yield levels of radioactivity higher than 
background, PAGE analysis showed bands corresponding to H and L 
chain-like material (see Fig. 30a).
8.2.1. Direct immunoprécipitation of Pi.17 and 5563 myeloma-products 
in the M.D.L.
Direct immunoprécipitation of samples of M.D.L. assays contain­
ing Pi.17 or 5563 poly(A) RNA was carried out as described in Materials 
and Methods, and the direct precipitates and total M.D.L. synthesized 
material were compared by PAGE (Fig. 30). Densitometric analysis 
of the direct precipitate and comparison with both the total M.D.L. 
products and intracellular products indicated the presence of a small 
amount of material electrophoresing with a mobility slightly greater 
than the mobility of intracellular H chain. A band with a mobility 
lower/
FIG. 30; PAGE analysis of direct and indirect immuno­
précipitation from M.D.L. containing 
5563 poly(A) RNA.
Standard M.D.L, assays, either containing or omitting
2yg 5563 poly(A) RNA,were carried out as described in Methods
35
7.2 , with 2.4yCi L-( S) methionine as radioactive label.
Direct and indirect immunoprécipitations were carried out on 
5yl aliquots of the assays as described in Methods 11.2.1. and
11.2.2(b) except that the precipitate size was 1/4 the standard
amount in the indirect precipitation. Samples of cell lysate
were run as markers. The gel showed abnormal running character­
istics but this did not appear to affect separation.
Key Well Description (counts/min)
1 M.D.L., no added mRNA - total products (12,000)
2 M.D.L., no added mRNA - direct ( 3,380)
precipitate
3 M.D.L., no added mRNA - indirect ( 2,200)
precipitate
4 M.D.L., 2yg 5563 poly(A) RNA -
total products (183,000)
5 M.D.L., 2yg 5563 poly(A) RNA -
direct precipitate ( 5,400)
6 M.D.L., 2yg 5563 poly(A) RNA -
indirect precipitate { 6,060)
7 5563 cell lysate - total products
1 2 3  1 5  6  7
FIG. 30a; Densitometric analysis of total products and 
direct precipitates from M.D.L. containing 
5563 poly(A) RNA, as shown in Fig. 30.
Densitometric analysis was performed on a Joyce-Loebel 
Scanning Densitometer, (Methods 8.3.3.). A wedge giving OD 
range O - 0.15 was used to scan the direct immunoprecipitate.
A wedge giving OD range O - 1.5 was used to scan the total 
products. The total products trace has been reduced in height 
by approximately 50% for greater ease of comparison with the 
direct precipitate.
Total 5563 
MDL products
pre-L
B  ûxtc a r o O  rMk
Electrophoresis
lower than that of intracellular L chain was also observed. These 
separations were reproducible on a further gel suggesting that they 
were not merely artefactual. Direct precipitation of a Pi. 17 M.D.L.
aliquot revealed no clearly defined material with mobility close to 
that of intracellular H chain although prominent bands of material 
were observed at positions of lower and equal mobility with intra­
cellular L chain. As with direct precipitation from cell lysates, 
the precipitation was not quantitative but was indicative of the 
presence of H and L-chain-like material in M.D.L, assays containing 
myeloma poly(A) RNA. Quantitative precipitation of material was 
investigated using indirect immunoprécipitation.
8.2.2. Indirect immunoprécipitation of Pi.17 and 5563 myeloma 
products in the M.D.L.
Indirect precipitation of Ig-like species synthesized in the 
M.D.L, containing 5553 and Pi.17 myeloma polysomes or poly(A) RNA 
was carried out as described in Methods 11.2.2(a). NRS controls 
for non-specific precipitation were used. The immunoprecipitates 
were redissolved in deionised 9M urea after washing and aliquots of these 
solutions were prepared for PAGE. These were electrophoresed with 
samples of cell lysate and total M.D.L. products. Fig. 31 shows 
the radioactive banding pattern obtained after fluorography.
A prominent band corresponding to the position of putative pre-L 
chain was observed in precipitates from M.D.L. containing either 
5563 or Pi.17 polysomes. In the case of 5563, precipitation of 
this material appeared quantitative by densitometry. Pi.17 
indirectly/
FIG. 31: PAGE analysis of M.D.L. products from Pi. 17 and
5563 polysomes.
Aliquots from (b) assays shown in Table 18, were treated 
as described in Methods 9.2.5. and electrophoresed overnight 
for 16 hrs. at 15mA/gel. Gel processing and exposure to X-ray 
film was as described in Methods 8.3.1. Films were developed 
by standard techniques. Approxinia'tely lOOOcpm WGre dGiGctabiG
Key Well Description (counts/min)
1 M.D.L./P1.17 polysomes, direct immuneprecipitation
NRS control
3 " indirect immunoprécipitation
^ I I If
NRS control
5 " total cell-free products
6 Pi.17 secreted, direct immuneprecipitate
7 " " total secreted material
8 " cell lysate, direct immuneprecipitate
9 " " " total cell lysate material
10 Blank
11 5563 cell lysate, total cell lysate material
12 " " " direct immuneprecipitate
13 " secreted, total secreted material
14 " " direct immuneprecipitate
15 M.D.L, /5563 polysomes, total cell-free products
16 " " indirect immuneprecipitable,
NRS control
17 " " indirect immuneprecipitate,
NRS control
IB " " direct immuneprecipitate,
NRS control
" " direct immuneprecipitate19
20 M.D.L. total cell-free products
21 
22
23
24
indirect immuneprecipitate 
direct immuneprecipitate
NRS control
NRS control
( 1,000)
60)
1,000)
300) 
10,000) 
2,500) 
3,300)
200)
15,400)
“ ) 
1,800)
500)
6,900)
2,000)
17,000)
450) 
1,700)
700)
3,000)
)
120)
240) 
50) 
1,600)
1 2 3 4 5 6 7 8 9 1 0 Î 1  12 13 U 15 16 17 18 19 2021 22 23 2U
L #  e
indirectly immunoprecipitated material was not quantitative for 
pre L chain material. In both cases, the area corresponding to 
the expected mobility of putative pre-H chain was distorted, implying 
overloading of the gel with protein at this point on the gel. This 
was probably due to a high concentration of unlabelled y chains 
present from the indirect immunoprecipitate. This heterogenous 
mixture of H chains from Goat and Rabbit presented severe problems.
Its distorting effect prevented accurate measurement of the mobility 
of putative pre H chain. It also hampered attempts to quantify 
production of putative pre-H chains,by immunoprécipitation. These 
problems have not been entirely resolved in this project nor have 
they been by other workers. Indirect immunoprécipitation of M.D.L. 
containing 5563 polysomes nevertheless yielded material which had a 
mobility approximately the same, or slightly greater than cellularly 
produced H chain. This agreed with the results of direct immuno­
précipitation. ■_ - . Comparison
with the gel profiles of immunoprecipitates with NRS showed that this 
radioactivity was specifically precipitated and not non-specifically 
"trapped" in the precipitate. Reducing the fraction of the immuno­
precipitate added to the gel from 1/2 to 1/5 to 1/10 in later experiments 
did not significantly improve the distortion by unlabelled H chain.
8.2.3. Comparison of direct and indirect immunoprécipitation of M.D.L.- 
synthesized Ig-like material.
It was shown that 5pl of antiserum removed 90% of precipitable 
material from a similar volume of M.D.L. containing myeloma mRNA- 
directed/
' M
directed products by the indirect immunoprécipitation method. This 
volume of antiserum was therefore used to compare direct and indirect 
immunoprécipitation of Ig-like products from M.D.L. stimulated by 
myeloma polysomes. Polysomes from two myeloma cell lines were used.
Pi.17 and 5563, and Fractions I and II of polysomes from these lines 
were tested separately. As shown in Table 1?, direct immuno­
précipitation was erratic in the amount of radioactively labelled 
material it precipitated, varying by up to 10 fold between two 
precipitations with the same polysome fraction. Consequently 
analysis by PAGE was not pursued in this experiment. Indirect 
immunoprecipi tation, although experiencing high background as shown 
in NRS precipitate? nevertheless gave more consistent figures for 
radioactive material precipitated. In both Pi.17 and 5563 experiments, 
a higher percentage of total products seemed to be specifically 
precipitable using the Fraction II polysomes.
8.2.4. Comparison of levels of specifically precipitable material from 
M.D.L. assays containing myeloma polysomes and from myeloma cells 
labelled in culture.
The cell labellings described in Sections 5*1».2 & 5*2*2 
were carried out using small samples of the cells used in the 
preparation of the polysomes assayed in Section8 .2.5&bov^' The 
cells were removed for labelling prior to the first step of the 
polysome isolation procedure (i.e. addition of cycloheximide to 
lOOpg/ml; see Methods Section 3.) Consequently, they allowed a 
direct comparison between the levels of production of Ig intra- 
cellularly and the levels of production of immunoreactive material 
in/
TABLE 18: Comparison of direct and indirect immunoprécipitation
from M.D.L. assays of various polysome fractions.
Legend:
Two separate series of assays were run using respectively
35
a) 60 min incubation, 6pCi (L-( S) methionine and 50pl M.D.L.
35 '
and b) 120 min incubation, 30yCi L{ S) 'methionine and lOOyl 
M.D.L. 5yl polysomes were added in assay a), lOyl in assay b). 
Otherwise,' standard M.D.L. conditions were used. Direct and 
indirect immunoprécipitation reactions, including normal rabbit 
serum controls, were carried out as described in Methods 11.2.1. 
and 11.2.2(b) respectively. Radioactivity was detected by 
dissolving precipitates in 9M urea and measuring radioactivity 
by liquid scintillation counting, using triton/toluene/PPO as 
solvent (Methods 8.1.2.).
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in the M.D.L. cell-free system. Comparison of Tables 11 and 18 
showed that in the cell line PI.17, incorporation of radioactivity 
into Ig-like material (as measured by immunoprécipitation) was a 
lower percentage of total incorporation in the M.D.L, than it was 
intracellularly. With the cell line 5563, the relative specifically 
precipitable percentage of total incorporation in the M.D.L. and 
intracellularly was approximately equal. These results suggested 
that relative production of Ig or Ig-like material compared to total 
protein production was not substantially different in M.D.L. assays 
and in cell lysates. This argued that the M.D.L. system did not 
selectively enhance or repress translation of the major myeloma cell 
mRNA species relative to other species ,although,as seen in Fig. 24, 
variations in the relative synthesis of some species occurred.
9. Effect of initiation inhibitors on the relative synthesis
of H and L chains in the M.D.L.*
According to the hypothesis of Lodish, (1974), inhibitors
of initiation of protein synthesis having a direct effect on the 
408
formation of thej^Met-tRNA^-mRNA complex should have a preferential 
inhibitory effect on mRNA's which are poorer initiators. On the 
other hand, inhibitors acting after this point should show no 
preferential effect.
Consequently, with myeloma mRNA,if either H or L chain mRNA 
is a poorer initiator, the effect of inhibition of initiation of 
translation/
^îhese results re>{iiire further
repetition to establish their 
lireproducibllity.
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translation should be more pronounced with that mRNA than with the
other. Inhibitors of initiation whose site of action is temporally
after the^met-tRNA^-mRNA complex formation event should have no
effect, i.e. inhibition should not significantly affect the ratio in
which H and L chains are synthesized.
Two inhibitors were studied for their effects on H and L chain
production. One of these inhibitors, aurintricarboxylic acid (ATA)
40S-
acts to prevent the formation of the met-tRNA^-mRNA complex. The 
other inhibitor used (pactamycin) acts at a point after this complex 
has formed.
M.D.L, assays containing Pi.17 poly(A) RNA were incubated with
3
L-( H)-leucine in the presence of varying concentrations of aurintri­
carboxylic acid (ATA), or of pactamycin. Aliquots of these assays 
were analysed by PAGE, followed by fluorography. Eluorographs 
produced were densitometrically analysed and the relevant peaks traced 
on thick plastic film. The film was cut around the tracing and 
weighed. From these weighings the peak areas could be inferred and 
measurements of the H:L chain ratios made. 18 1cm square samples 
of the plastic film gave an average weight of 23.45 ± 1.25mg. Hence 
accuracy was approximately ± 5%.
9.1. Effect of ATA on the H:L chain ratio.
Aliquots of M.D.L. assays with Pi poly(A) RNA, and containing 
ATA at final concentrations of O, 20, 40, and 80yM, were analysed, 
after incubation, by PAGE and fluorography. Densitometric
traces of the appropriate gel slots are shown in Fig. 32. The 
total/
FIG. 32: Effect of aurintricarboxylic acid (ATA) on
translation of Pi.17 poly(A) RNA in M.D.L.
Standard M.D.L. assays, containing lyg Pi.17 poly(A) RNA, 
3
2.5yCi L-{ H) leucine and 50 pmoles unlabelled leucine, were 
incubated at 30^c for 40 min in the presence of serial dilutions 
of ATA (0,20,40,80yM). 5yl aliquots were analysed by PAGE as 
described in Methods 9.2.5. and 9.2.6. Gels were processed 
and exposed to X-ray film (R.P. Royal X-omat) (Methods 8.3.1.). 
The developed fluorographs were analysed densitometrically 
by a Joyce-Loebel Scanning Densitometer (Methods 8.3.3,).
The traces obtained were displaced vertically from each other 
for clarity.
o
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total incorporation and the H:L chain ratios, measured as described
above are shown in Table 19.
TABLE 19, Effect of ATA on total incorporation and on the H:L ratio
in M.D.L. assays. (for legend see Pig. 32;) .
{ATA}
(yM
counts/min 
incorpor­
ated - 
background 
(3600 cpm)
% of 
control
H chain 
(mg)
% of 
control
L chain 
(mg) cSnSiol H :L
H : L 
*
0 44600 100 58.2 ■ 100 68.3 100 0.85 0.42
20 11450 25.7 60.9 104.6 31.3 45.8 1.94 0.97
40 2000 4.5 27.8 47.8 24.1 35.3 1.35 0.67
80 300 0. 7 n.d. n.d. n.d. n.d. n . d.
* Adjusted to take account of relative numbers of methionines (i.e.
H chain f 2).
From the Lodish hypothesis, this suggests that H chain mRNA is the better 
initiator of the two species of mRNA, since inhibition of its 
translation is less affected by low levels (20yM) of ATA, whilst 
translation of L chain mRNA is markedly inhibited. At higher 
concentrations of ATA, elongation steps are also inhibited, resulting in 
a partial recovery of L chain synthesis relative to H chain synthesis. 
These results contradict those of Sonenshein & Brawerman (1976b). ATA 
inhibited total protein synthesis relatively more than Ig synthesis 
at all levels of inhibition tested. This agreed with results of 
Sonenshein and Brawerman (1976b), using a wheat germ cell-free protein 
synthesizing system to test the effect of high salt concentrations in 
inhibition of initiation of myeloma cell mRNA. The results are also 
consistent with work on the effect of initiation inhibitors on 
myeloma cell cultures by Sonenshein and Brawerman, (1976a), and by 
Nuss/
6 1
Nuss and Koch, 1976.
9.2. Effect of pactamycin on the H:L chain ratio.
Aliquots of M.D.L, assays containing Pi.17 poly(A) r n a and 
pactamycin at final concentrations of O, 60, 120 and 250 nM were 
analysed, after incubation, by PAGE and fluorography. Densito­
metric traces of the appropriate gel slots are shown in Fig. 33.
The total incorporation and the H:L chain ratios, measured as 
described above are shown in Table 2o
TABLE 20: Effect of pactamycin on total incorporation and on the
H:L chain ratio in M.D.L. assays. (For legend see Fig. 3
counts/min 
incorpor- 
{pactar a ted -
mycin} background % of H chain % of L chain % of H:L H:L 
(n.M) ( 3600cpm) control (mg) control (mg) control ___  *
0 47300 100 33.5 100 49.1 100 0.68 0.34
60 10275 21.72 40.6 121.2 34.8 70.9 1.16 0.58
120 9740 20.6 n.d. n.d. n . d. n.d. n.d.
250 6550 13.8 34.92 104.2 37.8 77.0 0.922 0.46
* Adjusted to take account of relative numbers of methionines (i.e.
H chain f 2).
Lodish predicted and showed with a and g haemoglobin synthesis 
that pactamycin would not greatly affect the relative translation of 
two species of mRNA since its site of action is after the formation 
of the met-tRNA^-mRNA complex. These results showed a significant 
relative inhibition of L chain in the presence of pactamycin. As 
was found for ATA , total non-Ig protein synthesis was inhibited more 
severely/
FIG. 33: Effect of pactamycin on translation of Pi.17
poly(A) RNA in M.D.L.
Standard M.D.L. assays, containing lyg PI.17 poly(A)
3
RNA, 2.5yCi L-( H) leucine and SOpmoles unlabelled leucine
were incubated at 30°C for 40 min in the presence of several
-7 -7concentrations of pactamycin (O, 0.6 x 10 M, 2.5 x 10 M).
5yl aliquots of these assays were analysed by PAGE (Methods
9.2.5 and 9.2.6.). The gels were processed and exposed to
X-ray film (R.P. Royal X-omat) (Methods 8.3.1.). The
developed fluorograph was analysed by a Joyce-Loebel Scanning
Densitometer, (Methods 8.3.3.). The traces obtained were
displaced slightly both horizontally and vertically for clarity.
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severely by pactamycin than was Ig synthesis. Ig H chain synthesis 
was relatively unaffected by pactamycin whilst L chain synthesis 
dropped by a maximum of 30%. Total protein synthesis however, fell 
by up to 88% suggesting that non-Ig protein synthesis was relatively 
even more inhibited. These results appear to contradict the hypothesis 
of Lodish (1974). They will be discussed later.
10. ■ Comparison of cell-free products of polysomes from Pi.17.1
and Pi.17.4 cells.
Pi.17.1 was a recloned cell line derived from Pi.17 selected 
for high levels of Ig production, whereas Pi.17.4 was a similarly 
derived cell line selected on the basis of an absence of detectable 
H chain synthesis. They therefore provided a means for locating the 
position of the H chain precursor synthesized by the M.D.L. in 
response to myeloma polysomes. The band corresponding to this 
species would be absent in fluorographs of PAG's of cell-free 
products from Pi.17.4 but present in cell-free products of PI.17.1.
As shown in Figs 34 and 34a, both visual and densi tOmetric inspection 
revealed the presence of a major band with a mobility slightly 
greater than that of secreted H chain or cellular H chain, which 
appeared in densitometric traces of Pi.17.1 total cell-free products 
but not of Pi.17.4 total cell-free products. The relative mobilities 
of the secreted and cellular H chain and of the putative H chain 
precursor were 0.26, 0.26 and 0.27 respectively.
11./
FIG. 34; PAGE analysis of total M.D.L. synthesized products
of Pi.17.1 and Pi.17.4 polysomes.
Aliquots of standard M.D.L, assays, containing either 
Pi.17.1 or Pi.17.4 polysomes were analysed by PAGE (Methods 9.2.5. 
and 9.2.6.). Gels were processed and exposed to X-ray film 
(R.P. Royal X-omat) (Methods 8.3.1.).
Key Well Description
1 Pi.17 secreted total products
2 Pi.17 cell lysate total products
3 M.D.L./P1.17 polysomes - total products
4 M.D.L./Pl.17,1 polysomes - total products
5 M.D.L./P1.17.1 polysomes - total products
6 M.D.L./Pl.17.4 polysomes - total products
7 M.D.L./pl.17,4 polysomes - total products
8 Pl.17 cell lysate total products
P H ^
pL
FIG. 34a: Densitometric analysis of Wells 2,4,7 of Fig. 34.
Wells 2,4,7 of Fig. 34 were analysed densitometrically 
by a Joyce-Loebel Scanning Densitometer (Methods 8.2.3.).
The traces obtained have been displaced vertically from each 
other for clarity.

11. Effect of 2-deoxyglucose on myeloma Ig products.
2-deoxyglucose, an analogue of glucose,has been shown to 
block the addition of carbohydrate to Ig H chains (Melchers, 1973) 
and to Ig L chains (Eagon and Heath, 1977). In the cell lines 
used in this study, only H chains contain carbohydrate residues.
It also acts as a glucose antagonist, causing general inhibition of 
metabolism by blocking energy-supplying reactions. It has, 
however, other effects on cellular metabolism whose mode of action 
is not clear. M.D.L, synthesized H chain appeared to be higher in 
mobility than either secreted or intracellular H chain. It is 
known that the presence of carbohydrate side chains decreases the 
mobility of proteins on polyacrylamide gels by a greater amount 
than can be accounted for merely by the actual increase in MW which 
they cause. Murine chains generally have relative^ low amounts
of carbohydrate attached (Fougereau et al., 1976). Nevertheless, 
the increase in mobility displayed by the putative pre-H chain 
could have been due to a lack of carbohydrate residues, missing 
because the necessary enzymes for addition of carbohydrate were 
missing or inactive in the M.D.L. It was demonstrated (Table 2t]t> 
that M.D.L. containing myeloma polysomes or poly(A) RNA failed to
3
incorporate significant amounts of D (6- H)-glucosamine into TCA 
precipitable material.
2-deoxyglucose was used to attempt to produce H chains lacking 
in carbohydrate residues in cultured cells. These would provide 
markers for comparison with vitro synthesized putative H chain.
To determine the optimum concentration of 2-deoxyglucose, 5563
35
cell cultures were labelled with L-( S) methionine in the presence
of/
TABLE 2(1 Incorporation of D-(6-^H) glucosamine in M.D.L.
containing myeloma polysomes or poly(A) RNA.
M.D.L. containing
(^ H) *
COunts/min/assay counts/rain/assay
0 17800 135000
Pl polysomes 18800 424800
5563 polysomes 15400 547700
5563 poly(A) RNA 19000■ 659300
* Separate assays
Legend:
Standard M.D.L. assays containing excess unlabelled
methionine were incubated with various polysome fractions in
the presence of 5yCi D-(6-^H) glucosamine as described in
35
Methods 7.2. Duplicate assays, containing L( S) methionine 
were also incubated as above. Radioactivity incorporated 
into TCA-precipitable material was measured as described in 
Methods 8.2.1.
of different concentrations of 2-deoxyglucose, as described earlier 
in this section. The results in Table 12 showed that, in the 
presence of increasing concentrations of 2-deoxyglucose, incorporation 
of radioactivity into TCA precipitable material fell rapidly to an 
approximately constant level of 20% of the control cultures at 
concentrations of > 20mM 2-deoxyglucose. Incorporation of radio­
activity into specificially immunoprecipitable material, however, 
proved more sensitive to the presence of 2-deoxyglucose. Radio­
activity specifically precipitated continued to decrease with rising 
concentrations of 2-deoxyglucose, although its rate of decline 
decreased at higher concentrations of 2-deoxyglucose. 20mM 2- 
deoxyglucose was used as the optimum concentration, giving 80% 
inhibition of specifically precipitable material. Analysis of aliquots 
of several of the cell lysates by PAGE suggested that the presence of 
2-deoxyglucose produced a small but visible increase in the mobility 
of the cellular H chain of 5563. (see Fig. 35).
12. Translation of polysomes from SAMM 368 in M.D.L.
SAMM 368 is a "double-producing" cell line which synthesizes 
and secretes both a  and H chaire (Morse et al., 1977), and two
K-type L chains (T.R. Mosmann, personal communication), As such, it 
offered the possibility of comparing dm vitro the relative synthesis 
of two Ig H chains normally synthesized together im vivo. (The 
two K chains are generally not well resolved by PAGE, except with 4M 
urea present, and hence unsuitable for quantitative study). The 
a-type H chain of Ig molecules, moreover, have generally more attached 
carbohydrate/
FIG. 35: PAGE analysis of 5563 cell lysate products,
35labelled with L-( S) methionine in the 
presence of various concentrations of 
2-deoxyglucose.
5563 cells were labelled, as described in Methods 2.4. 
lOyl aliquots were analysed by PAGE as described in Methods
9.2.5. and 9.2.6. Gels were processed and exposed to X-ray 
film (R.P. Royal X-omat) (Methods 8.3.1.).
Well
1 Secreted material from 5563 cells
2 5563 cell lysate (No 2-deoxyglucose).
2  II II II II It
4 " " " (20^M 2-deoxyglucose).
5 " " " (lOOtnM 2-deoxyglucose) .
' M
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carbohydrate than y-type H chains. Hence the relative shift in 
mobility caused by synthesis of the H chains dm vitro should be 
different for a~and y-type H chains.
Polysomes from SAMM 368 cells were translated in the M.D.L.
The cell-free products were compared by PAGE with the cellularly 
synthesized products (Fig. 36 ) and the banding patterns compared.
The bands indicated in the cell lysate as a, y and k chains had 
previously been identified by immunoprécipitation (Fig, 20).
Cell-free products showed several differences from cellular products.
1. A band appeared in cell-free products with a mobility lower 
than that of SAMM 368 cellular L chains. This was tentatively 
identified as the precursor to L chain on the basis of its mobility 
and of its prominence.
2. Two prominent bands with mobilities higher than cellular c< 
and y chains were observed in the cell-free products. On the basis 
of their prominence, and also on the predicted effect of the absence 
of carbohydrate on mobility, they were tentatively identified as the 
cell-free translation products of a and y chain mRNA. Which band 
corresponded to a  chain and which to y chain required clarification by 
immunoprécipitation.
Densitometric analysis of the banding patterns obtained revealed 
no bias of synthesis towards one or the other H chain in the cell-free 
system (data not shown).
Immunoprécipitation, using antisera directed against k , y and 
a chains was investigated. PAGE analysis of the immunofrecipitates 
(Fig. 36 ) demonstrated that, as expected, the lower mobility band 
in the L chain region of the gel corresponded to the pre L chain.
Using/
FIG. 36: Comparison of SAMM 368 polysome-directed products
in M.D.L. with SAMM 368 cellular products.
SAMM 368 polysomes, prepared as described in Methods 
Section 3, were incubated in the M.D.L. under conditions 
described in Methods 7.2. Aliquots of the assay were analysed 
by PAGE (Methods 9.2.6.) and the gel processed for fluorography 
(Methods 8.3.1.). Aliquots of cell lysate were analysed 
similarly. Immunoprecipitates were carried out as in Methods
11.2.2; Positions of marker cellular a, y  and k chains are 
indicated.
Well Description
1 SAMM 368 total cell lysate products
2 SAMM 368 total M.D.L. products
^  II If If II
4 " " cell lysate products
5 SAMM 368 total M.D.L. products
6 SAMM 368 normal rabbit serum precipitate
7 " anti y  chain precipitate
8 " " K chain precipitate
oc
I<- <
Using anti-a antiserum, two species were precipitated, corresponding 
in mobility to the putative cell-free a and y chains. The anti-a 
antiserum had previously been demonstrated to have cross-reactivity 
with y chains, but of a weaker nature. Consequently, the more 
prominent precipitated species was identified as cell-free a chain, 
whilst the other species was identified as y chain. From mobility 
considerations, the a chain mobility seemed relatively more affected 
by translation in the M.D.L., as would be expected due to the differ­
ence in carbohydrate composition.
Hence it has been demonstrated that translation of two types
of H chain mRNA (one for a chain, one tar y chain) in a cell-free
system leads to the synthesis of H chains with lower apparent MW's.
That this is in part due to the lack of carbohydrate addition is shown
by the relatively greater change in the mobility of that H chain which 
in vivo contains more carbohydrate.
13. N-terminal amino acid determination of 5563 pre L chain.
The precursors of L chain from other myeloma cell lines have 
been found, by amino acid sequencing,procedures, to contain 
methionine as N~terminal amino acid (See Fig. l), although in 
some cases, the yield of methionine is very low (e.g. Burstein et al., 
1976). Dansylation was used to examine the N-terminal amino acid 
of 5563 pre L chain. Cellular 5563 L chain contains a blocked 
N-terminus (Awdeh et al., 1969). The dansylated protein was 
hydrolysed and the amino acids separated by two-dimensional 
chromatography on polyamide sheets, as described in Methods (Sections 
12/
12.1 and 12.2).
13.1 Separation of dansylated amino acid markers on polyamide sheets.
Mixtures of dansylated amino acids for use as markers (kindly 
donated by Drs. J. bumsden and J.R. Coggins) were separated on 
polyamide sheets as described in Methods 12.2. Under ultra violet 
light the reproducible spot patterns shown in Figs. 37 A and B were 
obtained. The various dansylated amino acids are identified in the 
key. In subsequent experiments, one side of the polyamide sheet was 
loaded with a dansylated amino acid mixture whilst the other side was 
loaded with the sample under investigation.
35
13.2 Dansylation of L( S) methionine.
35
5pCi of L( S) methionine was treated in a similar fashion to 
the dansylation procedure for proteins described in Methods 12.1.
After hydrolysis and separation of products on polyamide sheets, the 
sheet was examined under U-V light and by autoradiography (data not 
shown). Ultraviolet examination detected a weak spot in the position 
of DNS-methionine and a stronger spot in the position of DNS-leucine 
as well as several other weaker spots. Autoradiography suggested 
that apart from free methionine and Dansyl-OH, the major species formed 
were DNS-methionine and DNS-methionine sulfoxide. The spot seen at 
the DNS-leucine position with ultraviolet light was not radioactive.
13.3/
FIG. 37; Dansylation studies I : Analysis of dansylated
amino acids on polyamide sheets.
A: Dansylated amino acid mixture I; DNS-Arg, DNS-Glu,
DNS-Gly, DNS-Ile, DNS-Phe, DNS-Pro. Fig. C is a 
representation of Fig. A ,  with the dansylated amino 
acids corresponding to each spot represented by the 
appropriate three-letter amino acid designation. 
Unknown or minor spots represented by question marks 
and dotted lines, respectively.
B: Dansylated amino acid mixture II; DNS-Ala, DNS-Leu,
DNS-Met, DNS-Thr, DNS-Tyr, DNS-Val. Fig. C is a 
representation of Fig, B, with the dansylated amino 
acids corresponding to each spot represented by the 
appropriate three-letter amino acid designation. 
Unknown or minor spots represented by question marks 
and dotted lines, respectively.
Dansylated amino acids were applied to polyamide
sheets and chromatographed as described in Methods 12.2. 
Polyamide sheets containing dansylated residues were 
photographed under short-wave ultraviolet light.
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13.3. Behaviour of L( S) methionine on polyamide sheets.
35
Free L( S) methionine moved with the solvent front in the 
first dimension buffer and had no mobility in the second dimension 
(data not shown).
13.4. Dansylation of micrococcal nuclease.
The N-terminal amino acid of micrococcal nuclease (B.C.3.1.4.7) 
is alanine and is unblocked (Croft, 1973). After dansylation, 
digestion and polyamide sheet analysis, inspection under ultraviolet 
light revealed a dansylated amino acid spot in the position of 
DNS-alanine (Fig. 38).
13.5. Dansylation of 5563 H and L chains.
5563 H and L chains synthesized vivo are known to have 
"blocked" N-terminal amino groups (Awdeh ^t ad., 1969) and hence 
should be unreactive with Dansyl chloride (except for internal 
tyrosine and lysine residues). 5563 H and L chains, separated by
G-lOO Sephadex in a urea-formate buffering system, were taken 
separately through the dansylation, hydrolysis and analysis procedure 
as described in Methods 12.1. (Fig. 39). Ultraviolet light 
inspection revealed fluorescent spots only in the positions associated 
with 0-Tyrosine and e- or a-lysine. Hence, neither 5563 H or L chains 
had reactive (i.e. unblocked) N-terminal amino acids. (Lysine is 
ruled out as N-terminal amino acid since such a residue would be 
dansylated both in the a- and the e- positions, thus altering its 
mobility on polyamide sheets. An alteration such as this was not 
found/
FIG. 38: Dansylation studies II: Dansylation of a protein
of known N-terminus.
Dansylation and hydrolysis were carried out as described 
in Methods 12.1. The hydrolysed protein was separated by 
chromatography on polyamide sheets as described in Methods 12.2 
and the dansylated species identified under ultra-violet light. 
A: Dansylated amino acid mixture II + dansylated and
hydrolysed micrococcal nuclease (S. aureus).
Hatched spots indicate spots not present in the 
marker mixture alone,
B : Dansylated and hydrolysed micrococcal nuclease
(S. aureus). The dansylated N-terminal residue 
is marked (DNS-ala).
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FIG. 39: Dansylation studies III; Dansylation of cellular
35
5563 H and L chain and of L-( S) methionine- 
labelled cell-free synthesized L chain-like 
material.
h i  Dansylated products of 5563 H chain. 5563 H chain,
separated from 5563 L chain by column chromatography 
(Methods 10.3.), was dansylated and hydrolysed (Methods
12.1.) before separation of dansylated residues on 
■polyamide sheets (Methods 12.2.). The dansylated 
derivatives were examined under ultra-violet light.
B: As for A with 5563 L chain.
C*: Dansylated amino acid mixtures I and II.
D*: Dansylated products of pre-L chain of 5563. Pre L
chain, radioactively labelled with L-(^^S) methionine 
in an M.D.L. assay was separated from other radio­
active cell-free products by PAGE. The pre L chain- 
containing gel region was excised and the pre-L chain 
material extracted (Methods 9.2.7.). After 
lyophilisation of the extract, the radioactive material 
was dansylated, then hydrolysed, in the presence of 
carrier unlabelled 5563 L chain (Methods 12.1.). 
Separation of dansylated species was carried out on 
polyamide sheets (Methods 12.2.).
* The ultra-violet photographs of these sheets appear
lighter than normal, due to the presence of PPO, which 
was introduced into the sheets to improve the detection 
of radioactivity by fluorography. Removal of the PPO 
by washing with ether did not reveal any more ultra­
violet fluorescent spots.
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13.6. Dansylation of 5563 pre-L chain.
Bands corresponding to 5563 pre-L chain as localised by 
comparison with fluorographs, were excised from a polyacrylamide 
slab gel and the protein extracted as described in Materials and 
Methods (Section 9.2.7,). (4 times as much radioactivity was
released by the first extraction than was reibased by a second 
extraction). The extracted radioactively labelled material was 
lyophilised and re-dissolved in dansylation medium, dansylated, 
hydrolysed and analysed as described in Methods 12.1 and 12.2. 
Ultraviolet inspection (Fig. 34) revealed the presence of e-DNS- 
lysine and 0-DNS-Tyrosine as well as a few minor spots.
Fluorography, however, (Fig. 40) showed the presence of radioactivity 
only at the solvent front in the first dimension indicating the 
presence of free methionine. This suggested either that in 5563 
pre-L chain synthesized in the M.D.L. system, methionine is not the 
original N-terminal residue or (more probably) that the N-terminal 
amino acid is cleaved off rapidly by the system.
14./
FIG. 40: Dansylation studies IV. Fluorograph of hydrolysed
products of dansylated 5563 pre L chain,
35
radioactively labelled with L-( S) methionine.
Pre L chain was treated as described in Fig. 39 D.
After separation of hydrolysed products polyamide sheets,
the sheet was chromatographed in the second dimension with
7% (w/v) PPO in diethyl ether as solvent (Methods 8.3.2.).
Following chromatography, the polyamide sheet was dried and
exposed to R.P. Royal X-omat film for 3 weeks. The position 
35
of L-( S) methionine is indicated.
Is I dim^‘
14. Tryptic mapping.
14.1. General.
Proteolytic cleavage by trypsin followed by separation of the 
peptides generated by electrophoresis and chromatography was 
investigated as a method of comparing cellularly produced H and L 
chains with H and L chain-like products of the cell-free system.
Extra peptides, present in the cell-free system products but not in 
the cellular products, were looked for. The technique was also 
used to try to establish the identity of the cell-free products related 
to that of the cellular products.
14.2. Peptide mapping of cellular 5563 H and L chains.
Immun opre c ipi tate s from 5563 cells, radioactively labelled 
35
with L( S) methionine in the presence of 20mM 2-deoxyglucose, were
reduced, alkylated and acetone precipitated. The precipitate
(4.6 ^280 units:36000 cpm) was dissolved in 6m urea/2o% formate
buffer and separated on a 50ml G-lOO Sephadex column equilibrated
with 6M urea/20% formate buffer (Methods 10.3). 2.745 units of
protein were detected in the eluant in one peak with a shoulder to
the lighter side. This peak was separated into two fractions,
labelled "H" and "L". The eluant fractions were acetone precipitated,
and the precipitates redissolved in ammonium bicarbonate buffer.
Trypsin digestion was followed by electrophoresis and chromatography.
The silica gel plates containing the peptides were then chromatographed
in 7% (w/v) PPG in ether. Radioactivity was detected by fluorography.
35Figs. 41 and 42 also show H and L chain L( S) methionine labelled 
peptide maps rexpectively. In Fig. 41A, for H chain, 8 prominent 
and/
FIG. 41: Peptide maps of cellular and cell-free 5563 H chain.
A: 5563 cells were incubated with 20raM 2-deoxyglucose
35and L-( S) methionine as described in Methods 2.4.
Cell lysates were prepared (Methods 2.3.) and 5563 Ig 
was isolated by indirect immunoprécipitation (Methods 
11.2.2.). After reduction and alkylation the immune- 
precipitable 5563 Ig H and L chains were separated by 
G-lOO Sephadex chromatography (Methods 10.3.). 5563
H chain (+ unlabelled carrier ‘H chain from the immuno- 
precipitate) was digested with Trypsin-TPCK (Methods
13.1.) and the digestion products separated by electro­
phoresis and chromatography on cellulose sheets (Methods
13.2.) . Electrophoresis was carried out at pH 3.5 for 
5 hours at 20mA/sheet. Ascending chromatography was 
carried out using B.A.W.P. (Butanol: acetic acid: water: 
pyridine 15:3:12:10: by volume) as solvent. Cellulose 
sheets were then subjected to ascending chromatography,
using 7% (w/v) PPO in diethyl ether as solvent. After 
drying, the plates were placed in contact with R.P. Royal 
X-omat X-ray film for 3 weeks. The film was developed by 
standard methods. Visualisation of peptides by ninhydrin 
was not carried out due to the presence of excess 
heterogenous peptides from the carrier Ig H chain.
FIG. 41: Peptide maps of cellular and cell-free 5563 H chain.
35
B: L-( S) methionine labelled products of M.D.L. containing
5563 polysomes were separated by PAGE and the positions 
of the various species determined by fluorography.
The putative cell-free H chain band was excised from 
the gel and the radioactive material extracted (Methods 
9.2.7.). Tryptic digestion (in the presence of excess 
unlabelled 5563 Ig)was carried out as described in A.
©0
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FIG. 42; Peptide maps of cellular and cell-free 5563 L chain.
A. 5563 L chain isolated and digested as described
in Fig. 41 A.
B. 5563 pre-L chain, isolated and digested as
described in Fig. 41 B.
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and several minor spots can be seen. 5563 H chain contains 10
methionine residues (A.R. Williamson, unpublished results).
In Fig. 42A for L chain, four prominent spots and several less
(a,b,c)
prominent spots can be seen. Three of the prominent spots have 
similar chromatographic mobilities and vary only in electrophoretic 
mobility. These may be due to charge heterogeneity of a single 
species. The minor spots may be due to a contamination by H 
chain peptides caused by insufficient resolution of H and L chains 
by the gel filtration step. 5563 L chain contains 3 methionine 
residues (A.R. Williamson, unpublished results).
14.3. Peptide mapping of putative 5563 H and L chains produced 
in M.D.L.
Bands corresponding to putative 5563 H and L chains on PAG's 
were located by comparison with fluorographs. The bands were excised
and extracted as described in Section 9.2.7 (Materials and Methods). 
Radioactive material (containing 9600 counts/min) extracted from the 
pre L chain region of the gel and material (containing 21000 counts/ 
min) was extracted from putative pre H chain region. The extracts 
were lyophilised and redissolved in Tris HCl buffer pH 7.4, con­
taining either 125ug 5563 L chain or 250yg 5563 H chain (as 
appropriate). The sample was then precipitated with acetone, 
re-dissolved in ammonium bicarbonate and digestion, electrophoresis 
chromatography and fluorography were performed as described in 
Methods 13 and 8.3.2. The fluorographs are shown in Figs. 41 and 42. 
5563 pre L chain (Fig. 42B) shows three major spots similar in grouping 
to,/
A hJ
to, but with different mobilities from those found with cellular 
L chain. Such differences may have occurred due to differences 
in the silica gel plates used. The spot pattern obtained with 
digests of putative 5563 H chain did not closely resemble that of 
5563 H chain cells treated with 2-deoxyglucose (Fig. 4IB).
From this data, it can be stated that the spot patterns for 
cellular L chain and cell-free synthesized putative pre-L chain are 
similar and suggest that the cell-free species identified by 
mobility and immunoprécipitation contains similar methionine peptides 
to 5563 L chain.
The area removed from polyacrylamide gels and thought to 
contain putative pre H chain did not give a spot pattern similar to 
that of cellularly produced H chain. The region containing putative 
H chain (identified by immunoprécipitation) contains many other 
protein species. This may have obscured the spot pattern of putative 
H chain.
15. Attempted improvements of the M.D.L. cell-free system.
15.1. Rationale.
Earlier work (Results 4.3) had shown that the M.D.L. system
contained large endogenous pools of amino acids. Even the
relatively small pools of leucine and methionine, which were primarily
used for radioactive incorporation experiments, were at least an
order of magnitude larger than the amount of radioactively labelled
amino acid added. For example, the specific activity of added 
35L ( S) methionine was generally decreased by '\>10 fold due to 
dilution/
Aj)
dilution in assays with unlabelled methionine, either free or bound 
in met-tRNA complexes. Nevertheless, the high fidelity of 
translation of all sizes of mRNA and low background incorporation 
made the M.D.L. the cell-free system of choice for translation studies 
The cell-free protein synthesizing system derived from wheat germ, 
by contrast, has much lower efficiency in translating long mRNA's 
(Green ejt ad., 1976). It gives, however, much greater incorporation 
of radioactivity since endogenous amino acids are removed by a gel 
filtration step ( Roberts and Paterson, 1971). Methods of 
preparation of several other cell-free protein synthesizing systems 
have included a gel filtration step (McDowell et al., 1972; Hartley 
et al., 1975). Gel filtration was considered in the first instance 
as a method of removing endogenous amino acids and thereby improve 
incorporation of radioactively labelled amino acids. The use of 
dialysis to remove endogenous free amino acids was also investigated. 
The development of a cell-free system with low levels of endogenous 
amino acids was seen as a means whereby polypeptides, radioactively 
labelled with equal specific activity in most residues, could be 
obtained. These would be suitable for micro techniques of amino 
acid sequencing.
15.2. Preparation and running of gel filtration columns.
Sephadex beads were swollen as described in Methods 10.2 
and packed on a 25 x 1.5cm glass column. Final settled bed volume 
was ^120ml. The column was equilibrated with column buffer (20mM 
HEPES pH 7,6, 120mM KCl, 5mM MgOAc, 6mM 2-mercaptoethanol (Roberts 
&/
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& Paterson, 1971). After equilibration, 3-4ml reticulocyte lysate 
(containing 25yM haemin) was loaded carefully on the column.
After entering the column, the sample was washed through under a 50cm 
pressure head by column buffer. The void volume, identified by the 
colour, was collected in 2ml fractions, pooled, then dispensed in
0.8ml aliquots and stored frozen at -70°C. Passing over the column 
approximately doubled the volume of the 'lysate fraction*.
15.3. Preparation of M.D.L. from column eluant (cM.D.L.).
The eluant from gel columns differed in several ways from 
the original reticulocyte lysate,apart from an absence of amino 
acids
1. The eluted lysate was diluted approximately twofold
compared with the original lysate.
2. The following low MW molecules were expected to be
absent.
a) ATP/GTP
b) haemin
c) possibly tRNA, because of the closeness of 
its MW to the exclusion MW of the gel 
(^25000)
d) unspecified other small MW components.
3. The levels of salt, etc., should approximate those of
the column buffer, i.e. K =120mM, Mg ==5mM, HEPES 
20raM.
Compensation for the losses described above were made as 
follows/
^ ^
follows :-
a). ATP/GTP. To each 0.8ml aliquot of column eluant was added 
an ATP/GTP micture sufficient for a final concentration of 
lOOyM ATP, 20yM GTP.
b). Haemin. As in M.D.L. preparations, haemin was added as 
part of a haemin/Tris/K mixture to a concentration
of 25yM,
c). tRNA and other components. These will be discussed where
■ appropriate.
Preparation of cM.D.L. was as described in Methods 5.1.2. for 
M.D.L, except that no solution A was added. Instead, 50yl of a
ATP/GTP solution was added. Nuclease digestion conditions were as 
described in Methods 5.1.2.
15.4. Effect of G-25 Sephadex gel filtration on reticulocyte lysate.
Two 0.8ml aliquots of G-25 column eluant and two 0.8ml 
aliquots of reticulocyte lysate were supplemented, as described 
above and in Methods 5.1.2. respectively. In one of each pair, 
however, addition of unlabelled amino acids was omitted. Volumes 
were equalised with deionised water. 50yl samples from each were 
incubated with 5yCi (^H)-amino acid mixture (15 amino acids) for 
40 minutes at 30°C and aliquots taken for estimation of total 
incorporation of radioactivity.
TABLE 21/
fl)
TABLE 21 «ft. Comparison of incorporation of radioactivity by 
reticulocyte lysate and G-25 column eluant
Description 
Reticulocyte lysate
40yM 
unlabelled 
amino acids
+
Total 
incorporation of 
radioactivity 
(cpm/assay)
G-25 column eluant
157200 
240000 
+ 49200
" « . . .  - 918000
As Table 21&above showed, passage through a G-25 Sephadex 
column resulted in decreased incorporation of radioactivity 
compared with an equal volume of lysate in the presence of excess 
added unlabelled amino acids. This was probably due to a decrease 
in mRNA concentration, caused by the diluting effect of column 
treatment. In the absence of these unlabelled amino acids,how­
ever, the more dilute column eluant gave almost fourfold higher 
incorporation of radioactivity/unit volume. This suggested that 
treatment of lysate with G-25 Sephadex removed a substantial 
proportion of endogenous amino acids. This interpretation was 
corroborated by comparing the effect of addition of serial 
dilutions of a stock unlabelled methionine solution to assays of 
G-25 column eluant and of reticulocyte lysate. These assays
contained all other amino acids except methionine in excess and 
35L-( S) methionine as label, (see Figure 43). This experiment suggests 
that reticulocyte lysate contained 400 pmoles unlabelled endogenous 
methionine/50yl assay (compare with Results 4.3. ). Column eluant
however, contained <55 pmoles unlabelled endogenous methionine/50yl 
assay/
FIG. 43; Estimation of endogenous methionine pool sizes
in normal and gel-filtered reticulocyte lysate.
Reticulocyte lysate and G-25 Sephadex treated reticulocyte
lysate were supplemented as described in Methods 7.1.2. and
35
Results 15.3., respectively. Assays of each with L-( S) 
methionine as radioactive amino acid were performed in the 
presence of serial dilutions of unlabelled methionine. Radio­
activity incorporated into TCA-precipitable material was 
measured as described in Methods 8.1.1. No second radioactive 
amino acid was included to measure overall protein synthesis 
independently.
KEY: '-Ch Reticulocyte lysate, j 
' G-25 Sephadex-treatec
reticulocyte lysate.
50% ^
Inh ib ition
20 -
pmoles cold methionine added
 ^  ^ê
assay (the measured 55 pmoles included "^ 25 pmoles radioactively 
labelled methionine). Allowing for dilution (1:2) during gel 
filtration this indicated a removal of >80% of endogenous methionine. 
That level detected as not removed would include methionine present 
in association with tRNA. Amino-acid analysis of samples of G-25 
eluant also confirmed the removal of almost all free endogenous 
amino acids (Fig. 14).
15.5. Incorporation of radioactivity in column eluant M.D.L. (cM.D.L.)
The next experiment was devised to investigate whether an
M.D.L. made from column eluant (cM.D.L.) would translate exogenous
polysomes or poly(A) RNA. Four different polysome fractions, viz.
PlI, PlII, 55631 and 5563II, and poly(A) RNA derived from each of
these fractions, were added to M.D.L. assays. These were prepared
either from reticulocyte lysate (diluted 1:2 with column buffer -
dil M.D.L.) or from column eluant (cM.D.L.) , and either contained or
omitted normal levels of unlabelled amino acids. Translation was
3
measured by the incorporation of a mixture of 15 ( H)-labelled amino 
acids into TCA precipitable material. Results are shown in Tables 
22 and 23. In all cases addition of polysomes to cM.D.L. caused a 
stimulation of incorporation over background. This stimulation 
varied with polysome fractions but was between 50X and 70X background 
incorporation, when no added unlabelled amino acids were present, but 
was only about 2X to 3x background incorporation in the presence of 
40]iM unlabelled amino acids. In comparison, assays of diluted M.D.L. 
showed a stimulation of between 12X and 17X over background in the 
absence/
TABLE 22: Comparison of incorporation of (^ H) amino acids by
M.D.L.*s or cM.D.L.'s containing Pi.17 polysomes 
or Pi.17 poly(A) RNA.
Legend:
Dilute M.D.L. (dil M.D.L.) and gel filtered M.D.L. 
(cM.D.L.) were prepared as described in Results 15.3.
Assays with Pi.17 polysomes or Pi.17 poly(A) RNA were 
performed as described in Methods 7.2. with 5yCi (^ H) 
amino acid mixture as the radioactive label. Radio­
activity incorporated into TCA-precipitable material 
was measured as described in Methods 8.1.1.
Key:
U+ = Normal M.D.L. containing unlabelled amino acid mixture 
(M.D.L.) .
U- = Normal M.D.L. lacking unlabelled amino acid mixture 
(M.D.L.).
Ct = M.D.L, from G-25 treated lysate containing unlabelled 
amino acid mixture (cM.D.L.).
C- = M.D.L, from G-25 treated lysate lacking unlabelled 
amino acid mixture (cM.D.L.).
TABLE 22: Comparison of incorporation of ( H) amino acids by M.D.L.'s
or cM.D.L.'S Icontaining Pi .17 polysomes or Pi.17 poly(A) RNA,
Polysome
fraction
Poly 
(A) 
RNA fn
Treat­
ment
of
M.D.L
Radio­
activity
incor­
porated
counts/
min/
assay
. (xio“3)
Stimulation over
back non­
ground treated 
assay assay
appropriate:- 
amino 
acid 
containing 
assay
- - u+ 8.88 — - -
- - U- 9.85 - - -
— C+ 12.4 - - -
- - C- 7.94 - - -
P U - U+ 23.14 2.6 - -
- ü- 148.8 15.1 - 6.43
- c+ 34.2 2.76 1.48
— c- 485.64 61.16 3.26 14.2
— P U u+ 10.3 1,16 - -
- u- 12.1 1.23 1.17
- c+ 11.46 *" 1.11 -
- c- 20.62 2.6 1.70 1.8
Plu — u+ 16.75 1.89 - —
— u- 133.13 13.52 - 7.95
- c+ 26.57 2.14 1.59 —
- c- 380.04 4 S.O 2.85 14.3
- PIII u+ 8,78 - - —
- u- 8.93 - - 1.01
- ct 10.33 - 1.17 -
c- 20.63 2.6 2.31 2.0
TABLE 2 3 : Comparison of incorporation of (^ H) amino acids by 
M.D.L.'s or CM.D.L.'s containing 5563 polysomes 
or 5563 poly(A) RNA.
Legend:
Dilute M.D.L, (dil M.D.L.) and gel filtered M.D.L, 
(cM.D.L.) were prepared as described in Results 15.3.
Assays with PI.17 polysomes or Pi.17 poly(A) RNA were 
performed as described in Methods 7.2. with 5pCi (^ H) 
amino acid mixture as the radioactive label. Radio­
activity incorporated into TCA-precipitable material 
was measured as described in Methods 8.2.1.
Key:
Ü+ = Normal M.D.L. containing unlabelled amino acid mixture 
(M.D.L.).
U- = Normal M.D.L. lacking unlabelled amino acid mixture 
(M.D.L.).
C+ = M.D.L, from G-25 treated lysate containing unlabelled 
amino acid mixture (cM.D.L.).
C- = M.D.L. from g-25 treated lysate lacking unlabelled 
amino acid mixture (cM.D.L.).
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TABLE 23: Comparison of incorporation of ( H) amino acids by M.D.L.'s
or cM.D. L.'s containing 5563 polysomes or 5563 poly(A) RNA,
Polysome
fraction
Poly 
(A) 
RNA fn
Treat­
ment
of
M.D.L.
Radio-
activity
incor­
porated
counts/
min/
assay
(X10"3)
Stimulation over
back non­
ground treated 
assay assay
appropriate :- 
amino 
acid 
containing 
assay
- U+ 8.88 - - -
- — U- 9.85 - - -
- - C+ 12.4 - - -
— - C- 7.94 - - -
55631 - U+ 23.7 2.69 - -
— U- 174.0 17.66 - 7.34
- C+ 42.75 3.45 1.80 -
— c- 625.40 78.77 3.59 14.63
- 55631 u+ 10.28 1.15 - -
- u- 10.24 1.04 - -
- c+ 10.1 - -
- c- 19.0 2.4 1.87 1.87
5563II - u+ 18.6 2.1 -
_ u- 127.4 12.93 - 6.85
- c+ 32.9 2.65 1.77 -
- c- 452.5 5 7/0 3.55 13.75
- 5563II u+ 9.57 1.07 — —
- u- 9.76 - - 1.02
- c+ 11.13 - 1.16 -
_ c- 19.14 2.41 1.96 1.72
i  J o
absence of added unlabelled amino acids and between 1.9X and 2.6X over
background in the presence of unlabelled amino acids. Hence, column
treatment of lysate had improved incorporation in cM.D.L. about 3 fold
over an M.D.L. prepared from diluted reticulocyte lysate.
Incorporation with poly(A) RNA was generally much lower.
Only cM.D.L. with no added unlabelled amino acids gave incorporation
of radioactivity at much above the background levels. This was not
due to degradation of the poly(A) RNA. In subsequent experiments
35
with normal M.D.L., using L-( S) methionine as label, samples of the
same poly(A) RNA gave stimulations of incorporation of between 4x and
9X background (data not shown). Lack of stimulation of incorporation
by poly(A) RNA suggested that perhaps initiation of translation was
unable to take place in the cM.D.L. It also suggested that
incorporation observed with polysomes was due merely to "run-off" of
existing ribosomes from mRNA, resulting in completion of existing
polypeptides but with no reinitiation of translation. Other
explanations for this lack of incorporation were as follows:-
1. A limiting amino acid. This seemed unlikely in view of the
incorporation observed with polysomes. Nevertheless in the cM.D.L.
without added unlabelled amino acids (C-assays), 5 of the twenty amino
3
acids, viz., those not present in the ( H) amino acid mixture - 
methionine, cysteine, glutamine, asparagine and tryptophan, were 
present in very low amounts (in the case of methionine < 55pmoles). 
Consequently, subsequent assays were supplemented with unlabelled 
amino acids to contain at least 100 pmoles of each added amino acid 
(including the contribution of the radioactively labelled amino acids) 
per 50yl assay. This decreased the possible effect of limitation 
(see/
(see Table 24).
2. Limiting tRNA. With 25,000 MW as the exclusion limit of 
the gel beads, tRNA species might be retarded by the gel to produce 
a lack (either general or specific) of tRNA in the column eluant.
This possibility was investigated.
3. Limitation of some other low DM species. Possible candidates 
were:~
a) Low MW initiation factors,
■ b) haemin loss during the column separation,
c) Unidentified low MW cofactors.
4. Presence of some species which prevented initiation.
Possible candidates were excess reducing power (6mM mercaptoethanol)
++
or excess divalent cations (Mg = 5mM).
5. Effect of column treatment. The Sephadex beads might have
released an inhibitory substance which blocked initiation but not 
elongation reactions. Alternatively, the time required to run 
sample through the column might have allowed the inactivation of some 
labile component.
6. Effect of dilution. Dilution of the lysate might have
lowered the concentration of some substrate below a crucial level
for protein synthesis. The low incorporation with poly(A) RNA
observed in an M.D.L, derived from diluted lysate supported this view.
7. Some combination of the above.
These possibilities were systematically investigated.
15.6. Effect of an inhibitor of initiation on radioactive 
incorporation/
TABLE 24; Amino acid supplement for cM.D.L.
Amino Acid
pmoles/5yl(^H) 
amino acid mixture
pmoles amino acid added to 
give I00pmoles/50yl assay
Ala 12 88
Arg 21 79
Asp 2416
+
Asn
*
100
Cys
*
100
Gin
*
100
Glu 221
Gly 71 29
His 5 95
lie 15 85
Leu 10 90
Lys 9 91
Met
*
100
Phe 28 72
Pro 7 93
Ser 14 86
Thr 853
+
Trp
*
100
Tyr 5 95
Val 9 91
* Not present in (^ H) amino acid mixture
+ >100 pmoles (^ H) amino acid/50yl assay
i-&y
15.6. Effect of an inhibitor of initiation on radioactive 
incorporation by cM.D.L. with exogenous polysomes.
Aurintricarboxylic acid (ATA) is an inhibitor of initiation
of protein synthesis at low concentrations, and an inhibitor also
of elongation reactions at higher concentrations. Consequently,
if re-initiation occurs in the cM.D.L, with added polysomes, a
biphasic inhibition curve of incorporation of radioactivity should
be observed over a range of ATA concentrations. Serial dilutions
of a stock ATA solution were made and each added to duplicate 60yl
3
aliquots of cM.D.L. containing Pi.17 polysomes and ( H) amino acid 
mixture. After incubation, total TCA-precipitable incorporation was 
measured for each assay. As Fig. 44 demonstrates, a biphasic 
inhibition curve was observed in the range O - ImM ATA. In the 
concentration range 0 - 150yM, incorporation fell off sharply then 
levelled off at approximately 66% of the original level. In the 
concentration range 150yM - ImM, incorporation again fell off sharply 
before beginning to level off. At ImM ATA, incorporation was 10% 
of that observed with no ATA present. This suggested the operation 
of two inhibitable processes, one being labile to low ATA concen­
trations and the other to higher ATA concentrations. If these two 
processes are initiation and elongation, initiation of protein 
synthesis in the cM.D.L. therefore accounted for approximately 33% 
of the total incorporation.
By comparison, studies on the effect of ATA on initiation in 
the M.D.L. with poly(A) RNA (Results 9.1. ) showed that in the M.D.L.
incorporation of radioactivity was much more sensitive to inhibition 
(all incorporation of radioactivity was effectively halted by 80yM 
concentrations of ATA). This reflected the much more prominent role 
of/
FIG. 44: Dose response of incorporation of ( H^) amino acids
by cM.D.L. in the presence of ATA.
1 ml cM.D.L. was prepared and looyl Pi.17 polysomes and 
3
lOOyCi { H) amino acids were added. 50yl aliquots of this
solution were added in duplicate to assay tubes containing serial
“5
dilutions of ATA in 5yl volume (O-lOO x 10 M). Assays were 
incubated at 30°C for 120 min. and radioactive incorporation 
into TCA-precipitable material was measured (Methods 8.1.1.), 
using duplicate 5yl aliquots from each duplicate assay.
oo
Qcn
o
o
O
•s  i<
<
o
8
o
(e_Otx) P'S/U!iu/sî,uno3
of initiation processes in assays containing poly(A) RNA.
As a result of this finding, subsequent experiments were 
carried out to attempt to identify the reasons for lack of initiation 
in the cM.D.L. with poly(A) RNA and to optimise translation of 
polysomes.
15.7. Effect of tRNA on incorporation.
■ Addition of calf liver tRNA (ISyg/SOyl assay) stimulated 
incorporation of radioactivity by the cM.D.L. containing either PlI 
polysomes or 5563 polysomes (see Table 25). The effect was more 
pronounced with PlI polysomes. In view of these results, calf liver 
tRNA (15yg/50yl) was added to subsequent assays. The effect of the 
calf liver tRNA may be due to substitution for tRNA species removed 
by gel filtration treatment. Alternatively, the stimulation of 
protein synthesis may be due to addition to the endogenous tRNA pool 
of tRNA species which supplement those present in low amounts. 
Addition of tRNA produced no noticeable stimulation of incorporation 
with poly(A) RNA suggesting that tRNA limitation was not responsible 
for the lack of response to poly(A) RNA by cM.D.L,
15.8. Experiments with G-lO cM.D.L.
Among the possible reasons for the lack of stimulation of 
cM.D.L, by poly(A) RNA was the absence of some low MW species.
Removal of such species would occur during the gel filtration step, 
along with amino acids, ATP and GTP. Another possible cause of poor 
translation of poly(A) RNA was the presence of high levels of 
reducing/
35
TABLE 25: Effect of tRNA on incorporation of L( S) methionine
by the cM.D.L. containing various myeloma polysome 
or poly(A) RNA fractions.
Legend:
G-25 cM.D.L. assays, containing various myeloma polysome
35
or poly(A) RNA fractions were incubated with L( S) methionine 
in the presence or absence of 3yg calf liver tRNA under 
standard conditions (Methods 7.2.). Radioactivity incorporated 
into TCA-precipitable material was measured as described in 
Methods 8.2.1.
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TABLE 25: Effect of tRNA on incorporation of L ( S) methionine 
by the cM.D.L. containing various myeloma polysome 
or poly(A) RNA fractions.
Radioactivity 
Calf liver incorporated Fold
Polysome fraction tRNA____  cpm/assay stimulation
PI.171 Expt. 1 - 100000
+ 555000 5.54
Expt. 2 ~ ■ 91400
+ 430980 4.7
Expt. 3 . - 498700 -
+ 620950 1.25
5563 II Expt. 2 - 394900
+ 451500 1.14
Expt. 3 “ 533130
+ 688550 1.3
O Expt. 1 - 17120
+ 21270 1.24
Expt. 2 - 8580
+ 11170 1.302
Expt. 3 - 10855 -
+ 12350 1.13
PI.171 E x p t .  1 - 20244
poly A
+ 21270 —
Expt. 2 " 21084
5563 Expt. 2 - 17940
poly A
X  y
reducing compounds (6mM 2-mercaptoethanol) as a result of the gel 
filtration step. Reticulocyte lysate and M.D.L. assays normally contain 
only endogenous levels of reducing compounds. For these reasons a 
smaller pore-size for the gel (G-lO Sephadex) was tested and variations 
in buffer composition investigated. With a lower MW exclusion limit, 
G-lO Sephadex might not retard small factors concerned with translation 
of poly(A) RNA, but would still remove amino acids. Samples of 
reticulocyte lysate were run on G-lO Sephadex columns, as described 
for G-25 Sephadex columns. In one column, 6mM 2-mercaptoethanol 
was omitted from the buffer. In this column, after collection of the 
coloured fraction of the eluant, several ml of the subsequent eluant 
was collected and pooled. This fraction was collected to look for 
factors slightly retarded by the column. The pooled fractions ('v5ml) 
were lyophilised and resuspended in lOOyl of deionised H^O.
M.D.L. prepared from G-10 Sephadex eluant was assayed with PI.17 
polysomes or Pi.17 poly(A) RNA. These RNA fractions were shown to 
give stimulations of 4 fold and 3 fold respectively over background 
incorporation in M.D.L. assays. The results of these assays are 
shown on Table 26.
Several points can be made about the results
1. Removal of 2-mercaptoethanol stimulates incorporation of
radioactivity in assays containing polysomes, but did not significantly 
stimulate incorporation with poly(A) RNA.
2. Use of a smaller pore size gel did not improve the stimulation
of the system by poly(A) RNA. This suggested that any retarded
"factor" had a MW < 10,000.
3. Addition of a concentrate of the eluant fractions recovered
from the column after the coloured fraction did not stimulate 
incorporation/
TABLE 26: Effect of 6mM 2-mercaptoethanol and/or Q.5M KCl
wash factors on incorporation of radioactivity 
by cM.D.L. containing Pi.17 polysomes or 
poly(A) RNA.
Legend:
cM.D.L., prepared from G-25-treated reticulocyte lysate, 
was incubated with Pi.17 polysomes or poly(A) RNA, using 
L(^^S) methionine as radioactive label. Assays were performed 
in the presence and absence of 6mM 2-mercaptoethanol and/or
0.5M KCl wash factors from reticulocyte polysomes (prepared 
as described in Methods 6.1.5.). Assays were incubated at 
30°C for 120 min. Radioactive incorporation into TCA- 
precipitable material was measured as described in Methods 8.2.1. 
Control assays, using diluted reticulocyte lysate, were performed 
for comparison of incorporation.
TABLE 26 : Effect of 6mM 2-mercaptoethanol and/or 0.5M KCl wash factors
on incorporation of radioactivity by cM.D.L. containing 
PI.17 polysomes or poly (A) RNA.
RNA
O Expt. 1
Expt. 2
Expt. 1
Expt. 2
PI.17 
polysomes
PI.17 
poly (A)
Expt. 1
Expt. 2
Expt. 2
Expt. 1
Expt. 2
Expt. 2
6mM 2 ~  
mereaptoethanol
+
(UD
Added
"factors"
Fold
Radioactivity stimulation 
incorporated over
cpm/assay
9400
21576
9900
16980
105900
178000
10560
2l606
23338
12700
20176
20398
background
11.27
18.0
1.12
1.0
1.08
1.28
1.19
1.20
Controls
1:2 diln of retie lysate with column buffer (including 6mM 2-mercapto­
ethanol) .
O -f — 6000 —
■f — 27400 4.6PI.17 
polysomes
PI.17 
poly (A)
8300 1.38
j. %# -U
incorporation with poly(A) RNA significantly. This suggested that 
any retarded "factor" had low mobility through the column.
As a result of this experiment, 6mM 2-mercaptoethanol was 
omitted from further gel filtration buffers. Since G-lO Sephadex 
appeared to yield no improvement in the cM.D.L.'s ability to 
translate poly(A) RNA, further studies were carried out using G-25 
Sephadex.
15.9. Experiments with G-25 coarse cM.D.L.
Previous experiments using G-25 Sephadex for gel filtration
had used G-25-FINE Sephadex. Roberts and Paterson, 1971 used COARSE
grade G-25 Sephadex for their preparation of the wheat germ cell-free
system. G-25 COARSE Sephadex was used for preparation of gel-
filtered reticulocyte lysate and was found to have better flow
properties and fewer 'fines' than G-25 FINE Sephadex. Thus, the
time taken for the reticulocyte lysate to pass through the column
was reduced by two thirds. This reduced the time available for
inactivation of labile factors in the reticulocyte lysate. Several
batches of gel filtered reticulocyte lysate were made, using various
column buffer compositions. This investigated whether the column
buffer system was optimal for producing cM.D.L. capable of
translation of poly(A) RNA. From each of these reticulocyte lysate
eluants was prepared cM.D.L. Conditions for preparation of cM.D.L.
35were as before, except that since L-( S) methionine was used as
radioactive amino acid, a stock solution of 19 amino acids minus
35
methionine was added, as for the M.D.L, system. L-{ S) methionine 
was/
/ /
was used to allow improved fluorography of cM.D.L. samples separated 
by PAGE.
The following buffer systems were used:-
a) 20mM HEPES pH 7.6, lOOmM KCl, 5mM MgCl^
b) 20mM HEPES pH 7.6, lOOmM KCl, 5mM MgCl^, 25yM haemin
c) 20mM HEPES pH 7.6, lOOmM KCl, 0.5mM MgCl^
d) 20mM HEPES pH 7.6, lOrnM KCl, lOOmM KCl
e) 20mM HEPES pH 7.6
. In addition, a 0.5M KCl wash of reticulocyte ribosomes was 
prepared as described in Methods 6.1.5 by the method of Gross, 1977.
The high salt wash factors thus isolated were intended to replace 
protein factors essential for initiation of protein synthesis which 
might have been removed from reticulocyte lysate by the gel filtration 
step. The results of assays using the variously prepared cM.D.L.'s 
and the effect of added factors are shown in Table 27.
The following points can be made about the results shown in 
Table 27.
1. Poly(A) RNA translation in cM.D.L. was not stimulated by
the presence of haemin in the column buffer during gel filtration
of the reticulocyte lysate. This suggested that the formation of
translational inhibitor during column treatment was not the major
cause of the lack of response to poly(A) RNA.
+ ++
2. Variation of K and Mg concentrations in the column buffer (and 
hence in the cM.D.L. itself)did not significantly enhance 
translation of poly(A) RNA. In fact, the various buffer conditions 
tested prevented any incorporation above background levels. The 
original buffer system allowed some incorporation over background 
levels with poly(A) RNA.
3./
35
TABLE 27: Comparison of incorporation of L( S methionine by
cM.D.L. prepared using several different buffer 
systems.
Legend:
Reticulocyte lysate was passed over G-25 Sephadex in 
a number of buffer systems described in Results 15.9.
Incorporation of radioactivity by M.D.L.'s prepared 
from the G-25 treated lysates in response to the addition of 
5563 polysomes or poly(A) RNA was measured as described 
in Methods 8.2.1.
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TABLE 27 : Comparison of incorporation of L ( S) methionine by
cM.D.L. prepared using several different buffer systems.
High Radioactivity
salt incorporated/assay 
(5yl) cpm/assay in Expt. 
Cell-free Buffer wash (X10”5)
sys tern system RNA factors 1 2  3 4
M.D.L. - O - 35 201 - 61
— 5563 — 482 7o8 — —
polysomes
5563
poly(A) RNA - 158 369 - 168
cM.D.L. a O 28 171 105 47
a 5563 “ 3534 3945
polysomes
a 5563 poly - 178 323 505 145
(A) RNA
a O + - - 140 45
a ■ 5563 poly + - - 410 119
(A) RNA
b O - 197
b 5563 - - 5041 - -
polysomes
b 5563 poly - - 321 -
(A) RNA
c 0 — 68
c 5563 poly - - 41
(A) RNA
c O + — — — 63
c 5563 poly + - - - 58
(A) RNA
d O _ _ _ 5 7
d 5563 poly - - 72
(A) RNA
d O 4- — _ _ 72
d 5563 poly + - - - 60
(A) RNA
e O — — — — 64
e 5563 poly - - - - 47
(A) RNA
e O + — _ — 54
e 5563 Poly + - - - 57
(A) RNA
y ai p f'
^ y
3. Additions of high salt wash factors did not cause a
stimulation of incorporation in response to poly(A) RNA by any 
cM.D.L. tested. Those cM.D.L.'s which already gave stimulation 
over background in response to poly(A) RNA gave less stimulation 
in the presence of high salt wash factors.
As a result of the experiments described above using either 
G-lO or G-25 Sephadex, the following conclusions were reached about 
the lack of stimulation of cM.D.L. by added poly(A) RNA.
a. . Salt concentration did not appear to be a cause of the lack
of stimulation. It could be argued that the results supporting this 
conclusion could be interpreted as being due to degradatbn in the 
poly(A) RNA fraction used. This seemed unlikely since this fraction 
gave incorporation of radioactivity over background levels in the 
same experiment with G-25 Sephadex cM.D.L. prepared previously. 
Alternatively, RNase or some other degradative enzyme may have been 
present in the solutions used to prepare the cM.D.L.'s in question. 
The same stringent nuclease precautions were used, however, as had 
been successfully employed at other times (Methods 10.1).
b. Lack of high salt wash factors was not responsible for the 
lack of stimulation. Such a cause had already seemed unlikely in 
view of the probable size of any missing factors (<10,000MW) as 
deduced from previous experiments.
c. Absence of haemin during the column separation was not 
responsible for the lack of stimulation.
These results suggested that some small MW factor was 
involved which was either
1. Reduced to a limiting concentration by
Sephadex/
/ 0
Sephadex filtration either by partial 
removal, or by dilution.
2. Removed completely by Sephadex filtration.
3. Inactivated during the time involved in 
gel filtration.
15.10. Incorporation of radioactivity by M.D.L.;cM.D.L. mixtures.
■ The effect of mixing M.D.L. and cM.D.L. in various proportions
was investigated. Reticulocyte poly(A) RNA was used as the added
mRNA. M.D.L. and cM.D.L. with exogenous poly(A) RNA were used to
ensure that initiation of translation was studied. Varying
proportions of M.D.L. and G-25 coarse cM.D.L. were mixed and incubated
with reticulocyte poly(A) RNA. Protein synthesis was detected by
35
incorporation of L-( S) methionine into TCA-precipitable material.
The data shown in Fig. 45 suggested that with less than 4o% (v/v)
(^60% w/w) M.D.L. present no significant protein synthesis occurred. 
Above this level, TCA-precipitable radioactivity increased rapidly 
to over 13 times the incorporation at lower levels. Incorporation 
fell slightly again as the proportion of M.D.L. in the assay reached 
100%. This result suggested that the factor responsible for 
initiation was active only above a critical concentration. More­
over, the increase in incorporation observed when 80% (v/v) rather 
than 100% (v/v) M.D.L. was used was 16%, This was roughly the 
increase to be expected due to removal of 'V20% of the endogenous 
methionine. Below 80% (v/v) decreased incorporation suggested a 
progressive decrease in incorporation due to the "low MW" factor 
becoming limiting.
15.11/
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FIG. 45: Incorporation of L-( S) methionine by various
M.D.L.:cM.D.L. mixtures.
M.D.L, and cM.D.L. were mixed in various proportions 
35and incubated with L-( S) methionine and lyg reticulocyte 
poly(A) RNA/assay under standard conditions. 5yl aliquots 
were removed in duplicate and radioactivity incorporated 
into TCA-precipitable material was measured as described in 
Methods 8.2.1. \
Iiicorpora"J;iori with I 
poly(A) RNA. I
Incorporât!on with 
no additions..
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FIG. 46; The effect of dialysis on incorporation of L-( S)
methionine directed by 5563 polysomes and poly(A)
RNA in the M.D.L.
5 ml of reticulocyte lysate (25yM haemin added), was
dialysed against 3 changes of 1 litre of lOOmM KCl, 0.5mM
MgCl^ solution. The top of the dialysis bag could be opened
to allow removal of 500yl aliquots of lysate at various time
intervals. Dialysis medium was changed hourly. Aliquots
removed were treated to produce M.D.L. The incorporation
of these M.D.L.'s (dM.D.L.'s) in response to the addition of
5553 polysomes or poly(A) RNA was measured in 50yl standard 
35
assays, using L-( S) methionine as label. Radioactive 
incorporation into TCA-precipitable material was measured 
as described in Methods 8.1.1.
Incorporàtion with 
polysomes. 
Incorporation, with 
poly(A) RNA. 
Incorporation with 
no additions.
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15.11. Dialysis of M.D.L.
Dialysis was explored as a means of investigating the 
progressive changes occurring in incorporation in the cM.D.L. due 
to removal of small MW factors. A small volume of reticulocyte 
lysate (+ haemin) was dialysed against 3X 1 litre of column buffer 
(no 2-mercaptoethanol). Aliquots of lysate were removed at 
intervals and dialysed M.D.L. (dM.D.L.) prepared from these as 
for cM.D.L. Incorporation of radioactivity was measured in these 
dM.D.L.'s in the presence of 5563 myeloma polysomes and 5563 poly(A) 
RNA. The results obtained are shown in Fig. 46.
As can be seen, incorporation of radioactivity by dM.D.L.'s 
prepared from samples removed after short periods of dialysis 
(O - 60 min) showed an increase using polysomes and remained fairly 
constant using poly(A) RNA, relative to undialysed M.D.L. After the 
first buffer change, however, incorporation with both polysomes and 
poly(A) RNA declined consistently in dM.D.L. samples. After 180 
minutes of dialysis, incorporation with polysomes was lower than 
incorporation measured with M.D.L. prepared from undialysed 
reticulocyte lysate. Incorporation with poly(A) RNA had fallen to 
background levels by 120 min.
This fall-off in incorporation both with polysomes and poly(A) 
RNA may be time-dependent due to inactivation of labile components.
If it is due to removal of a factor concerned with initiation, it 
suggests that incorporation with polysomes is affected by its removal 
but only when it reaches much lower levels than for poly(A) RNA.
15.12/
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15.12. Gel analysis of cM.D.L. products.
Products of cM.D.L. assays with myeloma polysomes and poly(A)
RNA were analysed by PAGE and fluorography, sometimes followed by 
scanning densitometry. As shown in Fig. 47, a comparison of 
banding patterns produced by 5563 polysome-directed cell-free 
products in M.D.L, and cM.D.L. shows many similarities. This was 
more evident by comparison of fluorographs visually than by 
densitometry, where a high background tended to obscure detail.
This high background may be due to premature termination in the 
cM.D.L. resulting in many heterogeneous'peptide sizes forming a 
uniform background to those polypeptides synthesized as normal.
The banding pattern obtained with incorporated radioactivity in 
response to 5563 poly(A) RNA was much simpler. Above an even 
background of radioactivity, only one major band, corresponding to L 
chain precursor, was visible. This appeared to be the only message 
translated in sufficient quantities to yield a recognisable band.
It has been shown that cM.D.L. lacks some factor required for normal 
levels of initiation. Consequently, it is suggested by this result 
that only those mRNA's present in large numbers are translated. 
Alternatively, only those mRNA's with the most favourable initiation 
constants are translated. The second hypothesis would support the 
findings of Nuss and Koch (1976) and of Sonenshein and Brawerman 
(1976a,b) that L chain mRNA is less affected by factors tending to 
block initiation of protein synthesis. They do not, however, agree 
with results obtained in this project with Pi.17 poly(A) RNA 
(Results 9) which suggested that under conditions of inhibition of 
initiation, H chain mRNA was a better initiating message. Admittedly, 
however/
FIG. 47 ; PAGE analysis of cell-free products directed by 
5563 polysomes or poly(A) RNA in cM.D.L.
5563 polysomes or poly(A) RNA were assayed in G-25 
Sephadex cM.D.L. under standard conditions (Methods 7.2.) 
and analysed by PAGE and fluorography (Methods 9.2.6. and
8.3.1.).
Well 
1 )
) Cell-free products of 5563 poly(A) RNA in cM.D.L.
2 ) ■(12,000 counts/min/we11).
3 )
) Cell-free products of 5563 polysomes in cM.D.L.
4 ) (120,000 counts/min/we11) .
5-8 Cell-free products of 5563 polysomes in cM.D.L. 
(second gel; lower exposure).
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however, the two results were obtained with mRNA from two different 
cell lines.
15.13. Conclusion.
The aim of the attempts described above to remove endogenous 
amino acids from reticulocyte lysate was to produce a cell-free 
system which would incorporate high levels of radioactive amino 
acids.- Such a system could be used to label polypeptides to an equal 
specific activity in many amino acids, hence allowing amino acid 
sequencing to be readily carried out. While the system developed 
so far has little capacity for translation of poly(A) RNA, a measure 
of success was achieved in labelling cell-free products directed 
by polysomes to high level. Several improvements to the system to 
allow translation of poly(A) RNA are discussed later (see Discussion).
DISCUSSION
1. The existence of precursor sequences on secreted proteins.
Part of the intention of this project was to investigate the 
primary translation products of mRNA from several myeloma cell lines, 
using a heterologous cell-free protein synthesizing system. In 
particular, evidence was sought for the synthesis vitro of higher 
MW precursors to Ig H and L chains.
1.1. Ig L chain precursors and their nature.
As was reviewed in the Introduction (5.4.2.) the evidence for 
the synthesis of a precursor to Ig L chains in cell-free systems 
is strong. Precursors to L chains (pre L chains) have been 
demonstrated to be synthesized in a variety of cell-free systems, 
using mRNA isolated from a wide range of murine myelomas (see Table 
2). Their identity as precursors to mature L chain has been 
established by a number of techniques
a) Most importantly, amino acid sequence analysis has revealed, 
either in part or in whole, the amino acid sequence at the N-terminus 
of a number of cell-free synthesized Ig L chains (see Fig. 1).
These studies, mainly by Schechter and his coworkers, have demon­
strated the existence, at the N-terminus of cell-free synthesized 
L chain, of ^20 amino acid residues not found in the corresponding 
mature L chain.
b) Tryptic mapping of cell-free synthesized L chains from 
several myeloma cell-lines (Stavnezer and Huang, 1971; Milstein
et al., 1972; Schechter, 1973) indicated the existence of a peptide 
in/
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in the cell-free product with altered properties in electrophoresis 
and chromatography. It suggested that this peptide was located at 
the N-terminus.
c) Immunoprécipitation of cell-free synthesized pre L chain 
with antisera specific for the cellular L chain established that the 
cellular and cell-free products were closely related antigenically.
d) Mobility studies indicated that the L chain produced in 
cell-free systems was of a higher apparent MW than the mature 
cellular L chain. This was the first but least satisfactory piece 
of evidence for the synthesis of precursors to secreted proteins
in cell-free systems.
Evidence that these cell-free products may be synthesized as 
a normal part of the vivo process comes from a number of sources.
1. The determination of the N-terminal amino acid sequence of
several cell-free precursors to L chain has indicated that the cell- 
free product is not synthesized following an incorrect initiation 
of translation; the precursors contain methionine as their N-terminus, 
suggesting initiation occurs at an AUG codon. The L chain amino acid 
sequence following the precursor sequence is identical with the 
sequence of the mature L chain, suggesting that translation in the 
cell-free system is in the correct reading frame. It could be 
argued that there perhaps exists a secondary initiation site on the 
mRNA's which is only exposed or favoured for initiation as a result 
either of the mRNA isolation procedure or due to the conditions 
prevailing in the cell-free systems. The amino acid sequence data 
rule out this possibility. In the precursor, the only methionine 
is found at the N-terminus, and the precursor and L chain sequences 
are/
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are consecutive. In mature L chain no methionine is found at the 
N-terminus. Since, in general, eukaryotic mRNA's initiate protein 
synthesis at methionine,the pre L chain must be the precursor to 
the mature L chain. Models in which mature L chain is formed by 
removal only of an N-terminal methionine (as occurs in the synthesis 
of globin) are ruled out.
2. It has been shown that membrane fractions have the ability 
to cause the cell-free products of L chain mRNA translation to be 
synthesized as apparently mature size L chain (Introduction 5.4.1,). 
In most cell-free systems, an absence of membrane material exists. 
Consequently, these systems are unlike the normal environment of the 
L chain mRNA. The presence of membranes, either by virtue of the 
cell-free systems used (Swan, Aviv and Leder, 1972) or by deliberate 
addition (Dobberstein and Blobel, 1977) mimics to some extent the 
physiological conditions. It is difficult, however, to demonstrate 
a precursor-product relationship between pre L chain and mature
L chain material in this system. Consequently, it could be argued 
that the formation of an apparently mature L chain was merely the 
result of non-specific proteolytic cleavage of a particularly 
susceptible peptide bond in the cell-free product. Until amino 
acid sequence analyses have been performed of L chain material 
processed in cell-free systems by membranes, it cannot be stated 
that the processing events observed are physiologically significant.
3. Schmeckpeper et aA., (1975) have provided some evidence, based
on mobility data and serological evidence, that in a myeloma cell 
line incubated in the presence of a protease inhibitor, the 
existence of a precursor to L chain can be demonstrated. While 
this/
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this is indicative of an vivo occurrence of pre L chains, 
several ambiguities remain. Firstly, only one out of five cell 
lines examined (MOPC 41A) showed the appearance of a precursor under 
conditions of protease inhibition. Secondly, only one protease 
inhibitor was effective in demonstrating this precursor. Thirdly, 
only mobility data were used to compare the cell-free pre L chain 
and the cellular species. Until these points have been cleared up 
it is too early to claim positive proof of an occurrence of pre L 
chain as an in vivo precursor to L chain.
Admittedly, the demonstration of a precursor-product relation­
ship will be difficult if synthesis and processing are closely 
linked events. A demonstration of this relationship might be made 
by showing, for example, that the membrane-mediated cleavage of 
pre L chain to L chain was an event dependent on the time of addition 
of membranes (see Rothman and Lodish, 1977).
In this study, both mRNA and polysomes from three cell lines 
have been studied, viz. Pi.17 (including clones Pi.17.1 and PI,17.4), 
5563 and SAMM 368. Both mRNA and polysomes have been shown to direct 
the synthesis of cell-free products, which are thought to be 
precursors to mature L chain by several criteria,
1, Their quantitative occurrence in cell-free products is similar 
to their quantitative occurrence intracellulariy (Results 7.3.),
2, Their mobilities are lower than those of cellular L chains, 
in agreement with the findings of other workers (Results 7.3.).
3, They are serologically related to cellular L chain, being 
specifically precipitated (both directly and indirectly) by antisera 
directed against the appropriate mature L chain (Results 8.2.1. and 
8.2.2.)/
;8.2 IL) .
4. When 5563 pre L chain is digested with trypsin, radioactively labelle.
peptides show similar electrophoretic and chromatographic properties 
to peptides obtained by digestion of cellular L chain (Results 14.3.).
The tryptic digestion/peptide mapping result requires 
comment. Although the mobilities of the spots found by fluoro­
graphy were not identical for the cell-free and cellular L chain 
material, the pattern of spots was the same. It is possible that 
the varying mobilities were due to differences in silica gel plates 
used. This could be tested in future by separating mixtures of 
cell-free and cellular peptides on one plate in addition to 
separating the cell-free or cellular material individually.
Alternatively the differing treatments for isolation of the mature 
L chain (Methods 10.3.) and of the cell-free pre L chain (Methods
9.2.7.) could have altered the propoerties of the peptides subsequently 
generated. For example, the retention of SDS on the cell-free 
peptides might alter their mobility both in electrophoresis and 
chromatography. Extra radioactive spots in the cellular L chain 
peptide map were thought to be contaminating H chain spots. This 
was because of their general similarity in distribution to the peptide 
map of cellular H chain and because of the known difficulties in 
resolving H and L chains completely on G-lOO Sephadex.
Further data on the nature of 5563 pre L chain was obtained by 
dansylation studies of radiolabelled 5563 pre L chain (Results 13.6.).
These suggested that the N-terminal amino acid of the pre-L chain 
isolated from M.D.L. was not methionine. This does not necessarily 
imply that the initially translated product did not contain an 
N-terminal/
N-terminal methionine. As Schechter ejt a^.found (see Fig. 1.) using 
the Krebs ascites cell-free system, some myeloma pre L chains contain 
labile N-terminal methionines. Moreover, the reticulocyte is known 
to contain enzyme which rapidly remove N-terminal methionine from 
newly synthesized globin chains (Jackson and Hunter, 1970). Hence 
the absence of an N-terminal methionine may reflect post-translational 
processing. That the absence of N-terminal methionine was 
characteristic of a majority of 5553 pre L chain was suggested by 
the non-appearance of an additional radioactively labelled spot in 
tryptic mapping studies (Results 14.3)'.
Consequently, it was concluded in this project that myeloma 
L chain mRNA from all cell lines studied is translated in the M.D.L. 
as a higher MW precursor to cellular L chain. Moreover, in at least 
one case (5563), it appears to undergo removal of its N-terminal 
methionine, possibly as a result of processing by the cell-free system.
1.2. Ig H chain cell-free products and their nature.
The evidence for the existence of an additional precursor 
sequence at the N-termini of cell-free synthesized Ig H chains is 
at present debatable (Introduction 5.4.3.). In this respect, the 
effect of carbohydrate residues on cellularly synthesized or 
secreted H chain has sometimes been ignored (e.g. Bedard and Huang, 
1977) or not considered properly (Schmeckpeper at ad., 1977). 
Alternatively, the cell-free systems used for translation studies 
have been unsuitable for the drawing of rigorous conclusions 
(Cowan and Milstein, 1973).
In/
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In this project, an attempt was made to measure the relative 
effect of those mobility differences between cellular and cell-free 
H chain caused by lack of carbohydrate and those caused by the presence 
of a precursor sequence. The results obtained for each cell line 
used will be discussed separately.
In the M.D.L. cell-free system, 5563 polysomes or poly(A) RNA
consistently synthesized a polypeptide migrating on PAG's in the
region in which cellular H chain migrated (e.g. Results 7. &
8.2.1.). Although precipitation was. not quantitative, both direct
(Results 8,2*2)
immunoprécipitation (Results 8,2.1.) and indirect immunoprécipitation^ 
indicated that this polypeptide corresponded to the cell-free 
synthesized H chain. Measurement of mobilities suggested that it 
had a slightly lower apparent MW than cellular or secreted H chain.
This mobility difference could be further investigated, using lower 
percentage PAG's to improve the relative separation involved.
Alternatively, cellular and cell-free products could be mixed and 
co-electrophoresed to attempt to demonstrate this difference. The 
large number of polypeptides migrating with approximately the same 
mobility might, however, make interpretation difficult. The 
possibility that the mobility change was caused by lack of carbo­
hydrate addition, was investigated by the use of 2-deoxyglucose to 
block carbohydrate addition vivo. Again, PAGE analysis showed 
a small increase in the mobility of H chains synthesized by cells 
radioactively labelled in the presence of 2-deoxyglucose (Results 11).
Such H chains, however, appeared not to be well resolved by PAGE.
The possibility exists that these H chains are more susceptible to 
proteolysis, due to lack of carbohydrate. A direct comparison 
between cell-free synthesized 5563 H chain and 5563 H chain from 
2/
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2-deoxyglucose treated cells will be required before the question 
of the existence of precursors to 5553 H chain can be settled.
Peptide analysis of tryptic digests of 2-deoxyglucose-treated 
cellular H chain and cell-free H chain did not yield unambiguous 
results as to whether extra peptides (or peptides with altered 
mobility) occurred in cell-free H chain. This may have been due 
to the possible technical problems discussed earlier for L and 
pre L chain (Discussion 1.1), or alternatively may have reflected 
the fact that many other polypeptide species could contaminate cell- 
free H chain isolated from PAG's.
Using the cell line Pi.17, it was shown that the cell-free 
synthesized H chain had higher mobility (i.e. lower apparent MW) 
than the H synthesized ini vivo. The main evidence for this came 
from a study of the banding patterns obtained on PAG's using 
cellular Pi.17 products and the cell-free synthesized products from 
the cell lines Pi.17.1 and Pi.17.4 (Results 10). The presence was 
noted in the products of Pi.17.1 of a polypeptide species with a 
mobility greater than that of cellular PI.17. H chain. The absence 
of such a species in the products of Pi.17.4 (which synthesizes only 
Pi Ig L chains) strongly suggested that this species was the cell- 
free H chain. Immunoprécipitation studies of the M.D.L. products, 
however, have not so far been sufficiently free of non-specific 
precipitation to allow unambiguous identification of this species 
(data not shown). Another line of enquiry as to the nature of 
this qjecies could be developed by comparing its mobility with that 
of Pi.17 H chain produced by cells in the presence of 2-deoxyglucose. 
So far, the results obtained from these studies have not proved 
unambiguous/
unambiguous (data not shown).
Translation of polysomes from SAMM 368 polysomes resulted in 
the synthesis of two prominent polypeptide species with mobilities 
greater than the cellular a and y chains, previously identified by 
immunoprécipitation (Results 12). Specific precipitation of
M.D.L, samples with anti-a antiserum identified the two species as 
being antigenically related to a  and y chains (anti-a antiserum 
had been shown previously to cross-react with the y-type H chain.)
Some-non-specific precipitation appeared to occur with both anti-K 
antiserum and normal rabbit serum in the H chain regions of the gels 
but it did not have a similar mobility to the positions of cell-free 
a or y chains. The mobility of the cell-free a chain seemed to be 
relatively more greatly increased compared to the cellular a chain 
than did the mobility of the cell-free y chain.
These results could also be extended by investigations with 
2-deoxyglucose. Especially interesting in this respect would 
be the relative effect on a  and y chain mobility, bearing in mind 
the different extents to which carbohydrate addition occurs on 
different H chain classes (y>a>y, in general).
The drawback to the demonstration of the existence of H chain 
precursors by mobility studies has been the problem of distinguishing 
between the effects caused by changes in two different processes 
brought about by cell-free translation. Non-addition of carbohydrate 
would tend to decrease the apparent MW (and increase mobility) while 
non-removal of a putative precursor sequence would tend to increase 
the apparent MW (and decrease mobility).
It may prove difficult to resolve the effects of these 
processes sufficiently by mobility determination to allow an 
unambiguous/
unambiguous decision about the existence of a precursor sequence.
Even tryptic mapping studies could still lead to ambiguous results. 
For ultimate proof, the only unambiguous data might come from 
amino acid sequence analyses of the N-terminus of the cell-free and 
cellular H chains to discover whether a hydrophobic precursor 
sequence is present in the cell-free H chain but not in the cellular 
H chain. Given the small amounts of material involved, this 
sequencing could be most easily carried out using radioactively 
labelled material. It was with this aim in mind that gel filtration 
experiments were carried out on M.D.L. in an attempt to reduce 
endogenous amino acid pools. This would then allow the labelling 
of cell-free products to a fairly uniform specific activity with 
radioactive amino acids. Such material would be suitable for 
sequencing studies (Results Section 15.).
1.3. Speculations on the role of the "signal" peptide.
As shown in the Introduction (Table 1), precursor sequences 
at the NH^-terrainus of almost all secreted proteins and polypeptides 
so far synthesized are a well-established phenomenon of cell-free 
translation studies. The original idea that all such "signal" 
sequences would be identical (Blobel & Sabbatini, 1971) has now 
been shown to be wrong, as a result of amino acid sequencing data. 
"Signal" sequences vary widely in amino acid composition among 
different secreted proteins, although their length appears to be 
relatively homogeneous(^ 18 - 25 amino acids). Signal sequences 
do not appear to be strictly conserved even within the same cell 
type/
type. Devilliers-Thiery e]b aA., (1975) found heterogeneity 
between the sequences of "signal" peptides of dog pancreas secretory 
proteins, whilst Schechter's group have demonstrated wide sequence 
variability between the "signal" sequences of various myeloma L 
chain precursors (see Fig. 1.). It may, however, be argued that 
Ig L chains form a special case (see later). The basic point of 
similarity between "signal" peptides so far sequenced has been the 
high level of hydrophobic residues found. It has been speculated 
that this is a feature of "signal" peptides which is recognised 
by membrane receptors (Blobel and Dobberstein, 1974a), Rothman 
and Lodish (1977) have recently demonstrated that binding of polysomes 
containing a viral RNA-directed membrane protein to membranes,occurs 
after only a small portion of the polypeptide chain has been 
synthesized. While, in this case, it has not been demonstrated 
that the protein synthesized contains a precursor sequence, the data 
are consistent with the presence of a hydrophobic signal peptide on 
the protein. Palmiter (1977) has also claimed that transfer of s 
secreted proteins through membranes begins before the completion 
of translation. Hence, the evidence is suggestive of a membrane 
binding role Jfor the "signal" peptide.
It has been suggested (Blobel and Dobberstein, 1974a) that 
the signal peptide is removed rapidly after its appearance on the 
lumen side of the endoplasmic reticulum, but the characteristic of 
the signal peptide which allows its specific removal without 
protease digestion of the mature polypeptide is not clear. The 
balance of evidence suggests that processing of precursors to 
mature/
1mature polypeptides is not highly sequence specific. Dobberstein
and Blobel (1977), for example, have demonstrated the apparently 
correct processing of murine Ig pre L chain synthesized on wheat 
germ ribosomes in the presence of dog pancreas microsomes. The 
Krebs ascites system, moreover, has been shown to process murine Ig 
pre L chain as it is synthesized in the system (Swan, Aviv & Leder, 
1972). Admittedly, the suggestion that processing is completely 
accurate comes only from mobility studies by PAGE which might be 
unable to distinguish small discrepancies in MW (e.g. 'v 5 amino 
acids which is the difference in length between pancreatic secretory 
protein "signal" peptides and murine Ig L chain "signal" peptides). 
Nevertheless, it would seem likely that processing is a phenomenon 
of wide occurrence but is relatively independent of amino acid 
sequence. More likely, the "signal" peptide, upon appearance 
within the lumen,rapidly assumes a particular three-dimensional 
configuration as a small "domain" which is linked to the emerging 
mature polypeptide chain by several exposed amino acids. These may 
well be labile to protease attack by virtue of their exposed position. 
A model involving exopeptidase digestion appears to be ruled out by 
the discovery by Dobberstein et al., (1977) of a small peptide 
corresponding to the signal peptide in cell-free studies of the 
synthesis of a chloroplast-specific protein.
The evidence presented in the Introduction (Section 5.4.1.) 
suggests that precursors are found on almost all secreted proteins. 
While this project has not unambiguously demonstrated the existence 
of a precursor sequence on Ig H chains synthesized in cell-free 
systems, it is important to consider what form (if any) it might 
take/
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take. The most interesting point would be whether Ig H and Ig L 
chains produced by the same cell have identical precursor sequences. 
The evidence of Devilliers-Thiery ad., (1975) suggests that in
dog pancreas, secreted proteins do not necessarily have identical 
precursors (although this may reflect the different celX species 
present in the organ). Moreover, the evidence of Schechter (1977) 
suggests that in myeloma-L chains sequence variation among precursors 
so far sequenced is as great as is found among the mature L chain 
hypervariable regions. Consequently in Ig L chains (and hence, 
possibly, Ig H chains) the precursor may have to be considered as 
an extension of the variable region. Ig H and L chains from the 
same cell line (e.g. MOPC 315) have been shown to have different 
Variable regions. Hence, one would predict different precursor 
regions.
In cell lines producing two classes of H chains in the same 
cell (e.g. SAMM 368) sequence analysis would demonstrate whether the 
same variable region (and so the same precursor sequence) was found 
in both classes of H chains.
2. Effect of inhibitors of initiation on relative H and L chain
production.
Two major experiments carried out in this project pertain to 
studies of translational control. These experiments have involved 
the use of inhibitors of initiation to study the relative synthesis 
of H and L chains and the relative synthesis of Ig and non-Ig 
protein on a cell-free system under conditions in which initiation of 
protein/
protein synthesis is limiting.
It was first of all established by PAGE analysis that the cell- 
free products directed by myeloma polysomes or poly(A) RNA showed 
qualitative similarity to the cellular products (Results 7.3.). 
Consequently, translation in the M.D.L. was used as an analogue 
of the in vivo situation. It was also established by immuno­
précipitation techniques that the percentage of protein synthesis 
(directed by myeloma mRNA in the M.D.L.) which was devoted to the 
production of Ig-like material was approximately the same as was 
found intracellularly (Results 8.2.4.). With 5563 the percentage 
was similar, although with Pi.17 it was slightly less.
As shown in Results 9.1 and 9.2, both ATA and pactamycin 
had similar effects on the relative synthesis of Ig H, Ig L and 
non-Ig products.
ATA is an inhibitor of the initial binding of mRNA to the 
40S-met-tRNA^ complex. When used at the same concentrations as 
those employed by Lodish (1974) for investigations on a and g globin 
synthesis, ATA inhibited the synthesis of Ig H and L chains much less 
severely than non-Ig species. By the Lodish hypothesis, this 
suggested that Ig H and L chain mRNA's were better initiators of 
protein synthesis than non-Ig mRNA's. This is in agreement with 
the results of Nuss and Koch (1976) with an in vivo system and also 
with the results of Sonenshein and Brawerman (1976a) also vivo. 
Sonenshein and Brawerman's in vitro results (1976b) also concur 
with these conclusions although their interpretation is hampered 
by poorH chain (and high MW species) translation in their cell-free 
system. Such an effect suggests that, in general, proteins 
produced/
produced in large quantities by differentiated cells may be 
translated from mRNA's with higher than average initiation constants. 
This would ensure preferential synthesis of these proteins even under 
circumstances unfavourable to protein synthesis in general, e.g. 
starvation. It may also explain why, for example, Ig production 
can occur at such a high level in tumour cells, where Ig production 
is non-essential. Other proteins produced for maintenance of 
cellular metabolism and integrity may, in general, prove to be 
translated from mRNA's with poorer initiation constants since their 
synthesis may only be required at low levels in normal circumstances, 
and may be "turned off" in conditions of starvation.
This does not take account of situations where increases
in the rate of synthesis of all cellular proteins are required
naturally (as in differentiation) or pathologically (as in cancer).
Under these circumstances, replacements of initiation factors may 
occur.
With ATA, H chain synthesis was relatively less inhibited
than L chain synthesis in the M.D.L. This may imply that the H
chain mRNA is intrinsically a better initiator of protein synthesis 
than L chain mRNA, at least in the cell line Pi.17. Nuss & Koch 
(1976) and Sonenshein:. & Brawerman (1976a) concluded that in the cell 
line MPC 11, L chain mRNA is a better initiator than H chain mRNA. 
Moreover, in this project, translation of 5563 poly(A) RNA in the 
cM.D.L. (a system in which conditions are unfavourable for the 
initiation of translation of most species of mRNA), 5563 Ig L chain mRNA 
was nevertheless translated (Fig.47). This suggested that in 5563,
L chain mRNA has better initiating properties than H chain mRNA.
These/
These results suggest that, while in those myeloma cell lines 
studied,Ig mRNA’s are better initiators of translation than non- 
Ig mRNA's, variation in the initiation properties of H chain and 
L chain mRNA's may exist.
Pactamycin, the other inhibitor studied, acts to block 
protein synthesis subsequent to formation of the mRNA-40S-met- 
tRNA^ complex. In fact, it has been demonstrated that the initial 
dipeptide coded for by mRNA's can be formed (Goldberg et al., 1973; 
Cheung ^t ad., 1973) but thereafter protein synthesis ceases, due to 
an inhibition of translocation. According to Lodish's hypothesis, 
inhibition at this stage should not lead to preferential 
initiation by better initiating mRNA's.
The results obtained in this project (Results 9.2.) with 
Pi,17 poly(A) RNA in M.D.L, inhibited by pactamycin do not agree with 
the model proposed by Lodish. Using a concentration range, 
including those levels of pactamycin investigated by Lodish (1974) 
with globin synthesis, it was found that Ig synthesis in M.D.L. is 
less inhibited than non-Ig synthesis. Moreover, it was again 
shown that H chain synthesis was relatively less inhibited by 
pactamycin than L chain synthesis. The findings with Ig and non-Ig 
synthesis are not directly comparable with Lodish's results with 
globin. The resistance to inhibition of H chain synthesis relative 
to L chain synthesis, however, appears to contradict the results 
obtained by Lodish for a and g globin which he interprets in the 
light of his model. A possible explanation was that the levels 
of pactamycin used caused inhibition of elongation steps also.
The concentration range used included, however, as noted above, the 
levels/
levels used by Lodish. Moreover, the inhibition did not seem to have 
the same characteristics as elongation inhibition by cycloheximide 
in myeloma cells, viz. approximately equal inhibition of Ig and nnn-Ig 
synthesis. This comparison was not strictly valid, however, and it 
could still be argued that elongation was being inhibited. This 
would imply, however, with mRNA's being translated in proportion to 
their abundance, that a large excess of poorly initiating Ig mRNA's 
occurred in the normally growing cell. The results obtained with 
ATA, however, suggested that Ig mRNA's are good initiators of 
translation.
It may prove necessary to extend the scope of the Lodish model. 
The initiation constant , which governs the rate of initiation of 
any particular mRNA, may prove to cover all processes up to and 
including the first peptide bond formation, rather than the steps 
leading merely to the formation of the mRNA-40S~met tRNA^ complex.
This seems possible since all the steps up to and including the first 
peptide bond formation are unique events in the translation of any 
mRNA. Contrasted with this are subsequent elongation and termination 
reactions which are essentially either repetitive processes 
(elongation) or common processes for all mRNA's (termination).
Further study of the initiation process could be carried out 
with inhibitors specific for other steps in initiation.
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3. Improvements in systems .
3.1. Immunoprécipitation.
One of the major problems encountered in this project, and one 
not wholly overcome, was concerned with immunoprécipitation 
techniques. Two methods of immunoprécipitation - direct and indirect, 
were compared. Direct immunoprécipitation was found to have 
variable efficiency but was generally much less efficient than indirect 
immunoprécipitation. Indirect immunoprécipitation, using unfraction­
ated' rabbit antiserum and goat antiserum, was found to be very efficient 
in precipitation of specific proteins from cell lysates and cell-free 
systems (less so in cell-free systems) but involved the formation of 
a large precipitate. Such large quantities of protein in 
precipitates resulted from the specificity of the second antiserum 
for total rabbit IgG and from the unfractionated nature of the first 
antiserum. The large protein precipitates formed tended to cause 
problems of non-specific trapping of radioactivity, especially from 
the cell-free system,and overloading of Laemmli gels. Improve­
ments in immunoprécipitation would be made as follows. Preparation 
of purified rabbit antibodies with specificity for 5563 or Pi Ig 
could be obtained by passing the unfractionated antiserum over a 
column of Sepharose beads linked to pure 5563 Ig or Pi Ig. This 
would not decrease the size (amount) of primary complexes formed, 
but would reduce considerably the amount of goat antiserum required 
to precipitate these primary complexes. This would help reduce 
the amount of protein precipitated/unit of radioactivity precipitated.
A lowering of the protein : radioactivity ratio would mitigate the 
overloading problems found with immunoprecipitates on PAG's.
Alternative/
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Alternative methods of relieving this problem are discussed below.
3.2. Cell-free system.
As was demonstrated, (Results 4.5. ) the M.D.L. cell-free
system is highly efficient in its translation of added poly(A) RNA 
and also translates added polysomes well. Initiation and re­
initiation of protein synthesis appeared to be no problem with the 
M.D.L. (Results 4.5.). One drawback to the system was the presence 
of large pools of endogenous amino acids in the system. These 
were observed as a result of amino acid analysis studies (Results 
4.3) although only the level of methionine was measured (700 pmoles/ 
50pl).
These pools reduced considerably the specific activity of 
added radioactive amino acids and were, moreover, of variable size 
(data not shown).
Various procedures could help to overcome this problem. The
35use of much higher quantities of radioactively labelled L( S) 
methionine (e.g. 250yCi/50iil assay rather than 'v25yCi/50yl assay) . 
would increase the added methionine to a similar order of magnitude 
to the endogenous methionine pool size, e.g.
35Specific activity of L-( S) methionine = 1000 Ci/mmole
= lyCi/pmole 
.’.250 yCi = 250 pmoles
Endogenous pool size = 700 pmoles
35In this way, a much higher percentage of the added L-( S) methionine 
would/
would be incorporated, assuming total protein synthesis remained
constant.
35
e.g. L-( S) methionine incorporated (25yCi/assay) = 5 pmoles
" unlabelled " " " = x 5
25
= 140 pmoles
Total incorporation = 145 pmoles (20%) of total methionine present)
35
but if 250yCi (= 250pmoles) L( S) methionine added,
and total incorporation was 20% of the methionine added = 190 pmoles
pmoles L-(^^s) methionine incorporated = x 190 = 68 pmoles
= 68 yCi (~33%)
In situations such as this, account must be taken of solutes present 
35in the L-( s) methionine solution. KCl is present at 20mM
concentration; adding 5yl (^25yCi) to a 50yl assay adds 1.8mM
to the KCl concentration which is relatively small (normal KCl
35
concentration 95mM). Addition of 250yCi of an L~( S) methionine
solution (lyophilised) to a 50yl assay, however, increases the KCl
concentration by 'v20mM which would significantly affect incorporation
(Results 4.2.). Moreover, lyophilisation must also remove small
quantities of 2-mercaptoethanol present in the solution. It was
noted, although not systematically investigated, that assays
35
containing diluted L-( S) methionine or containing a lower percent- 
35age of L-( S) methionine solution, by volume, generally gave higher 
levels of incorporation of radioactvity/pmole mRNA added. It was 
thought that 2-mercaptoethanol might have a depressive effect on 
protein synthesis.
An alternative method of increasing incorporation of 
radioactivity incorporated would be to reduce the volume of M.D.L. 
used/
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used, whilst keeping the amount of hi S) methionine (lyophilised)
constant. Hence a lOyl assay should increase the final assay
35specific activity of L-( S) methionine 5-fold. A combination 
of the two methods described above should have an even greater 
effect.
3.3. Gel filtration of M.D.L.
Another method of increasing the specific activity of the 
assay methionine concentration was, however, sought. This was done 
with a view towards preparing a cell-free system which would allow 
radioactive labelling of all the amino acids to a constant level.
This step would allow amino acid sequencing studies to be carried 
out.
Analogously with various other cell-free systems, (e.g. 
wheat germ, Krebs II ascites), the use of a G-25 Sephadex filtration 
step was investigated. As described in Results 15 , the
removal of small molecular species (including amino acids) by this 
method was only partially successful as a means of increasing 
incorporation of radioactivity. Gel-filtered M.D.L. (cM.D.L.), 
in general, displayed a marked stimulation in the level of 
incorporation of radioactivity using polysomes compared to unfiltered 
M.D.L. but relatively little, if any, stimulation using poly(A) RNA. 
This suggested the removal, by gel filtration, of some low MW 
component (or components) necessary to promote initiation of 
translation.
ATA/
ATA inhibition studies of polysome translation in cM.D.L. 
(Results 15.6. ), showing 33% of synthesis was sensitive to
inhibition of initiation, suggested that gel filtration did not 
completely remove this component (alternatively the polysomes con­
tained this component) as did the demonstration of translation of 
poly(A) RNA, although translation was at a low level. As the 
experiments described in Results 15.7 and 15.9 suggested, several 
low MW species can be ruled out as the required molecules, e.g.
ATP, GTP, reducing agents (DTT).
The possibility of damage or inactivation of various 
components of protein synthesis had been ruled out in several 
experiments (tRNA, 0.5M salt wash factors, haemin concentration). 
That the inhibition of initiation was concentration-dependent was 
demonstrated by mixed M.D.L.:cM.D.L. assays of reticulocyte mRNA 
(Results 15.10). Only above levels of 50% (v/v) M.D.L./assay was 
significant incorporation of radioactivity detected. The role 
of the gel filtration step in causing the inhibition (e.g. by 
leaching out of an inhibitory substance) was checked by an 
alternative method of removing low MW species (dialysis) and found 
to be unimportant (Results 15.11).
Consequently, the conclusion drawn was that some low MW 
component (or components), which were partially removed by gel 
filtration (but were not added back to the lysate before making 
cM.D.L.) were required for initiation of protein synthesis. Such 
a requirement was concentration dependent; below a certain 
concentration, initiation of protein synthesis decreased abruptly. 
This implied a possible aliosteric mechanism, perhaps involving 
cooperative/
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cooperative effects, acting on a protein synthesis component.
After the completion of the work in this project, two 
pieces of information pertinent to this discussion came to light. 
Firstly, it was reported briefly in a review by Hunt (1976) that 
G-50 Sephadex filtration of reticulocyte lysate removed the capacity 
for protein synthesis. This capacity, however, was found to be 
restored by the addition to the filtered lysate of any of a range 
of intermediary metabolites (glucose, citrate, fructose-1,6
diphosphate). Also particularly helpful was DTT (not found so 
in this study), while c-AMP removed the inhibition completely.
This finding was subsequently confirmed by D. Wilde (personal 
communication) who also found that polyamines (spermine, spermidine) 
were essential for activity.
It can be envisaged that in a system, such as the rabbit 
reticulocyte, which is dependent on a constant flow of inter­
mediary metabolites for its energy supply, any shortage of an inter­
mediary metabolite would require a rapid cut-back in non-essential 
energy-requiring processes in order to maintain essential processes 
(e.g. maintaining correct ion levels by "ion pumps").
Protein synthesis is a relatively non-crucial process in 
reticulocytes (at least in the short term) compared, for example, 
to the maintenance of ion gradients. It requires, moreover, large 
quantities of energy for its functioning. It would therefore seem 
a convenient process to inhibit during energy starvation.
Conditions mimicking starvation are brought about by gel filtration. 
Although an energy source is then supplied (creatine phosphate/ 
creatine/
creatine kinase/ATP/GTP) , the absence of normal levels of inter­
mediary metabolites may cause inhibition. This suggests a normal 
situation of feed-forward activation of protein synthesis, by one 
or more of the metabolic intermediates of glycolysis, may obtain. 
Alternatively, some less direct control of protein synthesis via 
{amp},for example, may be exerted.
The initiation of translation was not entirely inhibited.
As Results 15.12 demonstrated 5563 L chain mRNA appeared to be 
translated in cM.D.L. in the absence of any other translation.
This may indicate that 5563 L chain mRNA is an extremely efficient 
initiator of protein synthesis (Discussion 2). It may offer a 
method of easily isolating 5563 L chain mRNA from myeloma cell mRNA 
mixtures. Myeloma mRNA could be added to cM.D.L. and after a short 
incubation, polysomes could be removed by centrifugation. These 
polysomes should contain only mRNA for L chain. If this is a 
general phenomenon, it might be applied to mRNA of other cell 
types (e.g. Pi.17).
4. Future experiments.
The way towards deciding the question of whether Ig H chain 
contains a precursor sequence when synthesized in cell-free systems 
is now clear. Preliminary comparisons of cell-free synthesized 
H chain with cellular H chain lacking carbohydrate should provide 
qualitative mobility and peptide-mapping data on the nature of 
differences between the two products.
Development of the cM.D.L., with the improvements noted by
other/
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other workers, should allow the use of the system as a means of 
producing Ig H and L chains, radioactively labelled with amino acids 
of equal specific activity, and suitable for amino acid sequence 
analysis. This will provide quantitative evidence to corroborate 
any findings from the above experiments.
The translation of myeloma mRNA in the M.D.L, also provides 
a system for further investigating translational control of protein 
synthesis, and particularly the control of the synthesis of Ig H 
and-L chains, A wide range of initiation (ATA, pactamycin, dsRNA,
7-methyl guanosine, polynucleotides) and elongation (emetine, 
cycloheximide) inhibitors could be investigated and results inter­
preted in the light of current theories of translational control. 
These experiments would test and possibly extend the validity of 
Lodish's hypothesis. The use of more physiological inhibitors 
of initiation, such as starvation, could be mimicked in the cell- 
free system by 2-deoxyglucose. The effect of 2-deoxyglucose in 
M.D.L, will be interesting in view of the potential role of 
intermediary metabolites in affecting protein synthesis in the 
M.D.L.
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